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Zn2+, as the second most abundant d-block metal in the human body, plays an important role 
in a wide range of biological processes, and the dysfunction of its homeostasis is related to 
many diseases, including Type 2 diabetes, Alzheimer’s disease, prostate and breast cancers. 
Small molecule fluorescent probes, as effective tools for real-time imaging, have been widely 
used to study Zn2+ related processes. However, the failure to control the small molecule 
probes’ localisation in cells has limited their utility somewhat, as they are generally incapable 
of studying individual processes in a specific cellular location.  
This thesis presents efforts to develop cellular and subcellular localised fluorescent probes for 
mobile Zn2+ imaging. Previously reported successful efforts towards cell-localised probes are 
outlined in Chapter 1 together with other relevant background information. These include 
genetically encoded site-directing proteins and the use of site-targeting peptides, which show 
very good targeting behaviour but are not without some disadvantages.  
In Chapter 2, the development of a biotin-tagged probe is reported, which can be used to 
specifically detect mobile Zn2+ in breast cancer cells. Chapter 3 describes two novel 
endoplasmic reticulum (ER) targeting probes through the incorporation of a cyclohexane 
sulfonylurea group into the probes with different Zn2+ binding ligands. Both show excellent 
ER localisation and good fluorescence response to Zn2+ in a number of cell lines. In Chapter 4, 
a new Golgi apparatus localised probe employing a trityl protected cysteine residue as the 
targeting group is presented in which the trityl protecting group was used to increase 
transport across the cell membrane before its removal inside cells being demonstrated by 
both its sub-cellular relocation and a significant increase in fluorescence response after an 
incubation time. Chapter 5 presents the development of an alternative modular ‘click-SNAr-
click’ approach towards subcellular localised fluorescent probes, and through this new 
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method a related series of ER, mitochondria and lysosome targeting probes were synthesized 
more effectively and efficiently. There then follows a future work section, an experimental 
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Chapter 1 Introduction 
1.1 The role of Zn2+ in the human body 
Zn2+ is the second most abundant d-block metal ion in the human body with the total amount 
being about 2 g which is mostly bound to proteins. It is estimated to exist in over three 
thousand proteins and is widely used for catalytic, regulatory, and structural roles. Zinc plays 
an important part in a wide range of biological processes, such as brain function and 
pathology, immune function, gene transcription, and mammalian reproduction. Due to this, 
it is unsurprising that problems with zinc homeostasis are associated with many diseases, 
including Alzheimer's disease,1 prostate cancer,2 type 2 diabetes,3 and immune dysfunction 
and infection.4 Whilst the majority of zinc is found in bound forms, there exists a pool of 
‘mobile’ or ‘free’ zinc, which initiates transient signals that stimulate various physiological 
processes, though its concentration in the cytosol is only in the picomolar range.5 The thiol-
rich metallothioneins  (MTs) and zinc transporters are normally involved in the processes to 
maintain cellular zinc homeostasis.5 MTs acting as Zn2+ buffers, can bind a large amount of 
Zn2+ and release it under oxidative stress due to the antioxidant role it plays. There are mainly 
two families of zinc transporters, ZIP and ZNT, which control the import and export of 
cytosolic zinc to intracellular organelles or extracellular space (Figure 1.1).6 Mobile Zn2+ is 
associated with the regulation of gene expression, insulin secretion, and is also considered as 
a signalling ion for intra- and intercellular communication, such as neurotransmission.7 
Therefore, effective methods are required to image mobile Zn2+ at the cellular or subcellular 





Figure 1.1 Zinc transporters (ZIP importers and ZNT exporters) and metallothioneins (MTs) to 
control cellular and subcellular zinc homeostasis, adapted from ref. 6.  
1.2 Fluorescent chemosensors to image Zn2+ 
Since Zn2+ has a d10 configuration, it is redox inert in biology and is rendered spectroscopically 
silent for most of the commonly used photo-spectroscopic techniques.9 As a result, the 
development of fluorescent chemosensors has become popular for non-invasive real-time 
Zn2+ imaging. A typical fluorescent chemosensor contains a fluorophore (the signal source), a 
spacer and a receptor (the recognition site). A change in the fluorescence intensity or 
wavelength occurs due to analyte binding, which leads to signal output. Notably, in the 
biological environment, fluorescent chemosensors are involved in a competitive exchange 
equilibrium with endogenous ligands and proteins and thus detect changes of mobile Zn2+ 
pools rather than total cellular zinc levels. Therefore, high sensitivity with low detection limit, 
high specificity and selectivity to distinguish Zn2+ from competing metal ions are preferred. 
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There are three main types of fluorescent sensors for biological zinc imaging:  small molecule 
probes, protein-based biosensors and peptide targeting fluorescent sensors. Protein-based 
biosensors and peptide targeting fluorescent sensors can localise to specific organelles by 
introducing genetically encoded site-directing proteins and selecting specific amino acid 
sequences which have high affinity for the particular targets.8 However, they are not without 
some limitations. The genetically encoded protein-based sensors cannot be transfected into 
all cell lines, have a small range of excitation and emission wavelengths available as well as 
low photochemical stability and brightness. The peptide-based sensors are sensitive to 
proteases in vivo and cell internalization can be difficult, except for specific peptide sequences. 
In contrast, small molecule fluorescent probes can display high sensitivity and selectivity, low 
toxicity, and good photophysical properties. However, the failure to control the small 
molecule probes’ cellular or subcellular location can limit their utility somewhat.  
1.3 Mechanism of Zn2+ sensing 
The change of fluorescence intensity, fluorescence lifetime, or a shift of fluorescence 
wavelength can all be measured and are useful attributes of fluorescent chemosensors. There 
are a variety of fluorescence mechanisms that can be used in the design of chemosensors, 
such as Förster resonance energy transfer (FRET), photoinduced electron transfer (PET)  
(sometimes also termed chelation enhanced fluorescence (CHEF)), intermolecular charge 
transfer (ICT) and excited state intramolecular proton transfer (ESIPT), which have been 
widely applied for Zn2+ imaging in living systems. 
1.3.1 The PET mechanism  
PET sensors commonly adopt the fluorophore-spacer-receptor scaffold. The fluorophore is 
usually connected via a spacer to a receptor, which contains a relatively high-energy non-
bonding electron pair, such as on an sp3 hybridised nitrogen atom. In the unbound state, the 
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high-energy non-bonding electron pair can transfer an electron to the excited state of the 
fluorophore, which quenches the fluorescence response (Figure 1.2). When this electron pair 
is coordinated with a cation, the redox potential of the receptor is raised and the HOMO of 
the receptor becomes lower in energy than that of the fluorophore. Thus, the PET process 
from the receptor to the fluorophore is blocked and the fluorescence is switched on. The 
spacer holds the fluorophore and receptor close enough to allow electron transfer and is 
generally less than a three-carbon linker, which guarantees the maximum efficiency of PET. 
Most of the effective PET type probes undergo a fluorescence “switch on” response to Zn2+. 
There are a number of PET probes that have already been used to image zinc in living cells. As 
an example, the structures of two probes utilising a PET mechanism are shown in Figure 1.3. 
Probe 1, with the typical DPA (di-2-picolylamine) Zn2+ ligand10 and a Bodipy fluorophore, 
exhibited a selective fluorescence enhancement (7 fold) upon Zn2+ binding with a low pKa 
value of 2.1 ± 0.1, low dissociation constant and high quantum yield of the zinc-bound species 
(Table 1). It has been successfully applied to image intracellular Zn2+ changes in PC12 cells 
(Figure 1.4). Compound 2 is another PET-based probe with a dimethoxylcoumarin fluorophore 
and cyclen as the receptor, which displays a similar switch on fluorescence response (4.4-fold 
enhancement) on binding to Zn2+.11 Once 2 passively diffused into cells, some or all the 
pendant esters are cleaved by cellular esterase, which produced a probe with carboxylate 




Figure 1.2 Orbital energy diagram to demonstrate the ‘off’ and ‘on’ states of a generic 
fluorescent chemosensor utilising the PET mechanism. 
 




Figure 1.4 A) The fluorescence spectrum of 1 (BDA) with addition of Zn2+ in tris–HCl buffer 
solution (20 mM, pH 7.4, 100 mM NaCl), F is the fluorescence intensity; B) fluorescence 
images of PC12 cells loaded with 1 (10 µM, a) and with subsequent addition of Zn2+ (50 µM, 
b). Adapted from ref. 10 
1.3.2 The ICT mechanism 
Probes based on ICT mechanisms are often made up of a fluorophore and receptor with no 
spacer, which form a conjugated system with an electron-rich and an electron-deficient 
region. If the charge distribution in the molecule is altered there is normally an apparent 
change in fluorescence emission that can be observed. When a receptor (playing the role of 
an electron donor within the fluorophore) interacts with a cation, it decreases the electron-
donating character of the receptor and a blue shift of the emission spectrum is expected. In 
the same way, if a cation receptor plays the role of an electron receptor, the interaction 
between the cation and the receptor would further strengthen the push-pull effects, then a 
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red shift in emission would be found. This behaviour often gives ICT probes a ratiometric 
response, i.e. the emission ratio at the two different wavelengths can be attributed to cation 
concentration, and these probes can potentially quantify zinc in the sample, such as solutions, 
cells or tissues. ICT mechanisms are also often extremely solvent dependent, since polarity 
plays an important part in stabilising the electronic states of the molecule. 
Compounds 3 and 4 are two examples of ICT based probes that have been used to image zinc 
in cellular environments. 3 (SBD-TPEA) is a visible light excited ratiometric probe with TPEA 
(N,N,N'-tri(pyridin-2-ylmethyl)-ethane-1,2-diamine) as the Zn2+ chelator and ICT donor linked 
directly to the sulfamoylbenzoxadiazole fluorophore.12 When excited at 460 nm, 3 displayed 
an emission band centred at 585 nm, and a 40 nm hypochromic emission shift was observed 
upon Zn2+ binding (See Figure 1.5B). With good photophysical properties, 3 was utilised for in 
cellulo and in vivo ratiometric Zn2+ imaging in HepG2 cells and live zebrafish larvae, 
respectively. Probe 4 is based on benzothiazole-terpyridine conjugate, which showed high 
selectivity to Zn2+.13 Upon the addition of Zn2+, it showed a 42 nm emission blueshift, 
accompanied by a strong fluorescence enhancement at 500 nm and when studied by  
microscopy in HeLa cells, the probe was observed separately in the red and green channel in 




Figure 1.5 A) Structures of ICT-based fluorescent probes, 3 (SBD-TPEA) and 4; B) the 
fluorescence spectrum of 3 (3 µM, λex = 460 nm) with the addition of aliquots of Zn2+ in HEPES 
buffer (50 mM, 0.1 M KNO3, pH 7.2, containing 0.15% DMSO). Adapted from ref. 12 
 
Figure 1.6 Fluorescence images of HeLa cells with probe 4 (10 µM, a-c) and with subsequent 







1.3.3 The FRET mechanism 
Förster resonance energy transfer (FRET) is defined as a distance-dependent energy transfer 
from an excited-state fluorophore (donor) to a ground-state fluorophore (acceptor), exciting 
the acceptor which then exhibits its fluorescence. The fluorophores of the FRET pair must 
have an appropriate extent of spectral overlap between the emission of the donor 
fluorophore and the absorption spectra of the acceptor. Upon binding the analyte, the 
distance between the FRET pair can be altered, thereby altering/arresting the FRET 
mechanism, which allows for ratiometric quantification of the analyte in live cells. This type 
of mechanism is generally utilised when employing two fluorescent proteins for a FRET-based 
sensor. Alternatively, in the case of small molecule probes, it is possible to disrupt the degree 
of overlap between the FRET pair of fluorophores by altering the emission of the donor 
fluorophore upon a binding event.  
Some fluorescent probes based on the FRET mechanism have been successfully applied for 
Zn2+ imaging in cells. In probe 5, the rhodamine spirolactam is a non-fluorescent fluorophore, 
and upon binding with Zn2+, the ring-opening reaction of the spirolactam was triggered, 
generating the long-wavelength rhodamine fluorophore which acts as the energy acceptor.14 
Fluorescein is the energy donor since its emission is well-matched with the absorption 
spectrum of rhodamine, excited at its absorption wavelength (λex = 485 nm). On addition of 
Zn2+, the fluoroscein fluorescence is decreased while the emission of rhodamine is increased 
(Figure 1.7B). The probe showed excellent selectivity for Zn2+ over competing cations, even 
Cd2+, which is a common problem of the di(2-picolyl)amine ligand and preliminary 





Figure 1.7 A) Structure of 5 and its complex with Zn2+; B) The fluorescence emission spectra 
of 5 (10 μM) in the presence of different concentrations of Zn2+ in buffered (0.1 M HEPES, pH 
= 7.2) 50% aqueous acetonitrile solution (H2O/CH3CN = 1:1, v/v), λex = 485 nm; C) The images 
of Hela cells incubated by probe 5 (10 μM, a,b) and then further treated with 10 μM Zn(NO3)2 
and 20 μM pyrithione (c,d). λem = 515 ± 10 nm and λem = 590 ± 10 nm respectively. Adapted 
from ref. 14 
1.3.4 The ESIPT mechanism 
Excited state intramolecular proton transfer (ESIPT) is a process whereby photoexcited 
molecules relax through tautomerization by transfer of protons. In general, molecules 
incorporating an intramolecular hydrogen bonding interaction between a hydrogen bond 
donor and a hydrogen bond acceptor can exhibit ESIPT fluorescence. Due to its unique four-
level photochemical process, shown in Figure 1.8, probes based on an ESIPT mechanism 
usually display a large Stokes shift (~200 nm) and ability for ratiometric sensing.15 However, 
because they are very sensitive to local surroundings, particularly the presence of polar and 
hydrogen bond donating solvents which can inhibit the ESIPT process, many ESIPT-based 
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probes require a large amount of organic solvents to be operationally effective, which limits 
their use in living systems. Consequently among the ESIPT-based probes reported for Zn2+ 
imaging, there are few reports of their application in cells, however, probe 6, developed from 
the thymolphthalein fluorophore, with hydroxyl and amino groups providing Zn2+ 
coordination sites displays a good ‘switch on’ fluorescence response since the ESIPT process 
was quenched upon binding with Zn2+ (Figure 1.9) and it was successfully utilized to image 
Zn2+ in A549 cells.16 
 
 
Figure 1.8 Orbital energy diagram description of the ESIPT process. Adapted from ref. 15 
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Figure 1.9 A) The structure of probe 6 and its complex with Zn2+; B) fluorescence spectrum of 
probe 6 (2 µM) in the presence of different concentrations of Zn2+ in EtOH. Adapted from ref. 
16 
1.3.5 The restriction of intramolecular motion (RIM) mechanism 
The restriction of intramolecular motion (RIM) mechanism is proposed to explain the 
aggregation induced emission (AIE) phenomenon, which is observed in certain organic 
fluorescent dyes that show higher photoluminescence efficiency in the aggregated state than 
in solution. Since the fluorescence of most organic fluorophores are quenched when 
aggregated, the luminogens displaying the AIE phenomenon are very limited, among these, 
tetraphenylethene, tetraphenylsilole, triphenylamine derivatives are widely studied.17 This 
type of molecule usually have freely rotating groups, which provide a pathway for relaxation 
of a photochemical excited state and is the reason for their low quantum yield in solution. 
However, when aggregated or crystallised, the rotational processes are restricted, thus they 





Based on this mechanism, AIE fluorophores have been applied for Zn2+ imaging showing an 
excellent turn-on fluorescence response, for example, Ning et al. reported the ratiometric 
probe 7 (8AQ) containing a bis-naphthylamide connected by an isobutylene unit.18 Upon Zn2+ 
binding, the fluorescence showed a bathochromic shift of 106 nm (the solution colour 
changed from blue to yellow-green), accompanied by a strong fluorescence increase. In 
HepG2 cells, it displayed ratiometric fluorescence response towards exogenous Zn2+ (Figure 
1.10). 
In addition to these classical AIE systems, it has been noted that many cases of fluorescence 
quenching in small molecule probes have been automatically ascribed to PET processes 
without compelling experimental proof. However, with the advent of time-dependent density 
functional theory (TD-DFT) and complete active space self-consistent field (CASSCF) 
calculations, the potential energy surfaces of the lowest-lying excited states can now be 
studied, and it has been found the fluorescence quenching in some systems, which were 
believed to be originated by PET, should be revised to a dark-state quenching mechanism19, 
which is specified to elaborate RIM mechanisms.20 Therefore, the fluorescence quenching of 
some Zn2+ probes is probably caused by non-radiative decay due to intramolecular motions. 
After binding with Zn2+, these intramolecular rotations are considerably restricted, which 




                 
Figure 1.10 A) The structure of probe 7 (8AQ); B) fluorescence microscopy images of 7 in 
HepG2 cells. 
 
Table 1.1 The photophysical properties of probes 1-6. 
Probe Solvent max λex / nm max λem / nm ε a / M−1 cm−1 Φ b Kd c LOD d 
  no Zn2+ with Zn2+ no Zn2+ with Zn2+ no Zn2+ with Zn2+ no Zn2+ with Zn2+  
1  Tris-HCl buffer 491 491 509 511 1.95 × 104 1.80 × 104 0.077 0.875 1.0 ± 0.1 nM N/A 
2 PIPES buffer 345 345 448 448 9.20 9.20 N/A > 0.26 < 1 µM N/A 
3  HEPES buffer 456 386 585 545 4.46 × 103 3,29 × 103 N/A N/A 2.1 ± 0.27 nM 0.5 nM 
4 HEPES buffer 467 376 542 500 N/A N/A N/A N/A 1.00 µM 35 nM 
5 H2O/CH3CN (1:1) 490 560 518 590 N/A N/A N/A N/A N/A 40 nM 
6 EtOH 278 278 510 510 N/A N/A N/A N/A N/A 25 µM 
7 Tris-HCl buffer 333 382 430 536 N/A N/A N/A N/A 20 nM 2.6 nM 
a Molar extinction coefficient; b fluorescence quantum yield; c dissociation constant; d the limit 
of detection for Zn2+. 
1.4 Subcellular localised small molecule fluorescent Zn2+ probes 
As discussed earlier, the failure to control the subcellular location of small molecule 
fluorescent probes has limited their utility somewhat, however, in the last two decades, there 
have been considerable efforts to overcome this problem. At the subcellular level, organelles 
require zinc for their normal function and the dysfunction of zinc homeostasis results in 
pathological processes, such as cellular stress, and these can induce cell apoptosis. Therefore, 
the development of Zn2+ probes capable of predictable and reliable subcellular localisation is 






1.4.1 Plasma membrane targeting 
1.4.1.1 Plasma membrane and the role of Zn2+ in its function 
The plasma membrane, also known as the cell membrane, is mainly formed by a lipid bilayer 
to protect cells from their external environment. The membrane controls the import and 
export of substances and the selective uptake of ions and organic molecules. Membrane 
transporters, a kind of membrane protein, play an important role in these processes. As 
shown in Figure 1.1, ZIP 1-6, ZIP8, ZIP10 and ZIP14 are zinc transporters that control zinc 
uptake, while ZNT1, ZNT5B and ZNT10 are responsible for zinc efflux through the membrane. 
Some data has suggested that when zinc is present in sufficiently high concentration it can 
act as a stabilizer of the cell membrane.21 It has also been reported that zinc deficiency in 
membranes causes a defect in calcium channels, which impairs the uptake of Ca2+.22 
1.4.1.2 Plasma membrane localised Zn2+ probes 
There are a few small molecule fluorescent probes reported to image Zn2+ in the cell 
membrane. Due to the phospholipid bilayer nature of the membrane, a highly hydrophobic 
group is normally used as a membrane targeting unit. In 2011, Yamamoto et al., reported that 
cholesterol could be applied as a cell membrane targeting unit.23 With fluorescein as the 
fluorophore and an o-aminophenol-N,N,O-triacetic acid-based zinc-chelating moiety, probe 8 
(LF-Chol) showed good cell membrane localisation and fluorescence response when Zn2+ was 





Figure 1.11 The structure of 8 (LF-Chol) and (b) its fluorescence response in cells; (c) 
fluorescence response in the presence of 20 µM Zn2+ and (d) response after the subsequent 
addition of 100 µM EDTA. Adapted from ref. 23 
Besides cholesterol, long alkyl chains have also been widely used for membrane targeting. 
Rutter and Li et al., reported the fluorescent probe 9 (ZIMIR, Figure 1.12) in which a pair of 
dodecyl alkyl chains were used as the membrane targeting unit as a Zn2+ indicator to image 
dynamic insulin release.24 The probe was quenched based on the PET mechanism and 
displayed a robust fluorescence increase after binding with Zn2+. 9 showed low toxicity and 
membrane labelling in a wide range of cell lines. Using this probe, the authors demonstrated 
exocytotic activity at subcellular resolution from pancreatic β cells in intact islets and found 
that the sites of Zn2+/insulin release are mainly in small groups of adjacent β cells. Similar 
results were observed by Watkinson et al. with the plasma membrane targeting Zn2+ probe 
10.25 The di-dodecylamide motif as the membrane targeting unit was introduced through a 
one-pot modular ‘click-SNAr-click’ approach, which was proven to be more efficient in the 
synthesis. Probe 10 showed a significant switch on fluorescence response to Zn2+ due to 
aggregation phenomena, and in cellulo experiments in mouse pancreatic islets demonstrated 
its localisation to the exterior of the plasma membrane. This probe was subsequently used to 
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measure dynamic insulin secretion by Hodson et al. since zinc is co-released from insulin-
containing granules.26    
Similarly, Cho et al., synthesized the two-photon (TP) probe, 11 (FZn-mem), to image near-
membrane Zn2+ by introducing a long alkyl chain to 2-amino-7-(3-oxo-1-dodecen-1’-yl)-9.9-
dimethylfluorene (ADF), a two-photon fluorophore with a large TP cross section.27 With the 
same ligand as 9, 11 was shown to be highly selective for Zn2+ over competing cations, and its 
dissociation constant Kd was determined to be 20 ± 0.4 nM and 19 ± 0.2 nM by one-photon 
and two-photon spectroscopy, respectively. After TP excitation by 820 nm femtosecond laser 
pulses, the fluorescence of 11 could be collected in the emission wavelength range of 450-
600 nm, and near-membrane Zn2+ could be detected in living cells and tissue at a depth of 
110 µm. 
 






Table 1.2 The photophysical properties of probes 8-21. 
Probe Solvent max λex / nm max λem / nm ε a / M−1 cm−1 Φ b Kd c 
  no Zn2+ with Zn2+ no Zn2+ with Zn2+ no Zn2+ with Zn2+ no Zn2+ with Zn2+  
8 HEPES buffer 470 470 517 517 N/A N/A < 0.005 0.18 126 nM 
9 HEPES buffer 493 493 515 515 7.3 × 104  N/A 0.0032 0.225 0.45 µM 
10 HEPES buffer 347 347 420 443 N/A N/A N/A N/A N/A 
11 MOPS/DPPC (1:1) 400 415 506 520 1.64 × 104 N/A 0.19 N/A 20 ± 0.4 nM 
12 MOPS buffer 545 N/A 575 575 N/A N/A N/A N/A 65 ± 10 nM 
13 PIPES buffer 497 490 522 517 3.3 × 104 4.2 × 104 0.36 0.80 1.5 ± 0.2 µM 
14 PIPES buffer 569 573 629 631 2.84× 104 3.67 × 104 0.0355 0.5025 3.25 ± 0.12 nM 
15 MOPS buffer 388 375 500 493 1.87 × 104 2.31 × 104 0.15 0.92 3.1 nM 
16 HEPES buffer 413 395 536 536 1.85 × 104 2.10 × 104 0.0048 0.33 1.4 nM 
17 MOPS buffer 392 N/A 559 N/A 1.32 × 104 N/A 0.023 N/A 17 ± 2 nM 
18 HEPES buffer 453 391 625 d 542 d 6.2 × 103 4.2 × 103 N/A 0.03 8.2 ± 0.2 nM 
19 HEPES buffer 420 370 550 504 N/A N/A 0.11 0.22 0.45 ± 0.01 nM 




633 633 81 × 103 e 
23 × 103 f 
67 × 103 e 
21 × 103 f 
0.28 g  0.29 h 9.1 µM 
21 PIPES buffer 510 510 535 529 N/A N/A < 0.001 0.75 ± 0.03 0.6 ± 0.03 nM 
a Molar extinction coefficient; b fluorescence quantum yield, and for the cases of two-photon 
probes, only one-photon excited quantum yield is recorded here; c dissociation constant; d λex 
= 466 nm; e the parameters of donor; f the parameters of acceptor; g λex = 565 nm; h λex = 400 
nm. 
1.4.2 Mitochondria targeting 
1.4.2.1 The mitochondrion and the role of Zn2+ in its function 
The mitochondrion is an important organelle in eukaryotic organisms. It generates most of 
the chemical energy supply of adenosine triphosphate (ATP) in all cells, and takes part in many 
biological processes, such as signalling, the cell cycle, cell growth and cell death.28 
Mitochondria are involved in intracellular Zn2+ storage in yeast and as a co-factor for a wide 
range of enzymatic reactions and Zn2+ is closely related to the mitochondrial respiratory 
chain.29 It was also reported that zinc can reduce mitochondrial damage under stress 
conditions, which can protect cells from oxidatively-induced apoptosis.30 In contrast, 
mitochondrial dysfunction may cause rapid Zn2+ entry, which is one of the major contributors 
to neuronal injury.31 Therefore, to better-understand these processes, mitochondria localised 
zinc imaging is in demand. 
1.4.2.2 Mitochondria localised Zn2+ probes 
The first example of mitochondrial fluorescent Zn2+ probe was reported by Gee et al., in 
2003.32 Probe 12 (RhodZin-3, Figure 1.13) displayed a 75-fold fluorescence increase after 
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binding Zn2+ and good selectivity over competing cations. The ester form was loaded into cells 
due to its membrane permeability and it showed co-localisation with a mitochondrial marker 
MitoTracker Green and Zn2+ response in cortical neurons. 
In 2006, Lippard et al., synthesized a series of probes and found 13 (ZS5), displaying green 
fluorescence, could localise to mitochondria.33 This strategy is perhaps not so effective since 
this was the only probe to display mitochondrial localisation within a larger series of 
structurally similar probes synthesized. Moreover, another probe 14 (ZBR4), a red fluorescent 
probe, was subsequently found to spontaneously accumulate in mitochondria in 2014 by the 
same group. However, the localisation was again serendipitous as this was the only probe in 
another large family of probes that failed to localise to the endoplasmic reticulum (ER) and 
accumulate in the mitochondria.34 
Delocalised lipophilic cations, such as the triphenylphosphonium salt (TPP), are known as 
effective mitochondrial targeting groups, since they can cross hydrophobic membranes and 
accumulate in the mitochondria in living cells. By introducing this group, Kim and Cho et al., 
obtained a mitochondria-targeting two-photon probe 15 (SZn-Mito) for Zn2+ imaging (Figure 
1.14).35 The probe showed a 7-fold increase of two-photon excited fluorescence after being 
bound with Zn2+ and was able to detect zinc in living tissues to a depth of 100-200 µm through 
two-photon microscopy. Just one year later, the same group developed a similar 
mitochondria targeting probe 16 (SZn2-Mito) which had a 70-fold two-photon excited 
fluorescence increase in response to Zn2+ and displayed similar properties.36 Besides these, 
another two-photon Zn2+ probe 17 (FZn-Mito) was synthesized with a different fluorophore, 
but had similar mitochondria targeting behaviour and two-photon emission response to 
Zn2+.37   
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In 2012, Guo et al., synthesized the ratiometric probe 18 (Mito-ST) which was capable of 
imaging zinc ions in the mitochondria.38 With Zn2+ associated, the probe showed a blue shift 
in both excitation and emission wavelength. Interestingly, they observed the concentration 
of Zn2+ in mitochondria started to increase immediately upon H2O2 (10 mM) stimulation and 
increased to 1.6 nM (from 0.6 nM) with the ratiometric imaging result based on the method 
reported by Tsien et al.39  However, the Zn2+ release stimulated by S-nitrosocysteine 
(SNOC,10 mM), a precursor of the NO radical, experienced a lag phase, and the concentration 
was much higher (76 nM) compared to that stimulated by H2O2. In the same year, Jiang et al., 
reported the quinoline-based ratiometric probe 19 (DQZn2) with similar properties.40 The 
emission of the probe showed a 46 nm blueshift, with about a 5-fold change of the emission 
intensity ratio after binding with Zn2+, which allowed the concentration of mitochondrial free 
Zn2+ to be quantitatively measured in NIH3T3 cells.   
The mitochondria localised Zn2+ probe 20 utilising a FRET mechanism was reported by Zhu et 
al.41 The FRET donor fluorophore displayed a bathochromic shift of emission when 
coordinated with Zn2+. The spectral overlap between the emission of the donor and the 
absorption of the acceptor increased upon Zn2+ binding, which enhanced the FRET efficiency. 
In HeLa cells, when the probe was excited at 405 nm, red fluorescence with emission 








Figure 1.14 (a) TPM and (b) OPM images of HeLa cells co-labelled with (a) 15 (0.5 μM) and (b) 
Mitotracker Red FM (1 μM) for 30 min; (c) Colocalised image. Adapted from ref. 35 
In 2014, a reaction-based fluorescent probe 21 (DA-ZP1-TPP) was reported to investigate 
mobile Zn2+ in mitochondria.42 As shown in Figure 1.15, the phenolic oxygen atoms of the 
xanthene ring in the fluorescein moiety was protected with an acetyl group, which rendered 
it non-fluorescent in metal-free media. In the presence of Zn2+, the ester group was 
hydrolysed, and the PET mechanism quenched by Zn2+ association, giving a strong 
fluorescence response (more than a 140-fold increase). Interestingly, using this probe, the 
authors found that tumorigenic epithelial prostate cells could not accumulate mobile Zn2+ in 





Figure 1.15 The structure of the reaction-based probe 21 (DA-ZP1-TPP). Its fluorescence 
response to Zn2+ and co-localisation with Mito-tracker red in HeLa cells. Adapted from ref. 42 
1.4.3 Lysosome targeting 
1.4.3.1 The lysosome and the role of Zn2+ in its function 
The lysosome acts as the waste disposal system in cells by digesting unwanted materials in 
the cytoplasm. Zn2+ homeostasis in the lysosome is regulated by zinc transporters, ZIP3, ZIP8 
and ZNT2, and its dysregulation is associated with a wide range of pathological processes at 
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the cellular level. For example, oxidative stress induced by H2O2 causes Zn2+ accumulation in 
the lysosome in hippocampal neurons, which eventually undergo lysosomal membrane 
permeabilization (LMP) and this may be the mechanism of oxidative neuronal death.43 It was 
also reported that lysosome-related organelles in intestinal cells of C. elegans (gut granules) 
are the major site of zinc storage, which promotes detoxification and subsequent mobilization, 
regulating cellular and organismal zinc metabolism.44 Therefore, it is vital to develop 
fluorescent probes to image Zn2+ in the lysosomal space to help understand these kinds of 
biological processes. 
1.4.3.2 Lysosome localised Zn2+ probes 
In 2009, Guo et al., synthesized the intramolecular charge transfer (ICT) based probe 22 (NBD-
TPEA, Figure 1.16).45 The probe demonstrated a good selectivity for Zn2+, a large Stokes shift, 
and was also applied for in vivo Zn2+ imaging in zebrafish larva. However, subcellular 
experiments showed it to not only accumulate in the lysosome but also in the Golgi apparatus, 
which limits its application in lysosomal Zn2+ imaging. 
The basic ethylenediamine group has been reported to accumulate in the lysosome since it 
can be protonated by the acid environment in lysosomal space (pH = 4.5 - 5.5). The basic 
dimethylethylamino moiety has therefore been introduced as a lysosome targeting group in 
the ratiometric probe 23 (DQZn4) based on quinoline and showed good targeting behaviour.46 
It performed well in the acidic pH environment, showing a significant turn-on fluorescence 
response and 47 nm blueshift of emission wavelength on binding Zn2+. With these desirable 
properties in vitro, it was successfully utilised for imaging lysosomal Zn2+ changes in NIH 3T3 
cells. 
Another group that has been frequently used for targeting the lysosome is the morpholine 
unit. One example is the two-photon probe 24 based on a naphthalimide dye with an N,N-di-
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(2-picolyl)ethylenediamine (DPEN) Zn2+ ligand, which can image intracellular Zn2+ in the 
lysosome and mouse brain tissues under two-photon excited microscopy.47 Unlike the other 
subcellular targeting probes, in this case organelle differentiation relied on a concentration 
gradient of the probe intracellularly. Probe 24 showed a strong fluorescence switch on 
response to Zn2+ in the lysosomal pH range (pH = 4.5 - 5.5) but the intensity increase was 
much smaller at cytosolic pH range (pH = 7.2 - 7.4), therefore it was able to detect lysosomal 
Zn2+ specifically. 
Using the same targeting unit, Peng et al., reported a ratiometric probe 25 (LysoZn-1) to image 
lysosomal Zn2+ (Figure 1.17).48 The authors introduced an electron donor 4-ethoxylphenyl to 
the meso-position of a styryl-Bodipy-DPA scaffold, which distinguished Zn2+ from Cd2+ very 
well. They explained this using Hard-Soft Acid-Base theory, which was supported by Gaussian 
calculations. Probe 25 exhibited a significant fluorescence increase and ratiometric (F578 
nm/F680 nm) changes upon Zn2+ binding and had a good response to Zn2+ in the lysosomal pH 
range. Using 25 it was observed that lysosomal Zn2+ concentration increased upon H2O2 
stimulation in neuronal stem cells and a similar phenomenon was observed by Uvdal et al. 
with a PET based lysosome localised probe 26 (Lys-NBD-TPEA)49 in which morpholine was 
again utilised as the targeting unit. 
Based on a FRET mechanism, two fluorescent Zn2+ probes 27 were prepared by Zhu et al. with 
different aliphatic amino groups as the lysosome targeting units.50 A Zn2+-sensitive 
arylvinylbipyridyl fluorophore was selected as the FRET donor, and through the efficient 
intramolecular FRET process, its broad emission band was transformed into a strong, narrow 
emission band of the acceptor Bodipy, which is preferable for multi-colour imaging. With a 
2:1 stoichiometry between 27 and Zn2+, the molar absorptivity of the donor was increased 
upon Zn2+ coordination, leading to the enhancement of acceptor emission. The lysosome 
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localisation was confirmed by confocal microscopy and with the high resolution of structured 
illumination microscopy (SIM), they found 27b localised to the interior of lysosomes in HeLa 
cells, rather than anchoring at the lysosomal membranes (Figure 1.18).  
Sessler et al. synthesized a series of probes 28 (LysoDPP-C2-C4), which were designed based 
on AND logic to detect both Zn2+ and the acidic pH of the lysosome.51 The morpholine moiety 
served not only as a lysosome targeting unit but also as a pH-responsive marker, since the 
nitrogen in the morpholine moiety was protonated at low pH and the PET was quenched, 
which increased the fluorescence of the diketopyrrolopyrrole (DPP) fluorophore in the same 
way as the PET quenching upon Zn2+ binding. The experiments in cellulo showed 28c was the 
most effective probe in terms of the initial fluorescence and the fluorescence response to 
Zn2+. When incubated with 28c, the cancerous prostate cell lines PC3 and DU145 showed no 
change in fluorescence intensity, while the normal human prostate epithelial cell line RWPE1 
displayed a significant increase on the addition of exogenous Zn2+. The authors also 
demonstrated that the probe was capable of imaging the prostate in vivo nude mice models 









Figure 1.17 25 (LysoZn-1) co-localises to lysosomes in neural stem cells (NSCs, a–c), MCF-7 (d–
f ) and Hela (g–i) cells. Cells were stained with LysoSensor Green (1 μM ) (a, d and g), and 25 
(1 μM )(b, e and h), (c, f and i) Overlap of these two channels. Adapted from ref. 48 
 
Figure 1.18 SIM images to show the localisation of compound 27b (green) compared to that 
of the lysosome-associated membrane protein (LAMP) fused to the fluorescent protein 
















Table 1.3 The photophysical properties of probes 22-37. 
Probe Solvent max λex / nm max λem / nm ε a / M−1 cm−1 Φ b Kd c LOD d 
  no Zn2+ with Zn2+ no Zn2+ with Zn2+ no Zn2+ with Zn2+ no Zn2+ with Zn2+  
22  HEPES buffer 496 469 550 534 2.10 × 104 1.40 × 104 0.003 0.046 1.0 ± 0.1 nM N/A 
23 e MES buffer  285 261 542 495 4.30 × 103 1.66 × 103 0.11 0.17 16 ± 1.1 nM N/A 
24 f MES buffer 435 444 528 536 1.55 × 104 1.81 × 104 0.03 0.23 8.5 µM 0.18 µM 
25 EtOH/tris-HCl (9:1) 597 568 647 578 N/A N/A N/A 0.23 68 ± 4 µM g 
123 ± 6 µM h 
0.48 µM 
26 MES buffer i 500 490 536 536 N/A N/A N/A N/A N/A 0.477 µM 
27a HEPES buffer / 
CH3CN (1:1) 
350 365 504 504 N/A N/A 0.25 0.24 1 nM2 N/A 
27b 350 359 504 504 N/A N/A 0.32 0.33 0.17 nM2 N/A 
28a HEPES buffer 456 454 515 515 N/A N/A 0.0027 0.0482 1.54 nM N/A 
28b HEPES buffer 454 451 509 515 N/A N/A 0.0064 0.2606 2.57 nM N/A 
28c HEPES buffer 453 453 512 517 N/A N/A 0.0077 0.3283 1.91 nM N/A 
29a PIPES buffer 478 530 625 628 1.93 × 104 2.64 × 104 0.067 0.41 0.69 nM N/A 
29b PIPES buffer 480 524 630 630 1.69 × 104 2.56 × 104 0.069 0.22 0.70 nM N/A 
29c PIPES buffer 480 535 623 628 1.33 × 104 1.93 × 104 0.342 0.60 < 0.001 nM N/A 
30 EtOH 406 N/A 490 N/A N/A N/A < 0.01 0.12 5.5 nM 5.8 nM 
31 PIPES buffer 515 507 530 525 7.95 × 104 8.40 × 104 0.39 0.87 0.7 ± 0.1 nM N/A 
32a PIPES buffer 499 496 519 514 2.72 × 104 1.60 × 104 0.004 0.73 j N/A 
32b PIPES buffer 498 492 515 515 6.41 × 104 4.00 × 104 0.012 0.51 k N/A 
33 HEPES buffer 302 360 532 532 420 4680 0.015 0.055 1.8 ± 0.1 pM 0.042 pM 
35 MOPS buffer 384 388 518 518 2.89 × 104 N/A 0.12 l 0.93 l 1.7 nM l N/A 
37 HEPES buffer 453 442 546 536  N/A N/A N/A 0.19 4 nM 57 nM 
a Molar extinction coefficient; b fluorescence quantum yield; c dissociation constant; d the limit 
of  detection; e all results shown here were recorded at lysosomal pH 5.2; f all results shown 
here were recorded at lysosomal pH 5.0; g calculated from turn on fluorescence emission at 
wavelength 578 nm; h calculated from the ratio of F578 nm/F680 nm; i the pH of the buffer is 5.0; 
j Kd1 = 3.5 ± 0.1 mM, Kd2 = 150 ± 100 µM; k Kd1 = 220 ± 30 µM, Kd2 = 160 ± 80 µM, Kd3 = 9 ± 6 
µM; l the results were obtained in solution EtOH:MOPS buffer (1:1, v/v). 
1.4.4 Endoplasmic reticulum (ER) targeting 
1.4.4.1 The ER and the role of Zn2+ in its function 
The endoplasmic reticulum (ER), an organelle in eukaryotic cells, serves a number of 
important cellular roles, such as protein synthesis and transport, protein folding, 
carbohydrate metabolism, lipid and steroid synthesis.52 Proteins synthesized in the ER are 
normally properly folded and transported to the Golgi apparatus. However, when there are 
changes to ER function, resulting from factors such as ageing, genetic mutations, or the 
environment, unfolded or misfolded proteins are synthesized and accumulate in the ER, 
causing ER stress, which activates the unfolded protein response (UPR).53  
It is known the ER acts as an intracellular store for biological mediators, including zinc, which 
it requires for normal function. For example, it has been found that zinc can be released from 
thapsigargin- and inositol 1,4,5-trisphosphate (IP3)-sensitive ER storage in cortical neurons.54 
ZIP7, ZIP9, ZIP13 and ZNT5-7 are the transporters to regulate Zn2+ inside the ER and the 
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depletion of zinc transporters and zinc deficiency can cause ER stress and upregulate the 
UPR,55,56 which results in a wide range of diseases, such as inflammation,57 diabetes58 and 
neurodegenerative disorders, including Parkinson’s and Alzheimer’s diseases.59 However, the 
role of ‘free’ or ‘mobile’ zinc in these processes is little understood due to the lack of suitable 
molecular tools to image this subcellular region that exist. 
1.4.4.2 ER localised Zn2+ probe 
Reports of ER localised small molecule Zn2+ probes are very limited, and all of them were 
found to accumulate in the ER adventitiously. In 2013, Lippard et al., reported a series of 
benzoresorufin based red-emitting fluorescent probes 29 (the ZBR family, Figure 1.19) for 
labile Zn2+.60 The probes displayed a broad absorption band and a bathochromic shift after 
binding with Zn2+, while the emission showed up to 8.4-fold increase with addition of Zn2+. In 
cellulo studies revealed all probes accumulated in the ER in a variety of cell lines (Figure 1.20), 
as the Pearson's correlation coefficient with ER tracker was much higher than the other 
organelle tracker dyes. Interestingly, with 29a, the authors observed the depletion of labile 
zinc in the ER of neural stem cells under ER stress induced by peroxynitrite.    
The conveniently prepared small molecular fluorescent probe 30 included benzothiazole as 
the fluorophore and an o-hydroxyl Schiff base as the Zn2+ receptor.61 Upon binding Zn2+, the 
PET process was blocked, and the fluorescence response had a 65-fold increase with a slight 
red shift, with a Job’s plot showing a 2:1 binding stoichiometry between 30 and Zn2+. In human 
liver hepatocellular carcinoma cells, 30 was able to detect intracellular endogenous Zn2+ and 
its subcellular localisation was found to be the ER with a Pearson's correlation coefficient of 
0.88 compared to ER tacker Red. Moreover, 30 was applied to investigate Zn2+ in plant tissues 
where it was shown that Zn2+ mainly accumulates in vascular tissue and epidermal cells in the 
cotyledons when treated with exogenous Zn2+. 
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Given the ongoing need to develop an effective and reliable strategy for targeting ER localised 
probes a sensible strategy, based on the previous experience of targeting other organelles, 
would be to identify methods to incorporate an ER targeting unit in the probe design. 
Glibenclamide is one option since the commercial ER tracker red and ER tracker green both 
have glibenclamide group, however, a number of recent reports have appeared in which the 
methyl sulfonamide group has been used as a targeting unit to visualize hydrogen peroxide,62 
methylglyoxal,63 hypochlorite64 and hydrogen sulfide65 in the ER. 
 
Figure 1.19 The structures of ER localised fluorescent probes 29 and 30. 
 
Figure 1.20 Co-localisation analysis of 29a (ZBR1) with organelle-specific markers in HeLa cells 
(A) Bright-field image; (B) 29a (5 μM); (C) Mito-Tracker Green (0.2 μM); (D) ER-Tracker (1 μM); 
(E) Overlay of 29a and ER-Tracker; (F) Overlay of 29a and Mito-Tracker Green. Scale bar = 25 
μm. Adapted from ref. 60 
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1.4.5 Golgi apparatus targeting 
1.4.5.1 The Golgi apparatus and the role of Zn2+ in its function 
The Golgi apparatus works as a central station in cells, receiving secretory cargoes exported 
from the ER packing proteins into membrane-bound vesicles and sending them to their intra- 
and extra-cellular destinations. Zn2+ is integral to these processes for a variety of proteins, 
functioning in catalytic, regulatory, and structural roles. For example, it was found that zinc 
takes part in the interaction between the two main Golgi proteins GRASP55 and Golgin45, 
maintaining the normal morphology of the Golgi apparatus;66 Zn2+ also coordinates with 
insulin monomers in the trans-Golgi network to package it into secretory granules, which are 
then released from pancreatic β-cells.67 To regulate Zn2+ homeostasis in the Golgi apparatus, 
transporters ZNT4-7 and ZIP7, ZIP9, ZIP11, ZIP13 were responsible for Zn2+ import and export, 
respectively. The breakdown of Zn2+ homeostasis in the Golgi apparatus is likely to be 
associated with a range of human disorders, such as cancer and neuronal, liver, kidney and 
eye diseases68 and the development of effective methods for its detection and monitoring are 
required. 
1.4.5.2 Golgi apparatus localised Zn2+ probe 
The first probe to localise in the Golgi apparatus was reported in 2000 by Lippard and Tsien 
et al.,69 With fluorescein as the signalling unit, probe 31 (Zinpyr-1, Figure 1.21) has a large 
extinction coefficient, high quantum yield, and good membrane permeability. Experiments in 
Cos-7 cells showed it colocalised well with a galactosyl transferase-enhanced cyan fluorescent 
protein fusion (GT-ECFP), confirming 31 stains the Golgi apparatus. Some years later, Lippard 
et al., presented two cell-trappable fluorescent Zn2+ probes: a carboxylic ester probe 32a 
(QZ2E) and its carboxylic acid analogue 32b (QZ2A).70 The probes were poorly emissive but 
had a significant increase in emission after binding with Zn2+ (120-fold for 32a, 30-fold for 
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32b). Interestingly, the authors found the 32b was cell membrane-impermeable due to its 
carboxylic acid moieties, but 32a was membrane permeable and mainly localised to the Golgi 
apparatus; after 18 hours’ incubation time, the ester was hydrolysed to produce 32b, which 
was trapped inside cells.  
Guo et al., modified the 8-sulfonamidoquinoline based commercial probe Zinquin to produce 
a new fluorescent probe 33 (BPSQ) to image Zn2+ with a 1:1 binding stoichiometry, which was 
better at discriminating mobile Zn2+.71 Colocalisation experiments showed it to accumulate 
preferentially in the Golgi apparatus. 
Following the previous experience on mitochondria targeting Zn2+ probes,35,36 Kim et al., 
reported a Golgi-localised two-photon probe 35 (SZnC), which had a strong two-photon 
excited fluorescence enhancement in response to Zn2+ for real-time monitoring of Golgi Zn2+ 
changes (Figure 1.22).72 According to theoretical predictions for Golgi apparatus staining, the 
lipophilicity value (logP value) should be within the range of 3-5.73 The logP values were 
calculated through measuring the probe’s partitioning ratio between n-octanol and buffer, 
and the value of 35 was found to be 2.9 ± 0.1, which is reasonably matched to the theoretical 
range whereas it was determined to be  2.5 ± 0.1 for the control compound 34 (SZn), which 
experiment proved to be non-Golgi targeting. However, the logP values of another control 
probe 36 was 3.1 ± 0.1 and this was spread over the entire cell except the nucleus. The authors 
attributed the Golgi localisation of 35 to the weakly basic pyridyl group, which 36 does not 
possess. Therefore, both the lipophilicity and pyridyl moiety of 35 appear to contribute to its 
accumulation in the Golgi apparatus and the probe was applied for imaging Zn2+ in rat 





Figure 1.21 The structures of Golgi apparatus localised fluorescent probes 31-36. 
 
Figure 1.22 The colocalisation of probe 35 (SZnC) (2 µM) and organelle markers (BODIPY TR 
ceramide and lysosome, mitochondria, ER marker red) in HeLa cells. Adapted from ref. 72 
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It appears that all of the probes described above were found to reside in the Golgi apparatus 
adventitiously, therefore a Golgi targeting unit is still required in order to develop reliable 
Golgi apparatus localised Zn2+ probes. Ceramide may be an option for Golgi apparatus 
targeting since it has been employed in commercial stains for the Golgi apparatus such as 
NBD-ceramide and Bodipy-ceramide. However, it requires multi-step synthesis (see Appendix 
8.1) and also co-localises to the plasma membrane, which limits its application somewhat. 
More recently cysteine has been reported as a Golgi apparatus targeting unit,74,75 since 
galactosyltransferase and protein kinase D were found to anchor to the Golgi region via their 
cysteine residues or cysteine rich domains76,77 and this may find utility. 
1.4.6 Nucleus targeting 
1.4.6.1 The nucleus and the role of Zn2+ in its function 
The nucleus, as the control centre of the cell, maintains the integrity of genes and controls 
the activities of the cell by regulating gene expression. In eukaryotic cells, there is a double 
membrane which encloses the organelle from the cytoplasm. This nuclear membrane is 
impermeable to large molecules, and the nuclear pores are the channels for large molecules 
which must be actively transported by carrier proteins, while also allowing free movement of 
small molecules and ions. Among these, ZNT9 and ZIP7 were found to be responsible for zinc 
influx and efflux.78 About 30-40% of total intracellular zinc is found in the nucleus, which plays 
an important role in the regulation of cell proliferation. It stabilises the structures of DNA, 
RNA, and is involved in DNA and protein synthesis.79 Nuclear hormone receptors use zinc 
finger domains to bind DNA, and zinc deficiency impairs this behaviour, which also has effects 
on metabolic processes related to growth.79 Some zinc-dependent proteins have been found 
in the nucleus functioning as transporters.80 It is therefore necessary to image Zn2+ in the 
nucleus to better understand zinc influx and distribution and its related biological processes. 
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1.4.6.2 Nucleus localised Zn2+ probe 
Nucleus localised Zn2+ probes have been realised by genetically encoded sensors81 or small 
molecule fusion protein tags,82 however there are no small molecule Zn2+ probes showing 
specific nucleus targeting, though the commercial probes Newport Green83 and Zinquin84 
have been reported to display entire cell distribution, including the nucleus. A fluorescent 
probe based on naphthalimide, 37 (Naph-BPEA), reported by Guo et al.,85 displayed a 4-fold 
fluorescence enhancement and blue shift of the ICT absorption band on Zn2+ binding. The 
intracellular distribution of the probe was studied in HeLa and HepG2 cells and when the cells 
were stained with 37, only cytosolic fluorescence was observed. However, when exogenous 
Zn2+ was added, the entire cell became fluorescent, including the nucleus, which was 
confirmed with the Hoechst stain, a commercial DNA dye (Figure 1.23). It demonstrated the 
ability of the probe to penetrate the nuclear envelope, but the nuclear fluorescence response 
was small due to the low nuclear concentration of mobile or free Zn2+. The authors speculated 
that incorporation of the 4-amino-1,8-naphthalimide moiety to be the reason for its nuclear 
envelope penetrability through positive and negative control experiments. Furthermore, the 




             
Figure 1.23 The structure of 37 (Naph-BPEA) and confocal fluorescence images of HeLa cells 
co-stained with Hoechst 33 342 (5 µg/mL, blue) and 37 (5 µM, green). (a-c): images of the co-
stained cells; (d-f): images of the co-stained cells followed by Zn2+-pyrithione incubation; (g-
i): images of cells which were subsequently treated by TPEN. Adapted from ref. 85 
1.5 Overall aims of the project  
In light of these findings, this project aims to develop a series of cellular or subcellular 
localised fluorescent Zn2+ probes. Based on the previous development of Zn2+ probes in the 
Watkinson group,25 the main aim was to overcome the difficulties of the control of small 
molecule fluorescent probes’ localisation in cellulo by introducing specific cell or specific 
organelle targeting units through the reported ‘click-SNAr-click’ strategy, which utilises the 
copper(I)-catalysed azide-alkyne cycloaddition (CuAAC) reaction. In particular at the 
subcellular level, a reliable strategy to develop ER and Golgi apparatus targeting Zn2+ probes 





Chapter 2 A biotin-tagged fluorescent probe to visualise mobile Zn2+ in cancer cells 
2.1 Introduction 
Cancer causes millions of deaths every year and is a major burden of disease around the world. 
There is evidence that zinc is important in cancer development.86 This is perhaps unsurprising 
as zinc is necessary for the human superoxide dismutase enzyme system to function, and 
cancer cells are highly dependent on superoxide dismutase for protecting themselves from 
the damage induced by reactive oxygen species, since the superoxide anion radical, O2-, is 
actively produced in cancer cells.87 Zinc is also a growth factor in cell proliferation,88 which is 
attenuated in the absence of zinc.89 However, it is found that the alterations of mobile zinc 
concentration in malignant cells are tissue specific. For example, zinc concentration increases 
by about 72% in breast cancer tissue,90 while it decreases by 75% in malignant prostate 
tissue91 compared to their non-cancerous counterparts. These differences have been 
explained by changes in the expression of zinc transporters, which directly influence the Zn2+ 
cellular influx and efflux. In prostate cancer, the low Zn2+ concentration is due to the 
downregulation of the zinc transporter ZIP1,91 whilst ZIP6,92 ZIP793 and ZIP1094 have been 
proposed to be important in the elevated levels in breast cancer. Though there is an 
increasing understanding of these processes, it is still unclear whether these changes are a 
cause or an effect of tumour growth. Furthermore, it is not clear whether zinc itself or zinc 
transporters are associated with cancer-related events.86 However, the difficulty of imaging 
in vivo represents a significant barrier to understanding its role in cancer. Therefore, the 
development of an effective way to detect mobile zinc specifically in tumour cells would allow 
us to achieve a better understanding of its role in the mechanism of cancer initiation, 
progression, and potentially, its prevention. 
52 
 
Biotin is a vitamin that is essential to cancer cells, and the sodium-dependent multivitamin 
transporter (SMVT) is overexpressed in many cancers, including breast, lung, ovarian, 
mastocytoma and renal,95,96 meaning that cancer cells take up more biotin than normal cells. 
Based on this, some biotin tagged cancer drugs have been developed and have shown good 
targeting ability.97–100 Therefore by incorporating a biotin tag into a zinc probe, using the 
previously reported methodology,25 a small molecule probe that could detect zinc specifically 
was targeted, and the results are discussed in this chapter. 
2.2 Probe design and synthesis 
The cyclam ligand has previously been shown to be an effective receptor unit for mobile 
zinc,101,102 and was therefore chosen in this study. The synthetic route to the target probe, 47, 
is shown in Schemes 2.1 and 2.2. Biotin azide, 43, was prepared from D-(+)-biotin by adapting 
literature procedures.103,104 The fluorophore and ligand were introduced via alkynes 38 and 
40, which were synthesized using the procedure reported previously.25,101,102 After double 
click reactions, the Boc-protected 46 was isolated in moderate yield and was de-protected 




Scheme 2.1 The synthetic routes to precursors 38, 40 and 43. 
54 
 
Scheme 2.2 The synthetic route to probe 47. 
2.3 Photophysical properties 
The absorption spectra of probe 47 and its complex with different equivalents Zn2+ is shown 
in Figure 2.1, which shows there is no blue shift or red shift after binding with Zn2+. The 
fluorescence of 47 is switched on by adding Zn2+ as shown in Figure 2.2, upon addition of Zn2+, 
the fluorescence intensity increased gradually with an approximately 5-fold maximum 





Figure 2.1 The UV-Vis spectra of probe 47 (50 µM) with different equivalents of Zn2+ in 0.1 mM 
HEPES buffer at pH 7.4. 
 
Figure 2.2 The fluorescence switch-on response of probe 47 (50 µM) to different equivalents 
Zn2+ in 0.1 mM HEPES buffer at pH 7.4. (λex = 346 nm, slit widths: 5/5 nm) 
56 
 
















Figure 2.3 The Job’s plot to determine the stoichiometry of the complex formed between 
probe 47 and Zn2+. 
As the binding stoichiometry is 1:1, the dissociation constant with Zn2+ was then measured 
through non-linear curve fitting (Figure 2.4) using Equation 2.1, in which the values CM and 
CL are the concentrations of Zn2+ and probe respectively, F is the observed fluorescence 
intensity, F(0) is the observed fluorescence of the probe alone (i.e. CM = 0) in absence of 
chelating agent, and F(max) is the observed fluorescence of the probe in presence of excess 
Zn2+ (5 equivalents). The Kd was determined to be 1.88 × 10-8 M. The quantum yield of 47 was 
determined by Equation 7.2, and was found to be 0.02, while this increased to 0.05 after 
binding to 1 equivalent of Zn2+ (Figure 2.5). Although this is rather modest, it is in line with 
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Figure 2.4 The non-linear curve fitting of the fluorescence intensity of 47 against different 
equivalents Zn2+. 
































Figure 2.5 Linear plots for standard sample, 47, and 47 + Zn2+ to obtain quantum yields. 
Anthracene (Φ = 0.27 in ethanol) was used as standard sample. (λex = 346 nm, λem = 414 nm, 
slit widths: 5/5 nm). 
The pH-dependent fluorescence response was measured, as it is known that although cancer 
cells maintain their pH near to neutrality, the cytoplasm is more alkaline than that of normal 
cells while the environment outside cancer cells is more acidic.105 As shown in Figure 2.6, 
probe 47 showed a good switch-on response to 1 equivalent Zn2+ in the range of pH 5.5-10.5, 
indicating that it should be able to detect Zn2+ in most cancer cells. The apparent pKa of 47 
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was measured by integrating the fluorescence intensity of emission spectra against pH (Figure 
2.7). Through non-linear curve fitting (Equation 7.5), the four apparent pKas of 47 are: pKa1 = 
1.64 ± 0.14, pKa2 = 4.18 ± 0.23, pKa3 = 9.24 ± 0.31, pKa4 = 11.18 ± 0.18. 
 
Figure 2.6 The pH profile of 47 (50 μM) and 47 with 1 equivalent Zn2+ in HEPES buffer (0.1 
mM). 
 
Figure 2.7 Normalized integrated fluorescence emission vs pH, the nonlinear curve fitting 
used to determine the apparent pKa values of 47. 
The selectivity of probe 47 to Zn2+ over other competing metal ions was also investigated. As 
shown in Figure 2.8, besides Zn2+, the fluorescence is not switched on after the addition of 
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other metal ions, with the exception of Cd2+, which shows a similar response and is in line 
with previous findings.101,102  However, as its concentration in tissues is negligible, this is not 
an issue for cellular imaging. Whilst Fe3+, Co2+ and Cu2+ induce significant quenching106 of the 
fluorescence of 47, they almost exclusively exist in bound forms in biology, rather than as the 
free cations tested here. The cations Na+, K+, Ca2+, and Mg2+, which are the main metal ions in 
cells, showed no effect on the fluorescence intensity of 47, meaning that it should have good 
selectivity for Zn2+ and can potentially be applied in cellulo. The water-solubility of 47 is also 
an attractive feature for cell imaging as it does not require the addition of co-organic solvents 
to solubilise the probe. 
 
Figure 2.8 Metal ion selectivity of 47 in 0.1 mM HEPES buffer at pH 7.4. Average normalized 
fluorescence intensities for 47 (50 μM) (black bars), after addition of 5 equivalents of various 
metal ions (red bars), followed by addition of 1 equivalent ZnCl2 (blue bars). 
2.4 DFT calculations 
DFT and TDDFT calculations were undertaken to understand the binding behaviour of 47 with 
Zn2+ and their excited states. The optimised structure of probe 47 with 1 equivalent of Zn2+ 
(Figure 2.9) shows the bottom triazole nitrogen is involved in binding with Zn2+ in addition to 
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the cyclam nitrogen donors, which is consistent with previous observations in closely related 
analogues.101,107  
The calculated vertical excitations are in good agreement with the experimental values. The 
deviations from the experimental values are due to the lack of explicit consideration of 
vibrational effects and the solvent molecules in calculations. In line with the experimental 
measurements, the predicted emission energy for the Zn2+ complex is very similar to that 
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Table 2.1. Comparison of the experimental data with the calculated result of vertical 













Absorption S0→S1 3.88 320 0.5493 3.58 eV/346 nm 
S0→S2 4.27 290 0.0438 
S0→S3 4.37 284 0.0001 
S0→S4 4.39 282 0.0002 
S0→S5 4.67 265 0.0004 
S0→S6 4.72 262 0.0011 
Emission S1→S0 3.18 390 0.7172 3.01 eV/412 nm 
Complex of 47 with Zn2+ 
Absorption S0→S1 3.95 314 0.5023 3.58 eV/346 nm 
S0→S2 4.26 291 0.0521 
S0→S3 4.34 286 0.0003 
S0→S4 4.62 268 0.0002 
S0→S5 4.94 251 0.0319 
S0→S6 5.29 234 0.0055 
Emission S1→S0 3.22 385 0.6672 3.01 eV/412 nm 
 
The S1-S0 electron density plots (Figure 2.10) show that the electron transition is localised on 
naphthalimide moiety and the vicinal triazole for both 47 and its complex with Zn2+. These 
calculations show that cyclam does not contribute to the process. The formation of the 
complex has a minor impact on the electronic densities. There is a slight decrease of the 
electron density on the nitrogen from the triazole involved in the complex formation, and the 
oscillator strength is not significantly affected. Consequently, this does not justify the 
enhancement of emission observed experimentally. Based on these results, the mechanism 
of fluorescence enhancement seems to be consistent with the restriction of the 
intramolecular rotations after complexation with Zn2+. When bound with Zn2+, the 
stabilisation of the complex hampers large amplitude vibrations in the vicinity of the 
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fluorophore, reducing the possibility of relaxation through non-radiative pathways and 
increasing the quantum yield of emission. The still small quantum yield can be associated with 
other nonradiative mechanisms that are not affected by complexation with Zn2+ including 




Complex with Zn2+ 
Figure 2.10 S1-S0 electron density map for probe 47 and its complex with Zn2+ (S1 minima).  
Red represents positive densities and blue negative values.  
2.5 In cellulo tests 
With the promising properties confirmed in solutions, the innate toxicity of 47 was then 
measured. The MCF-7 breast cancer and N-TERT keratinocyte cell lines were incubated in cell 
medium solution containing different concentrations of 47 for 24 hours. Then the solution 
was washed away, and AlamarBlue was added as an indicator of cell viability.108 From these 
experiments (Table 2.2), it can be concluded that the probe has no toxicity to either cell type 
since the viability of cells does not decrease as the concentration of 47 increases. 
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Fluorescence microscopy was used to detect mobile Zn2+ in MCF-7 and N-TERT keratinocytes 
cells and the results are shown in Figure 2.11. For MCF-7 breast cancer cells, when there was 
no probe, the fluorescence of the cells was very weak, resulting from their background 
autofluorescence. After incubation with a 100 µM solution of 47 for 2 hours, the fluorescence 
increased considerably, and the Zn2+ in cytoplasm can be visualised clearly, but there was no 
response from the nucleus. On the addition of zinc pyrithione, a membrane permeable zinc 
source,109 the fluorescence response of the cells became stronger, and a fluorescence 
response was observed from the whole cell, including the nucleus. Therefore, it is assumed 
that this probe is also permeable to the nucleus, but that the concentration of nuclear mobile 
zinc in MCF-7 cells is very low. When TPEN, a well-known zinc chelator,110 was added to 
remove Zn2+ inside cells, the fluorescence of the cells decreased markedly as expected. 
Pleasingly, as hypothesized, for the normal control N-TERT keratinocytes cells, no strong 
fluorescence response was observed even after the addition of zinc pyrithione, supporting 
the selective localisation of 47 in the cancer cells. 
Table 2.2 The fluorescence reading of AlamarBlue indicating cell viability. 
 MCF-7 N-TERT 
Concentration (µM) 0 10 30 50 70 100 0 10 30 50 70 100 
Fluorescence 
reading 
5255 5037 5050 5335 5454 5239 7631 7606 7517 7053 6874 8911 
5207 4920 4990 4922 5519 5133 7753 7324 7233 7349 9130 8404 
5197 4809 4422 5151 5268 5453 8800 6909 7214 7347 7110 8226 
5317 5207 4620 4902 5177 5340 7924 7515 7195 7189 7928 7999 
5558 5490 4861 5262 5001 5493 7017 7583 7896 7567 8536 8227 
Average 5260 5055 4824 5112 5230 5344 7769 7474 7321 7295 7858 8286 





Figure 2.11 Fluorescence microscopy images of MCF-7 cells (a-l) and N-TERT cells (a’-l’) 
treated with no probe (a-c and a’-c’), 100 µM probe 47 (d-f and d’-f’), probe 47 (100 µM) with 
saturated zinc pyrithione (g-i and g’-i’), and probe 47 (100 µM) after loading the cells with zinc 
pyrithione, then TPEN (2 µM) was added (j-l and j’-l’). 
2.6 Summary 
In conclusion, the biotin tagged fluorescent probe 47 was developed using a double click 
reaction. It is water-soluble, and has high selectivity, low toxicity, shows good fluorescence 
response and a low dissociation constant to Zn2+. Testing in cells confirms it can localise 
selectively in cancer cells, can image mobile Zn2+, and therefore has the potential to help 







Chapter 3 Endoplasmic reticulum targeting fluorescent probes to image mobile Zn2+ 
3.1 Probe design and synthesis 
As discussed earlier (see Section 1.4.4), glibenclamide could be a good option for endoplasmic 
reticulum (ER) targeting unit. Glibenclamide, an antidiabetic drug, is employed in the 
commercial dyes ER tracker red and ER tracker green because it binds and inhibits ATP-
sensitive K+ channels that are abundant on the ER membrane.111,112 There is also a report of 
the use of glibenclamide as the targeting group in a small molecule chemical probe which was 
shown to selectively accumulate in the ER and image glutathione.113 Therefore a synthetic 
route was developed towards a ‘clickable’ variant of glibenclamide 53 which was prepared 
through six steps in moderate yield (Scheme 3.1). The CuAAC reaction with alkyne 38 
proceeded, as expected, in good yield (Scheme 3.2), however, when installing the Zn2+ binding 
unit 54, the second ‘click’ reaction to give compound 57 failed completely, despite a range of 
Cu(I) sources being tested. Given the success of the first ‘click’ reaction, it was decided to 
investigate the development of a ‘reverse’ methodology in which the metal-binding unit was 
first installed into anhydride 58 before the addition of the targeting unit via a second ‘click’ 
process was attempted (see Scheme 3.3). Although the first ‘click’ reaction again worked well, 













Scheme 3.3 The modular click reaction for ‘bottom to top’ click. 
At this point, it was decided to review the synthetic strategy as a number of recent reports 
have revealed that the cyclohexyl sulfonylurea moiety of glibenclamide is an important 
element in binding with ATP-sensitive K+ channels.26,114,115 Therefore an alternative route in 
which this ER targeting unit was directly incorporated into the naphthalimide was designed, 
which also makes the synthesis route shorter and easier.  
The new synthetic route started from 4-(2-aminoethyl)benzenesulfonamide to give ER-
targeting group 62 through the route depicted (see Scheme 3.4) and this was directly 
introduced into the fluorophore through reaction with commercially available 4-bromo-1,8-
naphthalic anhydride (Scheme 3.5). This was then conveniently converted to azide 64 using 
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standard conditions for such SNAr reactions, which then underwent smooth and high yielding 
‘click’ reactions with alkynes 54 or 40 to yield probes 65 and 67, the latter after deprotection 
of 66 with TFA.  
 




Scheme 3.5 The successful synthetic route to probes 65 and 67 incorporating cyclohexyl 
sulfonylurea as the ER targeting unit. 
Another probe, 70, with the same ER-targeting unit but a different Zn2+ ligand was also 
prepared as shown in Scheme 3.6. The carboxyl ester should be hydrolysed by esterase 
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enzymes in cells after which it has been reported to have Zn2+ binding ability.116–118 However, 
it proved to be cytotoxic (shown in Figure 3.16c) and was not taken forward to in cellulo 
studies. All products were satisfactorily characterised by 1H, 13C NMR and IR spectroscopies 
as well as high-resolution mass spectrometry. 
 
Scheme 3.6 The synthetic route toward 70. 
3.2 Photophysical properties in solution 
Fluorescence titrations with Zn2+ were first undertaken to show that both probes 65 and 67 
have a switch-on response to Zn2+. From Figure 3.2, it can clearly be seen that with increasing 
Zn2+ equivalents, the fluorescence intensity of probes 65 and 67 increased gradually with 
about 16-fold and 4-fold maximal increase, respectively. Subsequent treatment with TPEN 
resulted in the expected decrease in fluorescence with that of 65 being completely quenched 
while that of 67 was partly quenched (Figure 3.3). The Job’s plot (Figure 3.4) revealed the 




Figure 3.1 The UV-Vis spectra of a) 65 (50 µM) and b) 67 (50 µM), and their complexes with 
1 equivalent of Zn2+ in 0.1 mM HEPES buffer at pH 7.4. 
 
Figure 3.2 The fluorescence response of a) 65 (10 µM) and b) 67 (10 µM) to different 
equivalents of Zn2+ in 0.1 mM HEPES buffer at pH 7.4 (λex = 346 nm, slit widths: 5/5 nm). 
 
Figure 3.3 The fluorescence response of a) 65 (50 µM) and b) 67 (50 µM) with 1 equivalent 
Zn2+ to different equivalents of TPEN in 0.1 mM HEPES buffer at pH 7.4. (λex = 346 nm, slit 




Figure 3.4 The Job’s plot to determine the stoichiometry of the complex formed between a) 
65 and Zn2+, b) 67 and Zn2+. The total amount of [Probe + Zn2+] is 50 µM, (λex = 346 nm, λem = 
414 nm). 
The dissociation constants Kd for probes 65 and 67 were obtained through non-linear curve 
fitting using reported methods119,120 at a number of probe concentrations (Figure 3.5, Table 
3.1). However, because of the very low Kd values for these compounds and to mimic the 
buffered nature of mobile zinc in cellulo, EGTA (ethylene glycol-bis(β-aminoethyl ether)-
N,N,N',N'-tetraacetic acid) was used as a competitive chelator and the Kd values again 
calculated at three different concentrations (Figure 3.6) with optimal fit being observed at 
0.01 µM in all cases (Table 3.2) revealing the dissociation constant of 65 to be 3.5 nM and 4.7 
nM for 67. The detection limits of 65 and 67 (Figure 3.7) were also estimated to be 47 pM and 
















Figure 3.5 The non-linear curve fitting of the fluorescence intensity as a function of [Zn2+] of 
65 and 67 at different concentrations to determine Kd (Blue = measured data, Green = fit). 
Residuals at each datapoint are shown in pink. For all complexes, 0.06 mL addition of Zn2+ 
solutions represent a 1:1 ratio of probe and Zn2+. (λex = 346 nm, λem = 414 nm (probe 65), λem 
= 406 nm (probe 67)). Fits for probe 65 incorporate fitting of an ML2 species at low abundance 
(see Table 3.1). Non-linear regression was carried out using Reactlab Equilibria software. 
Table 3.1 Summary of apparent Kd calculated for probes 65 and 67 using the free Zn2+ method 
as a function of concentration. 
Kd [Probe] = 50 µM [Probe] = 10 µM [Probe] = 1 µM 
65i 1.0 × 10-7 M 3.0 × 10-10 M 2.8 × 10-10 M 
67 1.0 × 10-5 M 1.1 × 10-6 M 4.5 × 10-8 M 
iThe best fit for probe 65 by this method was obtained by also allowing for the presence of a 
second species of the form ML2. In all cases, the second stepwise association constant K2 was 
1-2 orders of magnitude smaller than K1 indicative of strongly negative cooperativity, and this 
species was only observed in the presence of a large excess of probe in the early parts of the 
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titration. No improvement in fitting was observed by including any other stoichiometries in 
the fitting for probe 67. 







Figure 3.6 The non-linear curve fitting of the fluorescence intensity of 65 and 67 at different 
concentrations against different equivalents of Zn2+ to determine Kd applying Equation 7.1. 
(λex = 346 nm, λem = 414 nm). 
Table 3.2 Summary of Kd values for probes 65 and 67. 
 [Probe] = 1 µM [Probe] = 0.1 µM [Probe] = 0.01 µM 
 Kd  R
2 Kd  R2 Kd  R2 
65 4.70 ± 0.49 nM 0.9825 4.54 ± 0.38 nM 0.9883 3.50 ± 0.10 nM 0.9985 





Figure 3.7 Fluorescence response of a) 65 (1 µM) and b) 67 (1 µM) against [Zn2+]free in HEPES 
buffer solution (50 mM, pH 7.2, 0.1 M KCl).. (λex = 346 nm, λem = 414 nm) 
The quantum yields of both probes were measured using anthracene as the standard. It was 
found that the quantum yield of 65 was 0.041, which increased to 0.25 after binding with 1 
eq. of Zn2+. In line with the results seen in Chapter 2 (see Section 2.3) and previous 
reports,102,121 the quantum yield of 67 was much lower, 0.013 and only increased to 0.041 for 
the complex with 1 equivalent of Zn2+ (Figure 3.8). 
 
Figure 3.8 Linear plots for a) standard sample, 65, and 65 + Zn2+, b) standard sample, 67, and 
67 + Zn2+ to obtain quantum yields. Anthracene (Φ = 0.27 in ethanol) was used as standard 
sample. (λex = 346 nm, λem = 414 nm, slit widths: 5/5 nm). 
The pH-dependent fluorescence response of both probes was tested to confirm that they 
have fluorescence responses to Zn2+ in the biologically relevant pH range. Figure 3.9a shows 
that 65 has a good switch on fluorescence response to Zn2+ over a wide pH range of 3.0-10.0, 
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and the fluorescence of both probe and complex is increased in an acidic environment. In 
contrast, 67 (Figure 3.9b) shows a poor response in acid conditions, presumably due to the 
basic nature of the polyamine ligand, but works well in the pH range 6.0-12.0; given that the 
reported pH of the ER is the same as the cytoplasm, which is about 7.2,122 both probes should 
have a response to mobile Zn2+ in cellulo. Through non-linear curve fitting applied with the 
Equation 7.4 and Equation 7.5, the pKa values of both probes could be obtained, which are 
pKa1 = 0.81 ± 0.19, pKa2 = 4.34 ± 0.11, pKa3 = 6.83 ± 0.53, pKa4 = 11.63 ± 0.41 for 65, and pKa1 = 
3.20 ± 0.14, pKa2 = 8.07 ± 0.11, pKa3 = 11.07 ± 0.58 for 67 (Figure 3.10). These values are 
comparable to those reported for related compounds.121 
 
Figure 3.9 The pH profile of a) 65 (50 µM, black dots) and b) 67 (50 µM, black dots) and their 
complex with 1 equivalent of Zn2+ (red dots). 
 
Figure 3.10 Normalized integrated fluorescence emission of a) 65 (50 µM) and b) 67 (50 µM) 
vs pH, the nonlinear curve fitting used to determine the apparent pKa values. 
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The selectivity of the two probes over a range of other competing cations was also 
investigated. As shown in Figure 3.11a, beside Zn2+, the fluorescence of 65 was not switched 
on obviously after addition of 5 equivalents of other cations, except for the stereoelectronic 
isostere Cd2+, which is a common issue for many Zn2+ probes,123 but is not a problem in 
biological milieu due to its negligibly low concentration. Subsequent addition of Zn2+ resulted 
in recovery of a fluorescence response in most cases, however for Co2+, Cu2+ and Ni2+ 
fluorescence was not recovered, but as they mostly exist in bound forms in biology, rather 
than the free cations tested here this is unconcerning. For 67, results were similar, as shown 
in Figure 3.11b, with only Cu2+, Fe2+ and Fe3+ continuing to quench fluorescence after the 
addition of Zn2+. Importantly, the metal ions Na+, K+, Ca2+ and Mg2+, which are abundant in 
cells, show no effect on either probe. Overall these results indicate that they should show a 
selective response to ‘mobile’ Zn2+ in cellulo. 
 
Figure 3.11 Metal ion selectivity of a) 65 and b) 67 in 0.1 mM HEPES buffer at pH 7.4. Average 
normalized fluorescence intensities for probes (50 µM) (black bars), after addition of 5 
equivalents of various cations (red bars), followed by addition of 1 equivalent of ZnCl2 (blue 
bars). 
3.3 DFT calculations 
DFT and TDDFT calculations were undertaken to understand the binding behaviour of 65 and 
67 with Zn2+ and their excited states. The optimised structure of probe 65 with 1 equivalent 
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of Zn2+ (Figure 3.12) shows the Zn2+ is bound to the nitrogen in ligand DPEN and a nitrogen 
atom of the triazole. For 67 (Figure 3.13), the triazole nitrogen is involved in binding with Zn2+ 
in addition to the cyclam nitrogen donors, which is consistent with previous observations in 
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Complex with Zn2+ 
Figure 3.13 The optimised structures of 67 and its complex with Zn2+. 
The calculated vertical excitations and emissions are in relatively good agreement with 
experimental data (see Table 3.3 and 3.4). The excited state calculations also show that 
positions of the absorption maxima and the emission energies are not significantly affected 
by the formation of the complexes with Zn2+, as observed experimentally. This behaviour can 
be understood by visualising the S1-S0 electron density plots (Figure 3.14 for 65, Figure 3.15 
for 67). The electronic transition is localised on the naphthalimide moiety and the vicinal 
triazole, and that there is no major difference between probes and their complexes with Zn2+; 
only a slight decrease of electron density on the nitrogen from the triazole is observed when 
it is involved in complex formation, and the oscillator strength is not significantly affected. 
These calculations indicate that the enhancement of emissive behaviour of the complexes 
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should be related to a reduced decay through nonradiative pathways after complexation with 
Zn2+ in contrast with the typical PET mechanism. The role of alternative mechanisms to PET in 
enhancing the fluorescence of organometallic complexes has been recently highlighted (see 
also Section 1.3.5).19,124 The formation of the complex hinders large amplitude vibrations in 
the vicinity of the fluorophore hampering access to nonradiative mechanisms and increasing 
the quantum yield of the emission. The restriction of intramolecular rotations can also hinder 
the access to low energy conical intersections associated with ultrafast decay to the ground 
state. Tang et al., have recently shown how the restriction of intramolecular motions in a Zn2+ 
complex can hamper the access to a dark state enhancing the fluorescence response.125 
Table 3.3. Comparison of the experimental data with the calculated result of vertical 













Absorption S0→S1 3.84 322 0.5747 3.58 eV/346 nm 
S0→S2 4.27 290 0.0384 
S0→S3 4.39 282 0.0002 
S0→S4 4.71 263 0.0041 
S0→S5 4.72 262 0.0043 
S0→S6 4.90 253 0.0043 
Emission S1→S0 3.19 388 0.7145 3.01 eV/412 nm 
Complex of 65 with Zn2+ 
Absorption S0→S1 3.95 314 0.5437 3.58 eV/346 nm 
S0→S2 4.26 291 0.0501 
S0→S3 4.33 286 0.0006 
S0→S4 4.68 265 0.0082 
S0→S5 4.93 252 0.0328 
S0→S6 5.33 233 0.0138 










Table 3.4. Comparison of the experimental data with the calculated result of vertical 













Absorption S0→S1 3.87 320 0.5642 3.58 eV/346 nm 
S0→S2 4.06 305 0.0021 
S0→S3 4.27 290 0.0424 
S0→S4 4.39 283 0.0010 
S0→S5 4.68 265 0.0000 
S0→S6 4.73 262 0.0064 
Emission S1→S0 3.18 390 0.7329 3.01 eV/412 nm 
Complex of 67 with Zn2+ 
Absorption S0→S1 3.97 312 0.5188 3.58 eV/346 nm 
S0→S2 4.27 290 0.0534 
S0→S3 4.33 286 0.0008 
S0→S4 4.69 264 0.0045 
S0→S5 4.93 251 0.0310 
S0→S6 5.41 229 0.0126 





Complex with Zn2+ 
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Figure 3.14 S1-S0 electron density map for probe 65 and its complex with Zn2+ (S1 minima).  




Complex with Zn2+ 
Figure 3.15 S1-S0 electron density map for probe 67 and its complex with Zn2+ (S1 minima).  
Red represents positive densities and blue negative values. 
3.4 In cellulo tests 
3.4.1 Cell viability of probes 
Encouraged by the promising properties of 65 and 67 in vitro, their suitability for imaging Zn2+ 
in cells was assessed. Firstly, the innate toxicity of the probes was measured by AlamarBlue 
assays with HeLa cells (Figure 3.16). The cell viabilities were over 90% after 24 h incubation 
with both 65 and 67 in a concentration range 10-50 µM compared to the control group, 
demonstrating both have very low cytotoxicity. In contrast, the viability of cells incubated 




Figure 3.16 The HeLa cell viability against probe a) 65, b) 67 and c) 70 at different 
concentrations. 
3.4.2 ER-targeting ability 
The targeting behaviour of 65 and 67 was then studied using co-staining assays. HeLa cells 
were co-incubated with 65 and ER-tracker red, as shown in Figure 3.17, the fluorescence of 
65 from the green channel overlays well with that of ER-tracker red, which was obtained from 
the red channel, giving an excellent Pearson’s correlation coefficient of 0.92. The negative 
controls of 65 co-incubated with Mito-tracker red and Lyso-tracker red did not reveal a good 
overlay and Pearson’s correlation coefficients were 0.52 and 0.58, respectively. Similar results 
were observed for 67 (see Figure 3.18) with Pearson’s coefficients of 0.85, 0.52, 0.45 being 
measured for the ER, mitochondria and lysosome respectively.  
To confirm the probes have ER-targeting ability in different cell types, a human breast cancer 
cell line MCF-7, a sweat gland tissue cell line EC23 and a human liver cancer cell line HepG2 
were used to study the ER-targeting behaviour. The results (see Figure 3.19 to 3.21 for probe 
65, Figure 3.22 to 3.24 for probe 67) show that probe localisation is similar to that observed 
in HeLa cells demonstrating the general applicability of the probes. Based on these data, it 




Figure 3.17 The colocalisation images of HeLa cells incubated with 65 (20 µM, GFP filter: λex = 
470/30 nm, λem = 530/50 nm) and commercial red organelle tracker dyes (RFP filter: λex = 
530/40 nm, λem = 605/55 nm). (Scale bars = 20 µm). 
 
Figure 3.18 The colocalisation images of HeLa cells incubated with probe 67 (20 µM, GFP filter: 
λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 530/40 nm, 




Figure 3.19 The colocalisation images of MCF-7 cells incubated with probe 65 (20 µM, GFP 
filter: λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 
530/40 nm, λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 
0.87, 0.43 and 0.49 compared to ER-tracker red, Mito-tracker red and Lyso-tracker red, 
respectively. 
 
Figure 3.20 The colocalisation images of EC23 cells incubated with probe 65 (20 µM, GFP filter: 
λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 530/40 nm, 
λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 0.88, 0.48 and 




Figure 3.21 The colocalisation images of HepG2 cells incubated with probe 65 (20 µM, GFP 
filter: λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 
530/40 nm, λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 
0.91, 0.64 and 0.46 compared to ER-tracker red, Mito-tracker red and Lyso-tracker red, 
respectively. 
 
Figure 3.22 The colocalisation images of MCF-7 cells incubated with probe 67 (20 µM, GFP 
filter: λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 
530/40 nm, λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 





Figure 3.23 The colocalisation images of EC23 cells incubated with probe 67 (20 µM, GFP filter: 
λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 530/40 nm, 
λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 0.87, 0.48 and 
0.53 compared to ER-tracker red, Mito-tracker red and Lyso-tracker red, respectively. 
 
Figure 3.24 The colocalisation images of HepG2 cells incubated with probe 67 (20 µM, GFP 
filter: λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 
530/40 nm, λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 




3.4.3 Zn2+ fluorescence response in cells 
As 65 and 67 can localise to the ER, their fluorescence response to ‘mobile’ Zn2+ in cellulo was 
tested to demonstrate that they have the ability to image Zn2+ in the ER. As shown in Figure 
3.25, the fluorescence response of probe 65 in HeLa cells could be clearly observed in the ER. 
Upon the addition of zinc pyrithione, the fluorescence intensity increased considerably; the 
addition of TPEN, resulted in almost complete quenching of fluorescence, as expected from 
in vitro control experiments. Similar results were observed in other cell lines and also for 67 
(Figure 3.26 to 3.32) demonstrating that both probes are tractable in their ability to image 
mobile Zn2+ in cellulo. The fluorescence intensity read from these images (Figure 3.33) clearly 
reveals these changes. For example, in HeLa cells the intensity of the fluorescence response 
increases 3.6 times after the addition of zinc pyrithione and decreases by 30% on addition of 
TPEN compared to that observed for 65 alone.  
 
Figure 3.25 Fluorescence microscopy images of HeLa cells treated with 65 (20 µM), 65 (20 µM) 




Figure 3.26 Fluorescence microscopy images of MCF-7 cells treated with 65 (20 µM), 65 (20 
µM) with zinc pyrithione (100 µM), and 65 (20 µM) with TPEN (100 µM). (Scale bars = 20 µm). 
 
Figure 3.27 Fluorescence microscopy images of EC23 cells treated with 65 (20 µM), 65 (20 µM) 




Figure 3.28 Fluorescence microscopy images of HepG2 cells treated with 65 (20 µM), 65 (20 
µM) with zinc pyrithione (100 µM), and 65 (20 µM) with TPEN (100 µM). (Scale bars = 20 µm). 
 
Figure 3.29 Fluorescence microscopy images of HeLa cells treated with 67 (20 µM), 67 (20 µM) 




Figure 3.30 Fluorescence microscopy images of MCF-7 cells treated with 67 (20 µM), 67 (20 
µM) with zinc pyrithione (100 µM), and 67 (20 µM) with TPEN (100 µM). (Scale bars = 20 µm). 
 
Figure 3.31 Fluorescence microscopy images of EC23 cells treated with 67 (20 µM), 67 (20 µM) 




Figure 3.32 Fluorescence microscopy images of HepG2 cells treated with 67 (20 µM), 67 (20 
µM) with zinc pyrithione (100 µM), and 67 (20 µM) with TPEN (100 µM). (Scale bars = 20 µm). 
 
Figure 3.33 The fluorescence intensity (F) in different cell lines in the presence of zinc 
pyrithione (red bars) or TPEN (blue bars) relative to the intensity of the probe alone (F0, black 
bars, normalised to 1). 
3.4.4 Fluorescence changes under ER stress 
As 65 shows excellent ER-localisation and Zn2+ response, attempts were made to explore 
whether it could be applied to monitor changes in mobile Zn2+ levels. It has been reported 
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that ER stress can be induced by tunicamycin and thapsigargin, with tunicamycin causing 
unfolded protein accumulation and thapsigargin reducing Ca2+ levels.126 As shown in Figure 
3.34, the fluorescence intensity of 65 in HepG2 cells decreased significantly after treatment 
with both ER stress inducers, indicating that the mobile Zn2+ level in the ER was significantly 
depleted under ER stress within 1 hour. As a control, no fluorescence intensity change was 
observed in the absence of inducers (Figure 3.35). 
 
Figure 3.34 a) Fluorescence microscopy images and b) fluorescence intensity changes of 
probe 65 (20 µM) in HepG2 cells at ER stress state induced by tunicamycin (5 µg/mL) or 
thapsigargin (1 µM). (Scale bars = 20 µm). 
 
Figure 3.35 a) Fluorescence microscopy images and b) fluorescence intensity changes of 




Figure 3.36 Fluorescence spectra of probe 65 (20 µM) and after addition of ER stress inducers 
(1 equivalent), subsequent addition of ZnCl2 (1 equivalent), to show ER stress inducers do not 
affect fluorescence of probe 65 and its response to Zn2+. 
3.5 Summary 
In conclusion, the ER localised fluorescent probes 65 and 67 have been developed to image 
mobile Zn2+ in the ER through the introduction of a simple sulfonylurea targeting group. They 
show a good fluorescence response to Zn2+, high selectivity over biologically relevant 
competing cations, and can be used to detect Zn2+ over a wide range of pH in vitro. Their low 
toxicity, ER-targeting and ability to image mobile Zn2+ in different cell lines should allow them 
to be applied in imaging Zn2+ related biological processes in the ER. The fluorescence intensity 
of 65 was also shown to decrease under ER stress inducers, indicating that mobile Zn2+ levels 
are reduced. The ER localised probes may therefore provide a platform to understand the 
mechanisms cells use to respond to dysfunction of zinc homeostasis in the ER, and to develop 




Chapter 4 Golgi apparatus targeting fluorescent probes to image mobile Zn2+ 
4.1 Probe design and synthesis 
As described in Chapter 1 (see section 1.4.5), cysteine may be used as a targeting unit for the 
Golgi apparatus due to its propensity to accumulate in this organelle. However, cysteine as a 
targeting vector has its limitations in small molecule probes since it is rather hydrophilic,127 
and consequently not membrane permeable in some cases. Such poor membrane 
permeability has been classically addressed through the use of an ethyl ester protected 
carboxylic acid in the commercial probe Zinquin, which undergoes esterase catalysed 
cleavage in cellulo,128 and this strategy has also been utilised to load cells with small molecule 
zinc probes.42 To overcome the poor membrane permeability of cysteine, a trityl protecting 
group was used to increase the hydrophobicity of the probe in this work. Following passive 
diffusion into cells, the acid-labile trityl group is removed intracellularly releasing the free 
cysteine, which then anchors the probe to the Golgi apparatus (Figure 4.1). 
 
Figure 4.1 The structure of the trityl protected Zn2+ probe, 77, and subsequent targeting of 78 
to the Golgi apparatus after deprotection. 
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The synthetic route to both trityl protected probe 77 and its deprotected analogue 78 is 
shown in Scheme 4.1. Firstly, the cysteine thiol group was protected with a trityl group, as 
reported,129 to give 72. Following protection of the carboxylic acid as its methyl ester to give 
73,130 a ‘click’ azide group was then introduced to give amide 74. The trityl protected probe 
77 was then readily obtained by stepwise double ‘click’ reactions following the originally 
reported procedures.121 Although the deprotected probe 78 was ultimately ineffective in 
cellulo, as expected, it was also isolated for further characterisation and testing in vitro. All 
products were satisfactorily characterized by 1H, 13C NMR and IR spectroscopies, as well as 





Scheme 4.1 The synthetic route towards 77 and 78. 
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4.2 Photophysical studies 
Fluorescence Zn2+ titration of probe 77 (Figure 4.3a) shows it has a modest switch on response 
to Zn2+ with a dissociation constant of 3.28 nM (Figure 4.4 and Table 4.1), which is consistent 
with previous values observed in related probes with this zinc-binding motif and fluorophore. 
A titration of probe 77 with different equivalents of Zn2+ by 1H NMR spectroscopy (Figure 4.5 
to 4.7) was performed to further demonstrate the Zn2+ association. As expected, the ligand 
DPEN and the bottom triazole (protons Ha-g) are clearly involved in Zn2+ binding. In addition, 
a number of other proton signals (protons Hh-l and Hm-t) display changes to their chemical 
shifts with increasing equivalents of Zn2+, however this is comparable to the behaviour seen 
previously by us in related systems,131 (see also Section 5.3) which is attributed to global 
changes due to Zn2+ binding to DPEN. The de-protected probe 78 displays a similar switch on 
fluorescence response to Zn2+ (Figure 4.3b) and its dissociation constant was similarly 
determined to be 3.30 nM (Figure 4.4 and Table 4.1). However, it was unable to perform a 
titration by 1H NMR spectroscopy in this case due to poor solubility. 
 
Figure 4.2 The UV-Vis spectra of a) 77 (20 µM) or b) 78 (20 µM) and when saturated with Zn2+ 




Figure 4.3 The fluorescence spectra of a) 77 (1 µM) and b) 78 (1 µM) at different 
concentrations of free Zn2+ (nM) in HEPES buffer solution (50 mM, pH 7.2, 0.1 M KCl). (λex = 
346 nm). 







Figure 4.4 The non-linear curve fitting of the fluorescence intensity of 77 and 78 at different 
concentrations against different concentration of free Zn2+ to determine Kd applying Equation 
7.1. (λex = 346 nm, λem = 414 nm). 
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Table 4.1 The summary of Kd values for probes 77 and 78. 
 [probe] = 1 µM [probe] = 0.1 µM [probe] = 0.01 µM 
 Kd  R
2 Kd  R2 Kd  R2 
77 3.52 ± 0.22 nM 0.9926 3.28 ± 0.12 nM 0.9972 2.59 ± 0.19 nM 0.9897 
78 3.06 ± 0.35 nM 0.9760 2.96 ± 0.25 nM 0.9865 3.30 ± 0.13 nM 0.9971 
 
 
Figure 4.5 1H NMR titration spectra (whole range) of probe 77 (5 mM) with different 




Figure 4.6 1H NMR titration spectra (aromatic range) of probe 77 (5 mM) with different 
equivalents of ZnCl2 in CD3OD. 
 
Figure 4.7 1H NMR titration spectra (range 2.50 - 5.60 ppm) of probe 77 (5 mM) with different 




Figure 4.8 Fluorescence response of a) 77 (1 µM) and b) 78 (1 µM) against [Zn2+]free in HEPES 
buffer solution (50 mM, pH 7.2, 0.1 M KCl).. (λex = 346 nm, λem = 414 nm, slit widths: 5/5 nm). 
The fluorescence quantum yield of probe 77 was measured and was determined to be 0.0014, 
while its complex with one equivalent Zn2+ only increased to 0.0073 (Figure 4.9a), which is 
much lower than that of the similar probes in the last chapter. This is likely to be due to the 
large amplitude vibrations of the trityl group, which increases non-radiative decay pathways. 
It is therefore unsurprising that when the trityl protecting group was removed, the quantum 
yield increased significantly and the quantum yield of probe 78 reached 0.046 and that of its 
complex with 1 equivalent of Zn2+ became 0.092 (Figure 4.9b). Given that the quantum yield 
ratio between 78 and 77 is 33 it was anticipated that if 77 proved to be cell membrane 
permeable and could be converted to 78 in cellulo that this feature could prove to be 
experimentally useful since a significant increase in fluorescence output after deprotection of 




Figure 4.9 Linear plots for 77, 78 and their Zn2+ complexes to obtain quantum yield values.  
Anthracene (Φ = 0.27 in ethanol) was used as a standard sample. (λex = 346 nm, λem = 414 nm, 
slit widths: 5/5 nm). 
The fluorescence of probe 77 and 78 at different pH values was measured. Through non-linear 
curve fitting (Figure 4.10) of the fluorescence emission integration against pH based on 
Equation 7.4, three pKa values of each probe were determined: for 77 pKa1 = 3.95 ± 0.18, pKa2 
= 7.24 ± 0.17 and pKa3 = 9.31 ± 0.35 whilst for 78 they were pKa1 = 4.24 ± 0.17, pKa2 = 6.13 ± 
0.18 and pKa3 = 8.39 ± 0.34. After addition of Zn2+, the fluorescence intensity increased in the 
pH range of 3.0-11.0 (Figure 4.11), which more than covers the biologically relevant range and 
suggests that the probe should perform well in the cellular environment. 
 
Figure 4.10 Normalized integrated fluorescence emission of a) 77 (10 µM) and b) 78 (10 µM) 




Figure 4.11 The pH profile of 77 (10 µM, black dots) and its complex with saturated Zn2+ (red 
dots). F is the fluorescence intensity observed, F7.4 is the fluorescence intensity observed at 
pH 7.4. (λex = 346 nm, λem = 414 nm, slit widths: 5/5 nm). 
To specifically study the fluorescent stability of 77, time-dependent fluorescence 
measurements were undertaken at a range of cellularly relevant pH.132 The probe was stirred 
in PBS buffer solution at a range of different pH values and its fluorescence response 
measured after 1, 6, 12 and 24 hours (Figure 4.12). The fluorescence at pH 6.0 (the pH of the 
trans-Golgi) was higher than that at 7.2 (the pH of cytoplasm and endoplasmic reticulum) 
presumably due to the more acidic nature of the solutions, but all of them remained at the 
same level after 24 hours, indicating the probe to be stable at the relevant cellular pH values 
for prolonged periods. Furthermore, as no obvious fluorescence increase was observed with 
time under the acidic conditions, it also suggests that there is no S-trityl deprotection in 
solution at these pH values, indicating that any deprotection that may occur in cellulo is likely 




Figure 4.12 The time-dependent fluorescence intensity of 77 (10 µM) stirred in PBS buffer 
solution at different pH. 
The selectivity of the probe was investigated in the presence of a range of other cations. As 
shown in Figure 4.13a, the addition of a variety of cations has little or no effect on the 
fluorescence response of 77, even Cd2+. After subsequent addition of Zn2+, the probe 77 was 
still quenched in the presence of Co2+, Cu2+ and Ni2+, but this is not concerning as these cations 
are not abundant in free forms in biological environments. Probe 78 (Figure 4.13b) shows 
broadly the similar selective properties to 77. For the majority of cations tested, particularly 
the physiologically relevant cations (Na+, K+, Mg2+, Ca2+), both probes displayed nearly 
complete recovery after addition of Zn2+, meaning it has the potential to be applied in cellulo 




Figure 4.13 Metal ion selectivity of a) 77 and b) 78 in 0.1 mM HEPES buffer solution at pH 7.4. 
Average normalized fluorescence intensities for probe (10 µM) (black bars), after addition of 
5 equivalents of various cations (red bars), followed by addition of ZnCl2 (blue bars). 
4.3 DFT calculations 
DFT calculations were carried out to study the association between probe and Zn2+ in silico 
(Figure 4.14 and Figure 4.15). The calculated optimized structures supported the bottom 
triazole groups being involved in Zn2+ binding in addition to the DPEN ligands, which was also 
observed by 1H NMR titrations. 
In order to establish the excitation and emission profiles of the probe, TDDFT simulations 
were again undertaken. The calculated absorption energy from ground state S0 to excited 
state S1, and the emission energy from S1 to S0 were in agreement with the experimental data 
(Table 4.2 and Table 4.3). The S1-S0 electron density transition map (Figure 4.16 to Figure 4.17) 
shows the electron changes mainly occur at the naphthalimide moiety and the vicinal triazole. 
After binding with Zn2+, there is only a slight decrease of electron density on the triazole, and 
the oscillator strength is not significantly affected compared to the free probe. Therefore, the 
emission increase of the complex again appears to be related to a reduced decay through 
nonradiative pathways after binding with Zn2+. The stabilization of the complex hinders large 
amplitude vibrations in the vicinity of the fluorophore, which hampers access to nonradiative 
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mechanisms and increases the quantum yield of fluorescence. The restriction of 
intramolecular rotations can also hinder the access to low energy conical intersections 




Complex with Zn2+ 








Complex with Zn2+ 
















Table 4.2. Comparison of the experimental data with the calculated result of vertical 













Absorption S0→S1 3.90 318 0.5434 3.58 eV/346 nm 
S0→S2 4.26 291 0.0480 
S0→S3 4.38 283 0.0003 
S0→S4 4.66 266 0.0007 
S0→S5 4.84 256 0.0190 
S0→S6 4.93 251 0.0200 
Emission S1→S0 3.14 395 0.7226 2.99 eV/414 nm 
Complex of 77 with Zn2+ 
Absorption S0→S1 3.96 313 0.5070 3.58 eV/346 nm 
S0→S2 4.26 291 0.0552 
S0→S3 4.33 286 0.0003 
S0→S4 4.60 270 0.0003 
S0→S5 4.94 251 0.0327 
S0→S6 5.29 234 0.0027 
Emission S1→S0 3.23 384 0.6630 2.99 eV/414 nm 
 
Table 4.3. Comparison of the experimental data with the calculated result of vertical 












Absorption S0→S1 3.89 319 0.5438 3.58 eV/346 nm 
S0→S2 4.26 291 0.0476 
S0→S3 4.38 283 0.0003 
S0→S4 4.67 265 0.0007 
S0→S5 4.84 256 0.0175 
S0→S6 4.92 252 0.0226 
Emission S1→S0 3.14 395 0.7241 2.99 eV/414 nm 
Complex of 78 with Zn2+ 
Absorption S0→S1 3.96 313 0.4989 3.58 eV/346 nm 
S0→S2 4.25 291 0.0554 
S0→S3 4.33 286 0.0001 
S0→S4 4.61 269 0.0002 
S0→S5 4.90 253 0.0320 
S0→S6 5.27 235 0.0065 







Complex with Zn2+ 
Figure 4.16. S1-S0 electron density map for probe 77 and its complex with Zn2+ (S1 minima).  







Complex with Zn2+ 
Figure 4.17. S1-S0 electron density map for probe 78 and its complex with Zn2+ (S1 minima).  
Red represents positive densities and blue negative values. 
4.4 In cellulo tests 
4.4.1 Cell toxicity and permeability of probes 
As the probes showed promising photophysical properties in solution, their application in cells 
was also assessed. Firstly, the toxicity of 77 and 78 was measured through the AlamarBlue 
cell viability assay, and after 24 hours’ incubation with both probes, the viability of HeLa cells 
(Figure 4.18) did not show any obvious decrease even with probe concentrations up to 50 µM, 
indicating that they are not cytotoxic. However, initial fluorescence microscopy tests of the 
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probes in HeLa cells (Figure 4.19) showed that the cells incubated with 78 do not display any 
intracellular fluorescence, indicating that 78, as expected due to its hydrophilic nature, is not 
membrane permeable. In contrast, cells incubated with 77 clearly showed evidence of probe 
internalization. Therefore, further cell experiments only focused on probe 77. 
 
Figure 4.18 The HeLa cell viability against probe a) 77 and b) 78 at different concentrations. 
 
Figure 4.19 Fluorescence microscopy images of HeLa cells after 10 minutes’ treatment with 
probes 77 and 78 (10 µM) without any processing clearly showing internalisation of 77 and 
not 78. (GFP filter: λex = 470/30 nm, λem = 530/50 nm, scale bars = 20 µm). 
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4.4.2 Subcellular localisation 
To test the Golgi apparatus targeting ability of 77, HeLa cells were incubated in its presence 
for 1 hour and were then co-incubated with different organelle tracker dyes for a certain time 
period (normally 15-30 minutes). This revealed that the fluorescence response of 77 was 
almost exclusively only observed in the endoplasmic reticulum (ER) rather than the Golgi 
apparatus (Figure 4.20) and was of relatively low intensity. It was speculated that this was 
because the trityl protecting group was not removed in this time period in cellulo and that a 
longer incubation time was required to facilitate this and subsequent re-localisation into the 
Golgi apparatus. Indeed, this proved to be the case and when the incubation time was 
extended to 24 hours the fluorescent response showed a significant increase in intensity, with 
excellent co-localisation with Bodipy TR ceramide observed, a commercial Golgi tracker red 
reagent, with no evidence of ER fluorescence as had been the case for the shorter incubation 
periods. The same result was also observed in the MCF-7 cell line (Figure 4.21), suggesting 




Figure 4.20 Confocal microscopy images of HeLa cells after treatment with 77 (10 µM, λex = 
488 nm, λem = 509 nm) for 1 h or 24 h, compared to ER marker or Golgi marker (λex = 594 nm, 




Figure 4.21 Confocal microscopy images of MCF-7 cells after treatment with 77 (10 µM, λex = 
488 nm, λem = 509 nm) for 1 h or 24 h, compared to ER marker or Golgi marker (λex = 594 nm, 
λem = 620 nm). (Scale bars = 20 µm). 
The Pearson’s correlation coefficient was measured by comparing probe 77 (GFP channel) 
after 24 hours of incubation to different organelle trackers (RFP channel). In HeLa cells (Figure 
4.22), the fluorescence of 77 showed excellent correlation with that of Bodipy TR ceramide, 
giving a Pearson’s coefficient of 0.92. The values of negative control groups were much lower, 
with values of 0.42, 0.38 and 0.59 when compared to commercial ER, Mito and Lyso tracker 
red dyes respectively. Similar results were obtained in the breast cancer cell line MCF-7 
(Figure 4.23) and a sweat gland tissue cell line EC23 (Figure 4.24), revealing the probe’s 




Figure 4.22 The colocalisation images of HeLa cells incubated with probe 77 (10 µM, GFP filter: 
λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 530/40 nm, 
λem = 605/55 nm). (Scale bars = 20 µm). 
 
Figure 4.23 The colocalisation images of MCF-7 cells incubated with probe 77 (10 µM, GFP 
filter: λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 
530/40 nm, λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 





Figure 4.24 The colocalisation images of EC23 cells incubated with probe 77 (10 µM, GFP filter: 
λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 530/40 nm, 
λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 0.92, 0.52 and 
0.60 compared to Golgi-tracker red, ER-tracker red and Mito-tracker red, respectively. 
4.4.3 Zn2+ response in cells 
The response of probe 77 in cells was recorded to demonstrate its ability to respond to 
variation in Zn2+ levels in the Golgi apparatus. As shown in Figure 4.25, the fluorescence of 77 
in HeLa cells increased significantly after the addition of zinc pyrithione indicating it has a 
switch on fluorescence response to Zn2+ in cellulo. When TPEN was added, the fluorescence 
was almost completely quenched. Similar results were also observed in MCF-7 (Figure 4.26) 
and EC23 cell lines (Figure 4.27), and the fluorescence intensity read from the images is shown 




Figure 4.25 Fluorescence microscopy images of HeLa cells treated with 77 (10 µM), 77 (10 µM) 
with zinc pyrithione (50 µM), and 77 (10 µM) with TPEN (50 µM). (Scale bars = 20 µm, GFP 
filter: λex = 470/30 nm, λem = 530/50 nm). 
 
Figure 4.26 Fluorescence microscopy images of MCF-7 cells treated with 77 (10 µM), 77 (10 
µM) with zinc pyrithione (50 µM), and 77 (10 µM) with TPEN (50 µM). (Scale bars = 20 µm, 




Figure 4.27 Fluorescence microscopy images of EC23 cells treated with 77 (10 µM), 77 (10 µM) 
with zinc pyrithione (50 µM), and 77 (10 µM) with TPEN (50 µM). (Scale bars = 20 µm, GFP 
filter: λex = 470/30 nm, λem = 530/50 nm). 
 
Figure 4.28 The fluorescence intensity (F) of 77 in different cell lines with zinc pyrithione (red 




4.4.4 Zn2+ level changes during oxidative stress 
Given that 77 is able to image Zn2+ in the Golgi apparatus in three cell lines and respond to 
variations in its levels induced by the addition of zinc pyrithione or TPEN, it was applied to 
monitor mobile Zn2+ changes in the Golgi apparatus during changes to redox status, as this 
has not been investigated widely due to the lack of an effective tool to do so. MCF-7 cells, 
after 24 hours’ incubation with 77, were first treated with H2O2 to induce oxidative stress and 
the intensity of the fluorescence response in the cells monitored against time (Figure 4.29a). 
The fluorescence response was observed to be significantly reduced after the addition of H2O2 
with levels stabilising after approximately 30 mins. Then glutamine, was added to reverse 
oxidative status, and the fluorescence intensity then remained stable. In contrast, when 
glutamine was first introduced and H2O2 subsequently added the fluorescence remained 
largely stable with only a small decrease of its intensity (Figure 4.29b). The reasons for the 
reduced fluorescence response observed in Figure 4.29a may, in part, be due to the known 
antioxidant role zinc plays since it is a cofactor of the superoxide dismutase enzyme, which 
regulates the detoxification of reactive oxygen species, protecting cells against the oxidative 
stress.3 However, it has also been reported that the concentration of mobile Zn2+ increases in 
the mitochondria38 and lysosome48 under oxidative stress induced by H2O2. Metallothionein, 
which is mainly localised to the membrane of the Golgi apparatus,133 is known to play an 
important role in the regulation of Zn2+ homeostasis, as well as providing protection against 
oxidative stress in cells.134  It is therefore assumed that under oxidative stress, Zn2+ is 
transported from the Golgi apparatus to the mitochondria and lysosome to function. In 
contrast, if glutamine was first added, the addition of H2O2 should not cause high levels of 
oxidative stress, therefore zinc levels would not be reduced and therefore no significant 
fluorescence decrease would be expected, as observed. Similar results were also observed in 
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HeLa cells, (Figure 4.30), indicating that this process is likely to be general among different 
cell lines. Finally, an in vitro control experiment was undertaken to exclude the effect of H2O2 
and glutamine themselves on the fluorescence response of the probe, which showed there 
was no difference in response when the two reagents were added separately in the presence 
of zinc (Figure 4.31 and Figure 4.32). Therefore, it appears reasonable to propose that there 
is a lowering of the concentration of mobile Zn2+ in the Golgi apparatus in response to 
oxidative stress. 
 
Figure 4.29 Fluorescence intensity of 77 (10 µM) in MCF-7 cells treated with a) H2O2 (200 µM) 
and then glutamine (200 µM) or b) glutamine (200 µM) and then H2O2 (200 µM) and the cell 




Figure 4.30 Fluorescence intensity of 77 (10 µM) in HeLa cells treated with a) H2O2 (200 µM) 
and then glutamine (200 µM) or b) glutamine (200 µM) and then H2O2 (200 µM) and the cell 
images taken at different times. (Scale bars = 20 µm). 
 
Figure 4.31 Fluorescence spectra of 77 (10 µM) and with subsequent addition of excess ZnCl2, 




Figure 4.32 Fluorescence spectra of 78 (10 µM) and with subsequent addition of excess ZnCl2, 
H2O2 (100 µM) and glutamine (100 µM) in PBS buffer. 
4.5 Summary 
In summary, a Golgi apparatus targeted Zn2+ probe 77 was successfully synthesized that is 
able to undergo passive membrane diffusion as a result of the lipophilic nature of the S-trityl 
protecting group. It is apparent that initial probe localisation in cellulo occurs in the ER, 
however, after 24 hours the fluorescence response increases significantly, presumably due to 
S-trityl group deprotection forming 78, which displays a quantum yield that is 33-fold higher 
than 77, and the probe consequently becomes anchored to the Golgi apparatus. The probe 
shows excellent specificity for targeting of the Golgi apparatus and the ability to image mobile 
Zn2+ in different cell lines. This allowed it to be applied in the monitoring of changes to mobile 
Zn2+ levels in the Golgi apparatus in response to oxidative stress induced by H2O2, which 
indicated that the concentration of mobile Zn2+ decreases. This suggests that the probe may 
provide an effective tool to probe changes to mobile Zn2+ that occur in the Golgi apparatus in 




Chapter 5 An alternative modular ‘click-SNAr-click’ approach to develop subcellular localised 
fluorescent probes to image mobile Zn2+ 
5.1 Probe design and synthesis 
Previously a modular ‘click’ synthetic methodology to produce an array of fluorescent probes 
for imaging of zinc at specific cellular targets was described in Chapter 2 to Chapter 4. 
However, this methodology, based on a ‘top to bottom’ double click process (i.e. first 
incorporate the targeting unit through a click reaction and then to introduce the Zn2+ binding 
ligand through a second click reaction) can be hampered somewhat by the final synthetic step, 
which can be a slow, moderately low yielding reaction and can also lead to the unwanted 
formation of an aniline by-product that is difficult to remove. This is unattractive if the 
targeting unit is either expensive or requires complex multi-step synthesis. Therefore, an 
alternative approach to ameliorate these issues was sought utilising a modular strategy 
involving a ‘bottom to top’ double click reaction methodology (i.e. first incorporate the Zn2+ 
binding ligand through a click reaction and perform a click reaction in the last step to 
introduce the targeting unit), which would have the advantage that high value organelle 
targeting vectors could be introduced in the last synthetic step, which is generally fast and 
high yielding. Using this strategy, endoplasmic reticulum (ER), mitochondria and lysosome 
targeting probes were successfully prepared. 
The precursors 80,135 82,25 8425 were all synthesized according to reported procedures 
(Scheme 5.1). The conversion of azide 58, to alkyne 59, using the same procedure  as reported 
in Chapter 3 (see Section 3.1), was performed in a one-pot reaction because the intermediate 
formed after the ‘click’ reaction could not be readily extracted from the aqueous layer. It 
proved expedient to simply follow this step by the direct addition of propargylamine to the 
reaction mixture to give 59 in a moderate yield. With alkyne 59 and the range of different 
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organelle targeting azides 80, 82 and 84 in hand, the top ‘click’ reactions were performed 
successfully in moderate to good yields to produce the different organelle targeting probes 
85-87. As a control, the non-targeting probe 90 was also prepared as reported in 93% yield 
(Scheme 5.2).102 All products were satisfactorily characterized by 1H, 13C NMR and IR 




Scheme 5.1 The new ‘bottom to top’ modular synthetic route towards the sub-cellular 




Scheme 5.2 The synthesis of the non-targeting control probe 90. 
5.2 Photophysical properties 
Fluorescence titrations of the different probes with Zn2+ were undertaken to show their Zn2+ 
response. As shown in Figure 5.2, the addition of Zn2+ results in the fluorescence intensity of 
all probes increasing gradually, until a maximal more than 10-fold increase was observed. The 
Job’s plots of the probes (Figure 5.3) revealed the expected 1:1 binding stoichiometry with 
Zn2+. Dissociation constants, Kd, were evaluated from non-linear curve fitting analysis 
(Figure 5.4) of the data obtained from the fluorescence titrations of different concentration 
probes in a competitive system with EGTA and the results given in Table 5.1. The best fitting 
for all probes was observed at 0.01 µM and Kd values were determined to be 2.83 ± 0.11 nM 
for 85, 3.44 ± 0.22 nM for 86, 3.68 ± 0.26 nM for 87 and 3.24 ± 0.20 nM for 90, which are 
consistent and comparable to reported values for this chelate.35,136 The detection limit was 




Figure 5.1 The UV-Vis spectra of 50 µM a) 85, b) 86, c) 87 and d) 90 and their complexes with 
different equivalents of Zn2+ in 0.1 mM HEPES buffer at pH 7.4. 
 
Figure 5.2 The fluorescence response of 50 µM a) 85, b) 86, c) 87 and d) 90 to different 




Figure 5.3 The Job’s plot to determine the stoichiometry of the complex formed between 
probes a) 85, b) 86, c) 87 and d) 90 and Zn2+. The total amount of [Probe + Zn2+] was 100 µM. 
(λex = 346 nm, λem = 414 nm, slit widths: 5/2.5 nm). 
 
Figure 5.4 The non-linear curve fitting of the fluorescence intensity of probes a) 85, b) 86, c) 
87 and d) 90 at different concentrations against [Zn2+]free in HEPES buffer solution (50 mM, pH 
7.2, 0.1 M KCl). (λex = 346 nm, λem = 414 nm). 
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Table 5.1 The summary of Kd for probes 85-87 and 90. 
 [probe] = 1 µM [probe] = 0.1 µM [probe] = 0.01 µM 
 Kd  R
2 Kd  R2 Kd  R2 
85 3.16 ± 0.34 nM 0.9789 3.05 ± 0.18 nM 0.9931 2.83 ± 0.11 nM 0.9968 
86 3.38 ± 0.29 nM 0.9866 2.87 ± 0.23 nM 0.9878 3.44 ± 0.22 nM 0.9919 
87 2.78 ± 0.34 nM 0.9734 2.91 ± 0.26 nM 0.9845 3.68 ± 0.26 nM 0.9911 
90 3.15 ± 0.40 nM 0.9719 4.81 ± 0.47 nM 0.9850 3.24 ± 0.20 nM 0.9932 
 
 
Figure 5.5 Fluorescence response of 1 µM probes a) 85, b) 86, c) 87 and d) 90 against [Zn2+]free 
in HEPES buffer solution (50 mM, pH 7.2, 0.1 M KCl). (λex = 346 nm, λem = 414 nm, slit widths: 
5/5 nm). 
The fluorescence quantum yield was again measured using anthracene as a standard and 
linear plots of probes and their complexes with one equivalent of Zn2+ are shown in Figure 5.6. 
The calculated quantum yields are listed in Table 5.2 and show that the targeting units reduce 
the probes’ quantum yields significantly, compared to that of 90, with no targeting unit, 
presumably due to the increased access to non-radiative pathways that are available in the 




Figure 5.6 Linear plots for standard sample, probes a) 85, b) 86, c) 87 and d) 90, and their 
complexes with 1 equivalent Zn2+ to obtain quantum yields. (λex = 346 nm, slit widths: 5/5 nm). 
Table 5.2 The quantum yield of probes and their complex with 1 equivalent Zn2+. 
Probe Φprobe Φcomplex 
85 0.05 0.28 
86 0.06 0.30 
87 0.07 0.34 
90 0.11 0.81 
 
The pH-dependent fluorescence response was measured to show that all probes have 
fluorescence responses to Zn2+ in the biologically relevant pH range. As shown in Figure 5.7a, 
probe 85 shows a good switch on response to Zn2+ over a wide pH range 3.0-10.0, the same 
results were broadly observed for the other probes (Figure 5.7), as expected due to the 
identical metal-chelating motif. The fluorescence intensity of all probes increased in an acidic 
environment, however, compared to the other three probes, 85 and its complex were 
significantly brighter. Sessler et al. explained this behaviour based on a PET mechanism,51 
however, Veale and Gunnlaugasson have previously suggested that this is unlikely because 
133 
 
the PET quenching from groups connected via the imide moiety is normally prevented.137 It 
therefore seems more likely that the differences in emission observed at different pH values 
are due to the presence of different species formed by the protonation of the tertiary amine 
or by the deprotonation of coordinated water. Given the range of pH observed in different 
organelles and the cytoplasm (i.e. the pH is about 7.2 in ER and cytoplasm, 8 in the 
mitochondria and around 5 in the lysosome), all probes should display a response to mobile 
Zn2+ in cellulo. By integrating the intensity of the fluorescence emission spectra against pH 
(Figure 5.8) for different probes, their apparent pKa values were determined through non-
linear curve fitting applying Equation 7.5. 
 
Figure 5.7 The pH profiles of probes a) 85, b) 86, c) 87 and d) 90 (50 µM, black dots) and their 





Figure 5.8 Normalized integrated fluorescence emission of probes (50 µM) vs pH, the 
nonlinear curve fitting used to determine the apparent pKa values. The determined pKa values 
are: a) 85, pKa1 = 2.65 ± 0.26, pKa2 = 3.62 ± 0.09, pKa3 = 7.13 ± 0.17, pKa4 = 10.42 ± 0.41, R2 = 
99.83%; b) 86, pKa1 = 1.91 ± 0.27, pKa2 = 3.88 ± 0.13, pKa3 = 7.97 ± 0.32, pKa4 = 11.95 ± 0.12, R2 
= 98.57%; c) 87, : pKa1 = 0.70 ± 0.38, pKa2 = 4.33 ± 0.08, pKa3 = 6.99 ± 0.15, pKa4 = 11.91 ± 0.06, 
R2 = 99.64%; d) 90, pKa1 = 1.53 ± 0.29, pKa2 = 4.14 ± 0.10, pKa3 = 6.73 ± 0.21, pKa4 = 11.50 ± 
0.17, R2 = 99.39%. 
The selectivity of probes was investigated in the presence of a range of other biologically 
relevant cations.  From Figure 5.9, it can be seen that all probes display similar behaviour, 
which is to be expected given they contain the same metal binding motif. The fluorescence 
did not show an obvious increase after addition of 5 equivalents of other cations, except, as 
previously, for the stereoelectronic isostere Cd2+. Subsequent addition of 1 equivalent of Zn2+ 
resulted in recovery of a fluorescence response for most cations, except for Co2+, Cu2+ and 
Ni2+ for which fluorescence again remained quenched. Therefore, the results above suggest 




Figure 5.9 Metal ion selectivity of probes a) 85, b) 86, c) 87 and d) 90 in 0.1 mM HEPES buffer 
solution at pH 7.4. Average normalized fluorescence intensities for probes (50 µM) (black 
bars), after addition of 5 equivalents of various cations (red bars), followed by addition of 1 
equivalent of ZnCl2 (blue bars). 
5.3 NMR titration of 90 with Zn2+ 
In order to study the binding behaviour between 90 and Zn2+, a 1H NMR titration with different 
equivalents of Zn2+ was performed (see Figure 5.10). From Figure 5.11 and Figure 5.12, it can 
be seen that protons Hc-g are largely unaffected, while Hl-n, Hh and Hi,j have significant 
downfield shifts after binding with Zn2+. This indicates that the DPEN ligand and the triazole 
are involved in metal binding. This result is consistent with the behaviour observed by single 




Figure 5.10 1H NMR titration spectra (whole range) of probe 90 (5 mM) with different 
equivalents ZnCl2 in CD3OD. 
 
Figure 5.11 The aromatic region of the 1H NMR spectra of probe 90 (5 mM) with different 




Figure 5.12 1H NMR titration spectra (range 3.70 - 4.70 ppm) of probe 90 (5 mM) with different 
equivalents ZnCl2 in CD3OD. 
5.4 DFT calculations 
In addition to the 1H NMR spectroscopic titration, DFT calculations were also undertaken to 
study the association between the probes and Zn2+. The optimised structures of the 
complexes of probes with 1 equivalent Zn2+ (Figure 5.13 to 5.16) also show the nitrogen atoms 
in the triazoles adjacent to the DPEN ligand are involved in binding with Zn2+, in addition to 
those of the DPEN ligands. 
TDDFT studies were also undertaken to understand the excitation and emission profiles of 
probes. The results of calculated absorption energy from ground state S0 to the excited state 
S1, and the emission energy were in agreement with the experimental data (Table 5.3 to 5.6). 
There was also nearly no difference among the different probes, showing that the targeting 
groups have negligible effects on the Zn2+ association and photophysical properties, other 
than quantum yields, which is consistent with the experimental data above.  
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In keeping with the previous chapters, the S1-S0 electron density transition (Figure 5.17 to 
5.20) of all probes is mainly localised on the naphthalimide moiety and the vicinal triazole, 
and there is only a slight decrease of electron density on the triazole when it is involved in 
complex formation and the oscillator strength is not significantly affected. Therefore, the 
enhancement of emissive behaviour of the complexes should again be related to a reduced 
decay through nonradiative pathways after complexation with Zn2+. The stabilisation of the 
complex hinders large amplitude vibrations in the vicinity of the fluorophore hampering the 
access to nonradiative mechanisms and increasing the quantum yield of emission. The 
restriction of intramolecular rotations can also hinder the access to low energy conical 
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Table 5.3. Comparison of the experimental data with the calculated result of vertical 













Absorption S0→S1 3.90 318 0.5443 3.58 eV/346 nm 
S0→S2 4.26 291 0.0483 
S0→S3 4.38 283 0.0002 
S0→S4 4.68 265 0.0010 
S0→S5 4.84 256 0.0201 
S0→S6 4.93 251 0.0190 
Emission S1→S0 3.14 395 0.7240 3.01 eV/412 nm 
Complex of 85 with Zn2+ 
Absorption S0→S1 3.96 313 0.5015 3.58 eV/346 nm 
S0→S2 4.25 291 0.0557 
S0→S3 4.33 286 0.0002 
S0→S4 4.62 268 0.0004 
S0→S5 4.94 251 0.0329 
S0→S6 5.31 234 0.0055 
Emission S1→S0 3.21 386 0.6748 3.01 eV/412 nm 
 
Table 5.4. Comparison of the experimental data with the calculated result of vertical 













Absorption S0→S1 3.89 318 0.5149 3.58 eV/346 nm 
S0→S2 4.25 292 0.0493 
S0→S3 4.38 283 0.0009 
S0→S4 4.73 262 0.0034 
S0→S5 4.84 256 0.0302 
S0→S6 4.89 253 0.0049 
Emission S1→S0 3.14 394 0.7137 3.01 eV/412 nm 
Complex of 86 with Zn2+ 
Absorption S0→S1 3.95 314 0.4796 3.58 eV/346 nm 
S0→S2 4.25 292 0.0530 
S0→S3 4.33 286 0.0019 
S0→S4 4.68 265 0.0003 
S0→S5 4.84 256 0.0273 
S0→S6 5.13 242 0.0178 
Emission S1→S0 3.26 381 0.6351 3.01 eV/412 nm 
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Table 5.5. Comparison of the experimental data with the calculated result of vertical 













Absorption S0→S1 3.89 319 0.5481 3.58 eV/346 nm 
S0→S2 4.26 291 0.0479 
S0→S3 4.39 282 0.0001 
S0→S4 4.70 264 0.0022 
S0→S5 4.83 257 0.0142 
S0→S6 4.90 253 0.0012 
Emission S1→S0 3.14 394 0.7241 3.01 eV/412 nm 
Complex of 87 with Zn2+ 
Absorption S0→S1 3.94 314 0.5169 3.58 eV/346 nm 
S0→S2 4.25 292 0.0543 
S0→S3 4.34 286 0.0002 
S0→S4 4.64 267 0.0008 
S0→S5 4.95 250 0.0329 
S0→S6 4.97 249 0.0015 
Emission S1→S0 3.22 385 0.6710 3.01 eV/412 nm 
 
Table 5.6. Comparison of the experimental data with the calculated result of vertical 













Absorption S0→S1 3.92 316 0.4960 3.58 eV/346 nm 
S0→S2 4.27 290 0.0445 
S0→S3 4.35 285 0.0004 
S0→S4 4.69 264 0.0085 
S0→S5 4.88 254 0.0251 
S0→S6 4.96 250 0.0138 
Emission S1→S0 3.15 393 0.7005 3.01 eV/412 nm 
Complex of 90 with Zn2+ 
Absorption S0→S1 3.99 311 0.4455 3.58 eV/346 nm 
S0→S2 4.26 291 0.0518 
S0→S3 4.30 289 0.0009 
S0→S4 4.65 267 0.0072 
S0→S5 4.94 251 0.0369 
S0→S6 5.41 229 0.0385 







Complex with Zn2+ 
Figure 5.17 S1-S0 electron density map for probe 85 and its complex with Zn2+ (S1 minima).  









Complex with Zn2+ 
Figure 5.18 S1-S0 electron density map for probe 86 and its complex with Zn2+ (S1 minima).  










Complex with Zn2+ 
Figure 5.19 S1-S0 electron density map for probe 87 and its complex with Zn2+ (S1 minima).  









Complex with Zn2+ 
Figure 5.20 S1-S0 electron density map for probe 90 and its complex with Zn2+ (S1 minima).  
Red represents positive densities and blue negative values. 
5.5 In cellulo tests 
5.5.1 Cell toxicity of probes 
As all probes show excellent photophysical properties in vitro, their suitability for imaging Zn2+ 
in cellulo was assessed. Firstly, the innate toxicity of all probes was again measured through 
an AlamarBlue cell viability assay. After 24 hours’ incubation with probes, the HeLa cells’ 
viability (Figure 5.21) did not show an obvious decrease with increasing probe concentration 




Figure 5.21 The HeLa cell viability against probes a) 85, b) 86, c) 87 and d) 90 at different 
concentrations. 
5.5.2 Subcellular localisation studies 
Co-localisation experiments were undertaken to confirm the probes’ subcellular targeting 
ability. HeLa cells were co-incubated with probes and organelle tracking dyes, as shown in 
Figure 5.22, probe 85 displays excellent co-localisation with ER-tracker red with a Pearson’s 
correlation coefficient of 0.88, and its dispersion in the ER and other organelles compares well 
with recent reports.63  Probes 86 and 87 also displayed good co-localisation with Mito-tracker 
red and Lyso-tracker red (Pearson’s coefficients of 0.93 and 0.86 respectively, see Figure 5.23 
and 5.24). In contrast, control probe 90, which has no targeting group, was widely distributed 
in all three organelles (Figure 5.25). Therefore, it can be concluded that probes 85-87, which 





Figure 5.22 The colocalization images of HeLa cells incubated with probe 85 (20 µM, GFP filter: 
λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 530/40 nm, 
λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 0.88, 0.73 and 
0.50 compared to ER-tracker red, Mito-tracker red and Lyso-tracker red, respectively. 
 
Figure 5.23 The colocalization images of HeLa cells incubated with probe 86 (20 µM, GFP filter: 
λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 530/40 nm, 
λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 0.93, 0.41 and 




Figure 5.24 The colocalization images of HeLa cells incubated with probe 87 (20 µM, GFP filter: 
λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 530/40 nm, 
λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 0.86, 0.47 and 
0.71 compared to Lyso-tracker red, Mito-tracker red and ER-tracker red, respectively. 
 
Figure 5.25 The colocalization images of HeLa cells incubated with probe 90 (20 µM, GFP filter: 
λex = 470/30 nm, λem = 530/50 nm) and organelle tracker red dyes (RFP filter: λex = 530/40 nm, 
λem = 605/55 nm). (Scale bars = 20 µm). Pearson’s correlation coefficients were 0.85, 0.78 and 
0.81 compared to ER-tracker red, Mito-tracker red and Lyso-tracker red, respectively. 
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5.5.3 Zn2+ fluorescence response in cells 
As all probes displayed organelle targeting behaviour, their fluorescence response to 
increased levels of cellular Zn2+ was measured. As shown in Figure 5.26, the fluorescence of 
probe 85 in the ER can be observed, and after the addition of zinc pyrithione the fluorescence 
intensity increased considerably. The addition of TPEN, as expected caused almost complete 
quenching of the fluorescence. Similar results were obtained for the other probes (Figure 5.27 
to 5.29), indicating that all probes display a clear fluorescence response to mobile Zn2+ in cells 
and the fluorescence intensity read from the cells for each probe is shown in Figure 5.30. 
 
Figure 5.26 Fluorescence microscopy images of HeLa cells treated with 85 (20 µM), 85 (20 µM) 




Figure 5.27 Fluorescence microscopy images of HeLa cells treated with 86 (20 µM), 86 (20 µM) 
with zinc pyrithione (100 µM), and 86 (20 µM) with TPEN (100 µM). (Scale bars = 20 µm). 
 
Figure 5.28 Fluorescence microscopy images of HeLa cells treated with 87 (20 µM), 87 (20 µM) 




Figure 5.29 Fluorescence microscopy images of HeLa cells treated with 90 (20 µM), 90 (20 µM) 
with zinc pyrithione (100 µM), and 90 (20 µM) with TPEN (100 µM). (Scale bars = 20 µm). 
 
Figure 5.30 The fluorescence intensity (F) of probes in HeLa cells with zinc pyrithione (red bars) 





In conclusion, a new modular ‘bottom to top’ click approach has been developed to synthesize 
subcellular localised probes by incorporating organelle targeting vectors in the last step click 
reaction, which is an effective and efficient method to prepare an array of different organelle 
targeting Zn2+ probes. Three probes 85-87 have been successfully prepared through this 
approach, and have been proven to localise in the ER, mitochondria and lysosome, and all 
display a good fluorescence response to Zn2+ in vitro and in cellulo. It is believed that these 
probes have significant potential to be applied in the imaging of mobile Zn2+ related biological 
processes in these organelles and that through this method, other sub-cellular targeting 





Chapter 6 Conclusions and future work 
6.1 Conclusions 
In conclusion, a series of cellular or subcellular localised Zn2+ probes have been successfully 
prepared through the incorporation of specific targeting units. Their Zn2+ binding behaviours 
were explored by fluorescence and 1H NMR spectroscopic titrations, and all probes showed 
high sensitivity and selectivity to Zn2+ both in solution and in cellulo. The probes also showed 
good accumulation in the targeted cellular location as designed. At the cellular level, a biotin 
tagged Zn2+ probe 47 was synthesized and showed high accumulation in breast cancer cells 
rather than in normal tissue N-TERT cells. At the subcellular level, the originally designed 
endoplasmic reticulum (ER) targeting probes 65 and 67 incorporating a sulfonylurea targeting 
group, Golgi apparatus targeting probe 78 incorporating a cysteine targeting residue, which 
was deprotected from the membrane permeable probe 77 inside cells, showed their 
accumulation in the organelles expected, and good response to Zn2+ in various cell lines.  
Probes 65 and 77 were also applied to monitor Zn2+ level changes during biological processes, 
in the ER and Golgi apparatus under oxidative stress. In addition, an alternative modular ‘click-
SNAr-click’ approach was developed to make the subcellular localised probe synthesis more 
efficient and effective, and based on this strategy, the ER, mitochondria and lysosome 
targeting probes 85-87 were obtained. With these probes available, the mobile Zn2+ in 
different organelles could be studied and related biological processes monitored to help 
better understand the role Zn2+ plays in them. 
6.2 Future work 
In future, some further work could be undertaken to extend the project further and some 
suggestions for the design of new probes will be discussed below. 
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6.2.1 Nucleus targeting Zn2+ probe 
As an obvious extension of the current suite of probes, and as discussed in Section 1.4.6, it is 
necessary to develop a probe to image Zn2+ in the nucleus specifically, though the 
concentration of mobile Zn2+ in this organelle is very low. It is reported that the pyrrole-
imidazole (Py-Im) polyamides have some programmable sequence recognition properties, 
which can bind the minor groove of DNA with high affinity.138 Normally, they are used to 
modulate gene expression in cells.139,140 However, in this case, the non-fluorescent motif, 
which can bind to DNA could be introduced in probe 91 as a nucleus targeting group through 
a click reaction. 
A further interesting challenge would be to develop ratiometric probes to quantify mobile 
Zn2+ concentration in the nucleus. Besides the usually used mechanisms, such as ICT and FRET, 
it may be possible simply to incorporate a fluorescent nucleus targeting dye into a 
conventional Zn2+ probe. However, to prevent the spectral crosstalk between two channels, 
the nucleus stain must have an excitation and emission profile far away from that of the 
naphthalimide fluorophore. Therefore, a commercially available nuclear dye such as TO-PRO-
3 iodide, which has red fluorescence with λex = 642 nm, λem = 661 nm is a possible nucleus 




Figure 6.1 The structures of two proposed nucleus targeting Zn2+ probes, 91 and 92. 
6.2.2 Zn2+ probes to study metabolic processes 
It is known that spatiotemporal zinc fluctuations in response to intra- or extracellular 
environmental changes are related to many biological processes82 and tools to study the role 
Zn2+ plays in these are still required. Though the probes prepared in this thesis showed the 
expected subcellular organelle accumulation, to study the specific biological process, 
especially a specific protein involved process, protein-based sensors using genetically 
encoded targeting sequences may be better to control the cellular localisation, but as 
discussed, they have their limitations mainly in brightness and photostability. To overcome 
the disadvantages of the protein-based or peptide-based sensors, hybrid probes, such as 
SNAP-tag and HaloTag, the self-labelling protein tags based on O-6-methylguanine-DNA 
methyltransferase and haloalkane dehalogenase respectively, may provide a new strategy, as 
they have already been widely used as biomarkers. Protein tags are peptide sequences that 
can be genetically fused to any protein of interest and further specifically to tag with a suitable 
ligand, such as fluorescent dye by a covalent bond and Lippard et al. have reported a series 
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of organelle targeted small molecule-protein hybrid zinc probes based on SNAP-tag141 and 
HaloTag.82 Probes 93 and 94 are designed for SNAP-tag and HaloTag, respectively, which can 
be fused to the protein of interest to study the Zn2+ functions in the protein related processes. 
   
Figure 6.2 Proposed hybrid Zn2+ probes 93 and 94 capable of utilising SNAP-tag and HaloTag. 
6.2.3 Probes with other fluorophores 
In recent years, probes with longer wavelength excitation and emission profiles, such as the 
near-infrared range (650 – 900 nm), have found increasing application in vivo, since the longer 
wavelength light allows for deeper tissue penetration and less autofluorescence from 
surrounding tissues. Although previous studies have demonstrated zinc imaging systems that 
have a two-photon profile, problems with photostability have largely limited their 
applications to single photon excitation25 and consequently due to the short wavelength of 
excitation and emission, the naphthalimide may need to be replaced by another fluorophore.  
Furthermore, with the fast development of high spatiotemporal resolution fluorescent 
microscope, such as total internal reflection fluorescence microscope and super-resolution 
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microscope, probes able to provide real-time information about the locations, dynamics and 
interactions of individual molecules in living cells are highly desired. However, many 
fluorescent proteins and synthetic dyes are not suitable for these new techniques due to their 
low brightness and photostability under high photon intensity microscopy, including the 
naphthalimide probes prepared in this thesis. To find applications in biological labelling, 
probes must have good membrane permeability, suitable wavelength excitation and emission, 
high photostability, a good signal-noise ratio as well as specific targeting ability. Therefore 
modification of fluorophores, such as Rhodamine and Bodipy may be good options as they 
are widely used in cells imaging, can be readily structurally modified to obtain the long 
wavelength excitation and emission profiles desired and by modification of their substitutions, 
it may be possible to develop analogous modular routes towards a series of organelle 
targeted probes with probes like 95 and 96. 
 





Chapter 7 Experimental 
7.1 General experimental information 
Unless otherwise stated, reactions were carried out using commercially available reagents, 
used as supplied from Sigma Aldrich, Alfa Aesar, or Tokyo Chemical Industry (TCI), in 
combination with solvents from Honeywell Solvents. ER-tracker red, Mito-tracker red and 
Lyso-tracker red were purchased from Enzo Life Sciences. Bodipy TR ceramide purchased 
from Thermo Fisher was used as a control Golgi tracker dye. DAPI (4’,6-diamidino-2-
phenylindole) was purchased from Thermo Fisher for DNA stain to show nucleus. The HeLa, 
MCF-7 and HepG2 cell lines used for fluorescence imaging were provided from American Type 
Culture Collection (ATCC Middlesex, UK), and the EC23 cell line was provided by Prof. Michael 
P. Philpott of Barts and The London School of Medicine and Dentistry, Queen Mary University 
of London. Anhydrous DCM and DMF were purified from an MBRAUN MB SPS-800 solvent 
purification system. “H2O” refers to deionized water.  
For synthesis requiring anhydrous conditions, reactions were carried out under a  nitrogen 
atmosphere using oven-dried glassware. Solvents were removed in vacuo using a Heidolph 
Hei-VAP Value G1 rotary evaporator with a water and dry ice bath condenser. Analytical thin 
layer chromatography was carried out on Merck Kiesel gel 60 aluminium-backed silica plates, 
with visualisation using short-wave ultraviolet light (254 nm) or staining with KMnO4 or 
phosphomolybdic acid (PMA) stain. Column chromatography was carried out using BDH (40-
60 µm) silica gel. 
Infrared spectra were obtained on a Bruker Tensor 37 FTIR spectrometer in the range 4000-
600 cm-1. UV-Vis spectra were obtained on a PerkinElmer Lambda 35 UV/Vis spectrometer. 
Fluorescence spectra were measured on an Agilent Cary eclipse fluorescence 
spectrophotometer with a 1 cm path length cell. The fluorescence microscope images were 
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obtained from a Logos CELENA S digital imaging system. Confocal microscopy images were 
taken by Leica TCS SP5 Confocal microscope. 1H NMR spectra were recorded at 400 MHz on 
a Bruker Avance I or Bruker Avance III spectrometer. Chemical shifts are reported in δ (ppm), 
quoted to the nearest 0.01 ppm and referenced to the residual solvent peak used as the 
internal standard: CHCl3 (7.26 ppm), MeOH (3.31 ppm), DMSO (2.50 ppm) and CH3CN 
(1.94 ppm). Coupling constants (J) are measured in Hertz (Hz) and reported to 1 d.p. Peak 
multiplicities for resonances are noted as standard abbreviations: s, singlet; d, doublet; dd, 
double doublet; dt, doublet of triplets, t, triplet; q, quartet; m, unresolved multiplet; bs, broad 
singlet. 13C NMR spectra were recorded at 101 MHz on a Bruker Avance III spectrometer. 
Chemical shifts (δ) are quoted to the nearest 0.1 ppm, with reference to the given solvent 
CDCl3 (77.2 ppm), MeOD (49.0 ppm), DMSO (39.5 ppm) and CD3CN (118.3 ppm) as the internal 
standard. High resolution mass spectrometry was carried out by the Waters Synapt G2Si 
HDMS, while some spectra were provided by the EPSRC National Mass Spectrometry Service, 
University of Wales. Molecular ions are reported for 35Cl and 79Br isotopes. Melting points 
were measured on a Stuart SMP3 melting point apparatus and are uncorrected. 
Unless noted otherwise, the solution for all photophysical tests was a 0.1 mM HEPES (≥99.5%) 
buffer (pH 7.4) made up from a DMSO stock solution to dissolve probes with a 1% total DMSO 
concentration. ZnCl2 was used as the Zn2+ source to simulate the chloride-rich biological 
environment. The medium used to incubate HeLa, MCF-7 and HepG2 cells was Dulbecco’s 
Modified Eagle Medium (DMEM), supplemented with 10% heat-deactivated fetal bovine 
serum (FBS). The medium used for EC23 cells was DMEM/F12 1:1 supplemented with 10% 
heat-deactivated FBS and RM+ (Rheinwald Media: transferrin 5 µg/mL, hydrocortisone 0.4 
µg/mL, cholera toxin 10-10 M, epidermal growth factor 10 ng/mL (AbD Serotec, Oxford, UK), 
insulin 5 µg/ml, liothyronine 2 × 10-11 M, adenine 1.8 × 10-4 M). In all medium, 1% (v/v) 
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penicillin streptomycin was added as antibiotics. Unless noted otherwise, all cells were 
incubated at 37 °C in a 5% CO2/ 95% air incubator. AlamarBlueTM was used to check cells’ 
viability according to the manufacturer’s instructions. For ER stress or oxidative stress studies, 
the alive cells after probes’ treatment were washed with phosphate-buffered saline (PBS) and 
then the cells were cultured in PBS for imaging under microscopy. All the images of cells were 
processed by ImageJ software, and the fluorescence intensity in cells was read directly from 
ImageJ before processing. 
7.2 General procedures 
7.2.1 Fluorescence titration to determine dissociation constant Kd 
To determine the dissociation constant Kd, a series of HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) buffer solutions (50 mM, pH 7.2, 0.1 M KCl) containing various 
amounts of ZnCl2 (0 ~ 9.0 mM) and 10 mM of EGTA (ethylene glycol-bis(2-aminoethylether)-
N,N,N’,N’-tetraacetic acid) were prepared. The [Zn2+]free was calculated followed the reported 
methods.37,142,143 
The calculated [Zn2+]free concentration of each solution is: 
[Zn2+]total (mM)  0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 
[Zn2+]free (nM) 0.00 0.14 0.29 0.46 0.66 0.87 1.11 1.39 
[Zn2+]total (mM)  4.0 4.5 5.0 6.0 7.0 8.0 9.0  
[Zn2+]free (nM) 1.73 2.12 2.59 3.88 6.04 10.36 23.31  
 
To determine the apparent dissociation constants for probes, the fluorescence titration 
curves at concentrations 1 µM, 0.1 µM and 0.01 µM were obtained and fitted to 
Equation 7.1.37,136 F is the observed fluorescence intensity, F0 is the observed fluorescence of 












                                  (Equation 7.1) 
7.2.2 Quantum yield Φ measurement 
Based on the absorption wavelength of probes studied in this thesis, anthracene (Φ = 0.27 in 
ethanol) was chosen as a standard sample. In order to minimise the re-absorption effects, the 
absorbance of all samples should be below 0.1 at the excitation wavelength. For standard 
sample, each probe and its complex, UV-Vis and fluorescence spectra of five solutions with 
increasing concentrations were recorded, and the linear plots of integrated fluorescence 
intensity against absorbance were obtained. The gradient for each sample is proportional to 
the sample’s fluorescence quantum yield, which can be calculated through Equation 7.2 by 
comparing to the known quantum yield of the standard compound. Where the subscripts ST 
and X denote standard and test respectively, Φ is the fluorescence quantum yield, Grad the 
gradient from the plot of integrated fluorescence intensity vs absorbance, and η the refractive 
index of the solvent. 








                                     (Equation 7.2) 
7.2.3 Detection limit (LOD) measurement 
To determine the detection limit, the fluorescence spectrum of the probe only was measured 
20 times and the standard deviation of this blank measurement was obtained as σ. The slope 
K was obtained from linear fitting of the fluorescence Zn2+ titration data and the detection 




                                                    (Equation 7.3) 
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7.2.4 The apparent pKa values calculation 
The fluorescence spectra were recorded at different pH, the integrated fluorescence intensity 
against pH was plotted and through non-linear curve fitting with the Equation 7.4 or Equation 
7.5, three or four pKa values were obtained, respectively. Fmax is the maximum normalized 
emission integration (Fmax = 1), F0 is the minimum normalized emission integration obtained, 
and ΔF1max, ΔF2max, ΔF3max and ΔF4max are the maximum fluorescence integration changes 



























                                          (Euqation 7.5) 
7.2.5 The AlamarBlue assay to determine cell viability 
The cells were cultured in 96-well plate and treated with various concentration of probes (0 
~ 50 µM) in the medium at 37 °C in a 5% CO2/ 95% air incubator for 24 hours. After culture 
medium was removed, the cells were washed with PBS for three times, and further incubated 
with 10% (v/v) AlamarBlue assay in the medium for a certain time (normally 1 ~ 2 hours) until 
the colour changed to pink. Then the fluorescence was obtained by microplate fluorometer 
using 560/590 nm (λex/λem) filter settings. The fluorescence intensity is proportional to cell 
viability. 
7.2.6 The subcellular localisation studies 
The subcellular localisation of probes was studied by co-localisation experiments. The cells 
were cultured on 11 mm circular coverslips in 12-well plate and then treated with probes for 
a certain time (normally 1 hour unless noted otherwise) at 37 °C in a 5% CO2/95% air incubator. 
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After that, all cells were washed with PBS three times, and then Bodipy TR ceramide, ER-
tracker red, Mito-tracker red and Lyso-tracker red were added in different groups respectively 
for a certain time following the protocol. Again, the cells were washed with PBS for three 
times and fixed with 4% paraformaldehyde for 20 minutes. Then the cells were treated with 
DAPI, followed by three times washing. After the cover slips were mounted on the microscope 
slides, the probes’ subcellular localisation in cells can be investigated under microscope. The 
Pearson’s correlation coefficient was obtained through the comparison of the fluorescence 
of probes and that of the organelle markers in the same area of interest by ImageJ software. 
7.2.7 Zn2+ response in cells 
For Zn2+ response experiments, the cells were cultured on 11 mm circular coverslips in 12-
well plate and then treated with probes for a certain time (normally 1 hour unless noted 
otherwise) at 37 °C in a 5% CO2/ 95% air incubator unless noted otherwise, and then washed 
with PBS for three times. Zinc pyrithione and TPEN were added to different groups 
respectively for 15 minutes incubation, while no treatment needed for the control group. 
After all treatments, the cells were washed with PBS buffer three times and following with 
the DAPI treatment. After washing, the cover slips were mounted on the microscope slides, 
and the fluorescence of cells was investigated by microscope. The fluorescence intensity of 
the area of interest was read by ImageJ software before processing. 
7.2.8 DFT and TDDFT calculations 
To understand the binding behaviour of the probes with Zn2+ and its fundamental electronic 
structure, DFT and TDDFT studies were performed. The structure of probes and their 
complexes with Zn2+ were optimised using B3LYP functional and 6-31G* basis set in Gaussian 
09. The calculation of excited states and structures of the S1 minima were obtained at 
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CAMB3LYP/6-31G* level of theory. All calculations considered H2O as solvent using a 
continuum model (PCM). All calculations were performed on Queen Mary's Apocrita HPC 




7.3 Experimental data 
6-Bromo-2-(prop-2-yn-1-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (38) 
 
4-Bromo-1,8-naphthalic anhydride (1.0 g, 3.6 mmol) was dissolved in 1,4-dioxane (30 mL) and 
to this was added propargylamine (0.28 mL, 4.3 mmol). The yellow-brown suspension was 
stirred at room temperature for 1 h, and then heated to 70 °C overnight to give a dark brown 
solution. Then the mixture was cooled to room temperature and slowly poured into ice-cold 
H2O (120 mL). The resulting precipitate was collected by filtration and washed with H2O (30 
mL) and dried in vacuo to give 38 as a light brown solid (0.98 g, 87%). 1H NMR (400 MHz, CDCl3) 
δH 8.73 (dd, 1H, J = 7.3, 0.9, Hc), 8.64 (dd, 1H, J = 8.4, 0.9, He), 8.49 (d, 1H, J = 7.9, Hg), 8.09 (d, 
J = 7.9, Hf), 7.90 (dd, 1H, J = 8.4, 7.3, Hd), 4.98 (d, 2H, J = 2.5 , Hb), 2.22 (t, 1H, J = 2.4, Ha). 13C 
NMR (101 MHz, CDCl3) δ 162.8 (×2), 133.7, 132.5, 131.6, 131.2, 130.8, 130.7, 129.0, 128.2, 









Tri-tert-butyl 1,4,8,11-tetraazacyclotetradecane-1,4,8-tricarboxylate (39) 
 
Under an atmosphere of nitrogen, 1,4,8,11-tetraazacyclotetradecane (cyclam, 1.0 g, 5.0 mmol) 
was dissolved in dry DCM (200 mL). The colourless solution was stirred at room temperature 
and Et3N (3.5 mL, 25 mmol) was added, followed was added dropwise by a solution of Boc2O 
(2.0 g, 9.2 mmol) in anhydrous DCM (60 mL). The reaction was then cooled to -15 °C and a 
further portion of Boc2O (1.3 g, 6.0 mmol) in anhydrous DCM (40 mL) was added. The mixture 
was stirred overnight allowing warming to room temperature over this time. The reaction 
mixture was washed with 0.25 M Na2CO3 (5 × 20 mL), dried over MgSO4, and concentrated in 
vacuo. The resulting crude material was purified by column chromatography (eluent: 
DCM/MeOH 20:1) to give 39 as a viscous, colourless oil (2.1 g, 83%). 1H NMR (400 MHz, CDCl3) 
δH 3.41-3.30 (m, 12H, Hd-e, g-j), 2.80 (t, 2H, J = 5.6, Hc), 2.63 (t, 2H, J = 5.6, Hb), 2.02-1.88 (m, 2H, 
Hf), 1.76-1.68 (m, 2H, Ha), 1.47 (s, 27H, Hk). All other spectroscopic data were consistent with 








Tri-tert-butyl 11-(prop-2-yn-1-yl)-1,4,8,11-tetraazacyclotetradecane-1,4,8-tricarboxylate (40) 
 
Tri-Boc protected cyclam 39 (488 mg, 0.975 mmol) was dissolved in MeCN (12.5 mL) and to 
this was added Na2CO3 (207 mg, 1.95 mmol) followed by propargyl bromide (80 % wt. in 
toluene, 96.0 µL, 1.07 mmol). The mixture was heated to reflux and stirred overnight. Then 
the reaction was cooled to room temperature, filtered to remove insoluble salts, and 
concentrated in vacuo. The resulting crude material was purified by column chromatography 
(eluent: Petrol/EtOAc 2:1), to give 40 as a viscous, colourless oil. (363 mg, 69%). 1H NMR (400 
MHz, CDCl3) δH 3.42 (bs, 2H, Hl), 3.38-3.26 (m, 12H, Hd-e, g-j), 2.72-2.68 (m, 2H, Hc), 2.53 (t, 2H, 
J = 5.8, Hb), 2.18 (bs, 1H, Hm), 1.96-1.86 (m, 2H, Hf), 1.74-1.68 (m, 2H, Ha), 1.48 (s, 27H, Hk). All 
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Ethyl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate (41) 
 
D-(+)-biotin (500 mg, 2.00 mmol) was dissolved in absolute EtOH (20 mL) and to this was 
added concentrated H2SO4 (3 drops). The flask was covered and heated to reflux with stirring 
overnight. After that, the reaction was cooled to room temperature, and concentrated in 
vacuo, the residue was diluted with DCM (50 mL) and the organic phase washed with 0.25 M 
Na2CO3 (3 × 50 mL) and H2O (2 × 50 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo to give 41 as a white solid (461 mg, 83%). 1H NMR (400 MHz, CDCl3) δH 
5.53 (s, 1H, Hc), 5.14 (s, 1H, Hb), 4.59-4.51 (m, 1H, Hd), 4.39-4.31 (m, 1H, Ha), 4.15 (q, 2H, J = 
7.1, Hk), 3.22-3.17 (m, 1H, Hf), 2.95 (dd, 1H, J = 12.8, 5.0, He), 2.77 (d, 1H, J = 12.8, He), 2.35 (t, 
2H, J = 7.5, Hj), 1.79-1.64 (m, 4H, Hg,i), 1.55-1.43 (m, 2H, Hh), 1.28 (t, 3H, J = 7.1, Hl). 13C NMR 
(101 MHz, CDCl3) δ 173.7, 163.6, 62.0, 60.3, 60.1, 55.4, 40.6, 34.0, 28.4, 28.3, 24.8, 14.3. All 










Under a nitrogen atmosphere, 41 (100 mg, 0.370 mmol) was dissolved in anhydrous DCM (10 
mL) and the solution was cooled to -78 °C. DIBAL-H (1.0 M in hexanes, 1.3 mL, 1.3 mmol, 3.5 
eq.) was added dropwise over a period of 15 minutes and the solution was stirred at -78 °C 
for 30 min. After this time, the reaction was warmed to room temperature and stirred for a 
further 2 h. The reaction was then cooled to -78 °C and quenched by the dropwise addition 
of MeOH (3 mL) followed by MeOH: H2O (6 mL: 3 mL). The mixture was concentrated in vacuo 
and the crude material was transferred to a cellulose thimble and purified by Soxhlet 
extraction by EtOH for 3 days. The solvent was removed in vacuo to give 42 as a white solid 
(80 mg, 94%). 1H NMR (400 MHz, CD3OD): δH 4.51-4.47 (m, 1H, Hd), 4.32-4.29 (m, 1H, Ha), 3.55 
(t, 2H, J = 6.5 Hz, Hk), 3.24-3.19 (m, 1H, Hf), 2.93 (dd, 1H, J = 12.8, 5.0, He), 2.70 (d, 1H, J = 12.8, 
He), 1.75-1.40 (m, 8H, Hg-j). 13C NMR (100 MHz, CD3OD): δC 166.3, 63.6, 63.0, 61.8, 57.4, 41.2, 












Under an atmosphere of nitrogen, biotinol 42 (240 mg, 1.04 mmol) was dissolved in 
anhydrous DMF (10.4 mL) and the colourless solution was cooled to 0 °C. DPPA (0.448 mL, 
2.08 mmol) was added followed by DBU (0.310 mL, 2.08 mmol). The solution was stirred at 
0 °C for 15 min, then heated to 65 °C, covered and stirred for 18 h. Then the reaction was 
cooled to room temperature and the resulting red-orange solution was diluted with H2O (200 
mL), extracted with EtOAc (2 × 100 mL). The combined organic phase was washed with brine 
(2 × 100 mL) and saturated NaHCO3 (2 × 100 mL), dried over MgSO4, filtered and concentrated 
in vacuo to give a pale-yellow solid residue. This crude material was purified by flash 
chromatography (eluent: DCM/MeOH 20:1) to give 43 as a white solid (104 mg, 39%). 1H NMR 
(400 MHz, CDCl3) δH 5.13 (s, 1H, Hc), 4.90 (s, 1H, Hb), 4.56-4.48 (m, 1H, Hd), 4.35-4.29 (m, 1H, 
Ha), 3.28 (t, 2H, J = 6.8, Hk), 3.19-3.15 (m, 1H, Hf), 2.94 (dd, 1H, J = 12.8, 5.1, He), 2.74 (d, 1H, J 
= 12.8, He), 1.72-1.40 (m, 8H, He-h). 13C NMR: (100 MHz, CDCl3): δC 164.0, 62.2, 60.2, 55.7, 51.5, 














Biotin azide 43 (25 mg, 0.10 mmol), and 38 (31 mg, 0.10 mmol) were dissolved in anhydrous 
DCM (0.50 mL) under a nitrogen atmosphere. To this solution, tetrakis(acetonitrile)copper(I) 
hexafluorophosphate (7.5 mg, 0.020 mmol), DIPEA (10 µL, 0.057 mmol) was added and the 
flask was covered with aluminium foil and stirred at room temperature for 48 h. Then the 
yellow solution was washed with a saturated solution of EDTA in 17% NH4OH (5 mL), and the 
aqueous layer was extracted with DCM (3 × 15 mL). The combined organic layers were dried 
over MgSO4, filtered and concentrated in vacuo to give 44 as a white solid (54 mg, 95%, M.p. 
104-107 °C).  1H NMR (400 MHz, CDCl3) δH 8.67 (d, 1H, J = 6.8, Hn), 8.57 (d, 1H, J = 8.4, Hp), 
8.43 (d, 1H, J = 8.0, Hr), 8.04 (d, 1H, J = 8.0, Hq), 7.88-7.81 (m, 1H, Ho), 7.66 (s, 1H, Hl), 5.49 (s, 
2H, Hm), 5.29 (s, 1H, Hc), 4.76 (s, 1H, Hb), 4.54-4.50 (m, 1H, Hd), 4.36-4.28 (m, 3H, Ha and Hk), 
3.12-3.06 (m, 1H, Hf), 2.89 (dd, 1H, J = 13.0, 5.0, He), 2.70 (d, 1H, J = 13.0, He), 1.88-1.35 (m, 
8H, Hg-j). 13C NMR (101 MHz, CDCl3) δC 163.9, 163.4 (overlapping signal), 143.2, 133.6, 132.3, 
131.5, 131.1, 130.6, 129.0, 128.1, 123.4, 122.7, 121.8, 61.9, 60.0, 55.4, 54.2, 50.1, 42.3, 40.2, 
35.1, 29.8, 28.3, 26.1. IR: (υmax/cm-1) 3231, 2934, 2680, 1698, 1657, 1463, 1343, 1235, 1046, 












Bromide 44 (38 mg, 0.067 mmol) and NaN3 (6.5 mg, 0.10 mmol) were combined in DMF 
(2.0 mL) and the mixture was stirred at room temperature for 3 days. Then the mixture was 
diluted with water (20 mL) and extracted with EtOAc (3 × 15 mL). The organic layers were 
combined and washed with brine (2 × 30 mL), dried over MgSO4, concentrated in vacuo to 
give 45 as a yellow solid (33 mg, 93%, M.p. 154-157 °C). 1H NMR (400 MHz, CDCl3) δH 8.68 (d, 
1H, J = 7.4, Hn), 8.63 (d, 1H, J = 8.0, Hr), 8.47 (d, 1H, J = 8.6, Hp), 7.80-7.73 (m, 1H, Ho), 7.66 (s, 
1H, Hl), 7.50 (d, 1H, J = 8.0, Hq), 5.51 (s, 2H, Hm), 4.95 (s, 1H, Hc), 4.62 (s, 1H, Hb), 4.54-4.49 (m, 
1H, Hd), 4.35-4.28 (m, 3H, Ha and Hk), 3.16-3.09 (m, 1H, Hf), 2.93 (dd, 1H, J = 12.9, 5.0, He), 
2.72 (d, 1H, J = 12.9, He), 1.93-1.37 (m, 8H, Hg-j). 13C NMR (101 MHz, CDCl3) δC 168.0, 167.8, 
167.3, 147.9, 136.4, 136.0, 133.1, 133.0, 130.8, 128.2, 127.5, 126.1, 122.3, 118.7, 65.9, 64.0, 
59.5, 54.1, 44.2, 39.0, 33.8, 33.5, 32.3, 32.2, 30.1. IR: (υmax/cm-1) 3083, 2098, 1733, 1649, 1494, 














The azide 45 (32 mg, 0.060 mmol) and acetylene 40 (33 mg, 0.060 mmol) were dissolved in 
NMP (1.0 mL), followed by CuI (2.3 mg, 0.012 mmol), NaOAc (1.0 mg, 0.012 mmol), and EtOH 
(1.0 mL). The mixture was stirred at room temperature for 3 days under a nitrogen 
atmosphere. After that time a saturated solution of EDTA in 17 % NH3 H2O (5 mL) was added 
and the yellow precipitate was collected by filtration, washed with water and dried in vacuo. 
The crude product was dissolved in DCM (2.0 mL) and poured into petroleum ether (20 mL) 
to give 46 as a yellow powder (36 mg, 56%, M.p. 148-153 °C). 1H NMR (400 MHz, CDCl3) δH 
8.71 (d, 2H, J = 7.1, Hn and Hr), 8.27 (d, 1H, J = 7.6, Hp), 8.04 (s, 1H, Hs), 7.90-7.83 (m, 2H, Ho 
and Hq), 7.70 (s, 1H, Hl), 5.50 (s, 2H, Hm), 5.41 (s, 1H, Hc), 4.97 (s, 1H, Hb), 4.45-4.40 (m, 1H, 
Hd), 4.31 (t, 2H, J = 4.1, Hk), 4.25-4.20 (m, 1H, Ha), 3.96 (s, 2H, Ht), 3.42-3.30 (m, 12H, Hv-a’), 
3.10-3.05 (m, 1H, Hf), 2.87 (dd, 1H, J = 12.9, 4.9, He), 2.73 (t, 2H, J = 5.4, Hu), 2.67 (d, 1H, J = 
12.9, He), 2.58 (t, 2H, J = 5.6, Hc’), 1.94-1.86 (m, 4H, Hg,j), 1.83-1.75 (m, 4H, Hb’,d’), 1.65-1.61 (m, 
4H, Hh,i), 1.42 (s, 27H, He’). 13C NMR (101 MHz, CDCl3) δC 163.5, 162.9, 143.1, 138.4, 132.4, 
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131.0, 129.9, 129.1, 128.6, 126.5, 123.6, 122.8, 79.7, 61.8, 60.0, 55.6, 50.2, 47.3, 40.6, 35.4, 
29.9, 28.4, 27.9, 26.4. (overlapping signals). IR: (υmax/cm-1) 3016, 2970, 1741, 1729, 1435, 1366, 























The tri-Boc protected compound 46 (31 mg, 0.029 mmol) was dissolved in a solution of 20% 
TFA in DCM (1.2 mL) and stirred for 10 h at room temperature. Then the solvent was removed 
in vacuo and the residue was dissolved in chloroform (10 mL) and washed with 1M aqueous 
NaOH solution (2.0 mL). The aqueous layer was extracted with chloroform (3 × 10 mL) and 
the organic layers were combined, dried over MgSO4, filtered and concentrated in vacuo to 
give 47 as a brown solid (13 mg, 58 %, M.p. 197-201 °C). 1H NMR (400 MHz, CD3OD) δH 8.66 
(d, 1H, J = 7.8, Hn), 8.63 (d, 1H, J = 7.3, Hr), 8.56 (s, 1H, Hs), 8.25 (d, 1H, J = 8.6, Hp), 8.05 (s, 1H, 
Hl), 7.99 (d, 1H, J = 7.3, Hq), 7.89- 7.83 (m, 1H, Ho), 5.45 (s, 2H, Hm), 4.48-4.43 (m, 1H, Hd), 4.41 
(t, 2H, J = 6.9, Hk), 4.27-4.22 (m, 1H, Ha), 4.01 (s, 2H, Ht), 3.29-3.23 (m, 4H, Hv,y), 3.21-3.16 (m, 
4H, Hw,x), 3.16-3.09 (m, 1H, Hf), 3.05-3.01 (m, 4H, Hz,a’), 2.97-2.92 (m, 4H, Hu,c’), 2.87 (dd, 1H, J 
= 12.8, 5.8, He), 2.64 (d, 1H, J = 12.8, He), 2.18-2.11 (m, 2H, Hd’), 1.95-1.89 (m, 2H, Hb’), 1.70-
1.33 (m, 8H, Hg-j). 13C NMR (101 MHz, CD3OD) δC 164.6, 164.1 (×2), 146.3, 144.6, 139.4, 133.2, 
131.9, 130.7, 130.0, 129.7, 127.5, 127.5, 125.4, 125.2, 124.9, 123.9, 63.4, 61.6, 57.0, 55.4, 
187 
 
54.0, 51.3, 51.1, 50.5, 49.5, 49.3, 49.1, 48.1, 46.8, 46.3, 41.0, 36.3, 31.0, 29.6, 27.4, 26.5, 24.6. 
IR: (υmax/cm-1) 2921, 2851, 1662, 1587, 1427, 1233, 1199, 952, 785. HR-ESI MS (m/z) [M+H]+ 









5-Chloro-2-methoxy-3-nitrobenzoic acid (48) 
 
5-Chloro-2-methoxybenzoic acid (1.08 g, 5.80 mmol) and concentrated sulfuric acid (3.8 mL) 
were mixed in a 50 mL round bottom flask in ice-salt water bath. The mixture of 0.9 mL 
concentrated sulfuric acid and 0.4 mL nitric acid was added dropwise to the flask over 30 min 
while the temperature was kept below 5 °C. Then the cooling bath was removed and the 
reaction was stirred for another 5 h at room temperature. When the starting material was 
completely consumed, the reaction was quenched by pouring into ice water. The precipitate 
can be collected by filtration and washed by water (100 mL). The product was dried in vacuo 
to obtain 48 (1.30 g, 97%, M.p. 171-174 °C) as a pale yellow solid. 1H NMR (400 MHz, DMSO-
d6) δ 8.55-8.47 (bs, 1H, Hd), 8.35-8.21 (bs, 1H, Hb), 8.09-8.76 (bs, 1H, Hc), 3.89 (s, 3H, Ha). 13C 
NMR (101 MHz, DMSO-d6) δ 164.4, 150.3, 145.6, 134.4, 129.7, 127.8, 127.3, 64.0. IR: (υmax/cm-
1) 3080, 1709, 1533, 1361, 1293, 1248, 1167, 979, 900, 693. HR-NSI MS (m/z) [M+H]+ calcd for 






   
191 
 
5-Chloro-2-methoxy-3-nitrobenzoyl chloride (49) 
 
Compound 48 (1.16 g, 5.0 mmol) was dissolved in thionyl chloride (2.0 mL), and the mixture 
was heated to reflux for 6 hours. When the starting material was consumed confirmed by TLC, 
the reaction mixture was cooled down and evaporated under reduced pressure to obtain the 
49 (1.23 g, 98.4 %) as a red oil. 1H NMR (400 MHz, CDCl3) δ 8.16 (d, 1H, J = 2.6, Hb), 8.01 (d, 
1H, J = 2.6, Hc), 4.01 (s, 3H, Ha). 13C NMR (101 MHz, CDCl3) δ 162.9, 151.6, 145.5, 136.3, 131.9, 
130.2, 129.5, 65.0. IR: (υmax/cm-1) 3081, 1785, 1753, 1534, 1342, 1219, 960, 887, 782. EI MS 












The benzoyl chloride 49 (720 mg, 2.88 mmol) was added slowly to a stirred solution of 4-(2-
aminoethyl)benzenesulfonamide (576 mg, 2.88 mmol) in dry pyridine (15 mL). The resultant 
mixture was stirred overnight at room temperature. Pyridine was removed in vacuo and 
absolute ethanol (10 mL) was added to the residue. The precipitate was collected by filtration 
and dried in vacuo to obtain the 50 (963 mg, 81%, M.p. 208-212 °C) as a white solid. 1H NMR 
(400 MHz, DMSO-d6) δ 8.70-8.65 (m, 1H, Hd), 8.11 (d, 1H, J = 2.6, Hb), 7.75 (d, 2H, J = 8.1, Hh), 
7.70 (d, 1H, J = 2.6, Hc), 7.45 (d, 2H, J = 8.1, Hg), 7.28 (s, 2H, Hi), 3.69 (s, 3H, Ha), 3.58-3.51 (m, 
2H, He), 2.96-2.90 (m, 2H, Hf). 13C NMR (101 MHz, DMSO-d6) δ 163.4, 148.4, 144.5, 143.4, 
142.2, 134.0, 132.9, 129.2, 127.5, 125.7, 125.4, 63.2, 40.3, 34.4. IR: (υmax/cm-1) 3152, 1600, 
1540, 1453, 1331, 1156, 968, 807, 693. HR-NSI MS (m/z) [M+H]+ calcd for C16H17ClN3O6S 













To a stirred solution of sulfonylamine 50 (207 mg, 0.500 mmol) and CuCl (2.5 mg, 0.025 mmol) 
in DMF (2.0 mL) under N2 atmosphere, cyclohexyl isocyanate (0.1 mL, 0.750 mmol) was added 
dropwise.  The reaction was stirred at room temperature for 24 hours. The resulting mixture 
was filtered off and the filtrate was poured slowly into ice cold water (50 mL), acidified with 
concentrated HCl (0.1 mL) and the precipitate formed was collected by filtration, washed with 
H2O, dried in vacuo to obtain the 51 (194 mg, 72%, M.p. 221-225 °C) as a white solid.  1H NMR 
(400 MHz, CDCl3) δ 8.22 (d, 1H, J = 2.8, Hb), 7.90 (d, 1H, J = 2.8, Hc), 7.85 (d, 2H, J = 8.3, Hh), 
7.68-7.60 (bs, 1H, Hi), 7.44 (d, 2H, J = 8.3, Hg), 6.44 (d, 1H, J = 7.7, Hj), 3.84-3.76 (m, 2H, He), 
3.76 (s, 3H, Ha), 3.63-3.54 (m, 1H, Hk), 3.07 (t, 2H, J = 7.1, Hf), 1.88-1.18 (m, 10H, Hl-n). 13C NMR 
(101 MHz, CDCl3) δ 162.8, 149.9, 149.1, 144.9, 144.6, 135.8, 130.9, 130.3, 129.7, 128.4, 127.9, 
64.2, 49.5, 41.1, 35.2, 33.9, 25.1, 24.8. IR: (υmax/cm-1) 3293, 2930, 2854, 1645, 1535, 1449, 
1342, 1250, 1163, 1087, 1030, 904, 661. HR-NSI MS (m/z) [M+H]+ calcd for C23H28ClN4O7S 












The compound 51 (568 mg, 1.05 mmol) was dissolved in acetic acid (9.0 mL) and heated to 
70 °C under N2 atmosphere. Fe powder (177 mg, 3.16 mmol) was added in this solution and 
the reaction mixture was stirred at 70 °C for 30 minutes. Then the mixture was cooled to room 
temperature and concentrated under reduced pressure. The residue was dissolved in ethyl 
acetate (30 mL) and washed with saturated NaHCO3 (30 mL × 3). The organic layer was dried 
over MgSO4 and the solution was concentrated in vacuo. The product was purified by silica 
gel chromatography (2% methanol in dichloromethane) to give 52 (260 mg, 51%, M.p. 101-
104 °C) as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, 2H, J = 8.4, Hi), 7.75-7.68 (m, 1H, 
Hj), 7.41 (d, 2H, J = 8.4, Hh), 7.29 (d, 1H, J = 2.6, Hc), 6.80 (d, 1H, J = 2.6, Hd), 6.42 (d, 1H, J = 7.9, 
Hj), 3.80-3.73 (m, 2H, Hf), 3.60-3.54 (m, 1H, Hl), 3.48 (s, 3H, Ha), 3.08-3.01 (m, 2H, Hg), 1.82-
1.15 (m, 10H, Hm-o). 13C NMR (101 MHz, CD3OD) δ 166.5, 151.5, 145.5, 143.3, 143.0, 138.3, 
129.5, 129.3, 128.4, 127.5, 117.0, 116.5, 59.6, 48.8, 40.1, 34.6, 32.4, 25.1, 24.4. IR: (υmax/cm-
1) 3459, 3016, 2970, 1757, 1714, 1426, 1367, 1216, 1092, 900. HR-ESI MS (m/z) [M+H]+ calcd 













The compound 52 (127 mg, 0.250 mmol) was dissolved in acetonitrile (3.0 mL) and cooled in 
an ice-water bath. To this solution was added dropwise t-BuONO (50 µL, 0.38 mmol) and 
TMSN3 (38 µL, 0.30 mmol). After stirring for 30 min, the ice-water bath was removed and the 
mixture was stirred for 6 hours at room temperature. Then the solvent was evaporated under 
reduced pressure and the residue was washed with petroleum ether and water, dried in vacuo 
to obtain the 53 (91 mg, 68%, M.p. 191-194 °C) as a pale yellow solid. 1H NMR (400 MHz, 
CDCl3) δ 8.65 (bs, 1H, Hi), 7.85 (d, 2H, J = 8.3, Hh), 7.78 (d, 1H, J = 2.4, Hc), 7.41 (d, 2H, J = 8.3, 
Hg), 7.16 (d, 1H, J = 2.4, Hb), 6.42 (d, 1H, J = 7.7, Hj), 3.82-3.70 (m, 2H, He), 3.63 (s, 3H, Ha), 
3.61-3.52 (m, 1H, Hk), 3.08-3.00 (m, 2H, Hf), 1.83-1.16 (m, 10H, Hl-n). 13C NMR (101 MHz, 
CD3OD and CDCl3) δ 166.0, 149.6, 146.3, 139.4, 136.1, 131.2, 130.8, 130.3, 128.6, 127.2, 126.8, 
123.7, 62.9, 54.4, 41.4, 35.7, 33.6, 26.2, 25.4. IR: (υmax/cm-1) 2930, 2111, 1739, 1631, 1533, 












A mixture of propargylamine (1.50 g, 27.3 mmol) and potassium carbonate (22.8 g, 164 mmol) 
was stirred in acetonitrile (140 mL) for 5 mins. Then 2-picolyl chloride hydrochloride (9.84 g, 
60.0 mmol) dissolved in acetonitrile (140 mL) was added.  The resulting solution was stirred 
under reflux for 5 days. After the reaction was complete, the mixture was filtered and the 
filtration evaporated under reduced pressure. The resulting brown oil was dissolved in 
distilled water (100 mL) and extracted with dichloromethane (3 × 50 mL). The organic layers 
were combined and dried over MgSO4. The solvent was evaporated to afford 54 (6.04 g, 93%) 
as a brown oil. 1H NMR (400 MHz, CDCl3) δ 8.56-8,53 (m, 2H, Hg), 7.65 (td, 2H, J = 7.7, 1.8, He), 
7.51 (m, 2H, Hd), 7.17-7.13 (m, 2H, Hf), 3.92 (s, 4H, Hc), 3.42 (d, 2H, J = 2.4, Hb), 2.29 (t, 1H, J = 
2.4, Ha). 13C NMR (101 MHz, CDCl3) δ 158.8, 149.3, 136.5, 123.2, 122.1, 78.4, 73.6, 59.5, 42.6. 












Under a nitrogen atmosphere, the glibenclamide azide 53 (53.5 mg, 0.10 mmol) and alkyne 
54 (31.4 mg, 0.10 mmol) were dissolved in anhydrous DCM (5.0 mL), then DIPEA (20 µL, 0.18 
mmol) and tetrakis(acetonitrile)copper(I) hexafluorophosphate (7.5 mg, 0.020 mmol) was 
added to the above solution. The flask was covered with aluminium foil and stirred at room 
temperature for 48 h. After the reaction complete, the reaction mixture was diluted with DCM 
(20 mL) and washed with saturated EDTA in 17 % NH3·H2O (10 mL), water (20 mL) and brine 
(20 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo to give 
55 (78.1 mg, 92%, M.p. 117-120 °C) as a yellow solid. 1H NMR (400 MHz, CDCl3) δ 8.77 (d, 1H, 
J = 6.5, Hq), 8.62 (d, 1H, J = 8.5, Hs), 8.53 (d, 1H, J = 7.9, Hu), 8.20 (s, 1H, Ho), 8.11 (d, 1H, J = 2.7, 
Hm), 8.09 (d, 1H, J = 7.9, Ht), 7.95 (d, 2H, J = 8.3, Hg), 7.92-7.86 (m, 1H, Hr), 7.82 (d, 1H, J = 2.7, 
Hl), 7.57-7.51 (m, 1H, Hk), 7.46 (d, 2H, J = 8.3, Hh), 6.48 (d, 1H, J = 8.0, He), 5.63 (s, 2H, Hp), 
3.85-3.78 (m, 2H, Hj), 3.63-3.50 (m, 1H, Hd), 3.16 (s, 3H, Hn), 3.06 (t, 2H, J = 6.7, Hi), 1.81-1.17 
(m, 10H, Ha-c).13C NMR (101 MHz, CDCl3) δ 175.1, 167.5, 163.6, 148.7, 145.1, 144.1, 135.3, 
133.8, 132.6, 131.9, 131.8, 131.7, 131.3, 131.0, 130.7, 129.8, 129.0, 128.8, 128.3, 127.5, 125.4, 
122.7, 121.8, 62.2, 60.4, 53.5, 35.2, 33.0, 25.3, 24.6, 21.1. IR: (υmax/cm-1) 3142, 1600, 1534, 
1483, 1344, 1242, 1169, 1025, 968, 807, 777, 688. HR-NSI MS (m/z) [M+H]+ calcd for 














Compound 55 (67.9 mg, 0.08 mmol) was dissolved in DMF (2.0 mL), and sodium azide (6.5 mg, 
0.1 mmol) was added in the reaction mixture and it was stirred at room temperature for 24 
h. Then the reaction mixture was diluted with water (20 mL) and extracted with EtOAc (3  × 
20 mL). The organic layers were combined and washed with brine, dried over MgSO4, and 
concentrated in vacuo to obtain the 56 (56.5 mg, 87 %, M.p. 190-194 °C) as yellow solid. 1H 
NMR (400 MHz, CDCl3) δ 8.72 (d, 1H, J = 7.3, Hq), 8.68 (d, 1H, J = 8.0, Hu), 8.47 (d, 1H, J = 8.4, 
Hs), 8.19 (s, 1H, Ho), 8.09 (d, 1H, J = 2.7, Hm), 7.94 (d, 2H, J = 8.3, Hg), 7.79 (d, 1H, J = 2.7, Hl), 
7.77-7.74 (m, 1H, Hr), 7.61-7.57 (m, 1H, Hk), 7.50 (d, 1H, J = 8.0, Ht), 7.44 (d, 2H, J = 8.3, Hh), 
6.45 (d, 1H, J = 7.6, He), 5.61 (s, 2H, Hp), 3.83-3.78 (m, 2H, Hj), 3.57-3.50 (m, 1H, Hd), 3.16 (s, 
3H, Hn), 3.07 (t, 2H, J = 6.8, Hi), 1.82-1.13 (m, 10H, Ha-c). 13C NMR (101 MHz, CDCl3) δ 164.1, 
163.7, 163.1, 150.5, 148.8, 145.3, 144.5, 138.6, 133.0, 132.6, 132.0, 131.8, 131.1, 129.9, 129.8, 
129.5, 129.1, 128.9, 127.6, 127.2, 125.5, 124.5, 123.1, 122.3, 118.5, 115.0, 62.3, 49.3, 40.6, 
35.3 (× 2), 33.1, 25.5, 24.7. IR: (υmax/cm-1) 2930, 2124, 1704, 1663, 1534, 1342, 1242, 1161, 













To the solution of 4-bromo-1,8-naphthalic anhydride (500 mg, 1.80 mmol) in DMF (5.0 mL), 
NaN3 (175 mg, 2.69 mmol) was added and the mixture was stirred at room temperature for 
12 h. After the reaction complete judged by TLC, water (30 mL) was added and the precipitate 
was collected by filtration, then washed with water (50 mL), dried under vacuum to obtain 58 
(418 mg, 97 %) as a pale-yellow solid. 1H NMR (400 MHz, CDCl3) δ 8.67 (dd, 1H, J = 7.3, 1.1, 
Ha), 8.62 (d, 1H, J = 8.0, He), 8.55 (dd, 1H, J = 8.5, 1.1, Hc), 7.82 (dd, 1H, J = 8.5, 7.3, Hb), 7.53 
(d, 1H, J = 8.0, Hd). 13C NMR (101 MHz, CDCl3) δ 160.5, 160.0, 145.2, 134.4, 134.0, 131.4, 130.4, 
127.3, 124.6, 118.9, 115.1, 114.6. All other spectroscopic data were consistent with those 












Under nitrogen atmosphere, the azide 58 (23.9 mg, 0.100 mmol), alkyne 54 (23.7 mg, 
0.100 mmol), and tetrakis(acetonitrile)copper(I) hexafluorophosphate (10.0 mg, 0.030 mmol), 
was added in the mixture of NMP (1.0 mL) and EtOH (1.0 mL). The reaction mixture was stirred 
at room temperature for 24 h, after the starting material finished judged by TLC, the 
propargylamide (9 µL, 0.140 mmol) was added and the mixture was stirred at room 
temperature for overnight. After the reaction complete, the saturated EDTA in 10% NH3·H2O 
(5.0 mL) was added and the precipitate was collected by filtration. The crude product was 
purified by column chromatography on silica gel (eluent DCM: MeOH = 20:1) to give 59 (24 mg, 
47%, M.p. 182-185 °C) as a brown solid. 1H NMR (400 MHz, CDCl3) δ 8.79-8.73 (m, 2H, Hc,g), 
8.57 (d, 2H, J = 4.2, Hn), 8.32 (dd, 1H, J = 8.6, 0.9, He), 8.17 (s, 1H, Hh), 7.88-7.82 (m, 2H, Hd,f), 
7.72-7.66 (m, 2H, Hl), 7.63-7.57 (m, 2H, Hk), 7.21-7.15 (m, 2H, Hm), 5.00 (d, 2H, J = 2.4, Hb), 
4.09 (s, 2H, Hi), 3.97 (s, 4H, Hj), 2.23 (t, 1H, J = 2.4, Ha). 13C NMR (101 MHz, CDCl3) δ 163.0, 
162.5, 159.0, 149.3, 145.1, 138.8, 136.8, 135.8, 132.7, 131.2, 130.3, 129.3, 128.7, 126.6, 125.8, 
123.6, 123.5, 122.7, 122.4, 78.3, 71.0, 59.9, 48.6, 29.8. IR: (υmax/cm-1) 1744, 1707, 1665, 1581, 










tert-Butyl (4-sulfamoylphenethyl) carbamate (60) 
 
4-(2-Aminoethyl) benzenesulphonamide (0.40 g, 2.0 mmol) was dissolved in CH2Cl2 (5.0 mL) 
and cooled to 0 °C in an ice bath. Di-tert-butyl decarbonate (0.44 g, 2.0 mmol) was dissolved 
in CH2Cl2 (5.0 mL) and then added to the above solution slowly. After the completion of the 
addition, the ice bath was removed and the mixture was stirred at room temperature for 6 
hours. The solvent was evaporated in vacuo and the residue was diluted with water (20 mL) 
and extracted with CH2Cl2 (20 mL × 2). The organic layers were combined and dried over 
MgSO4, filtered and dried under vacuum to give 60 as a white solid (0.58 g, 97%, M.p. 188-
189 °C). 1H NMR (400 MHz, DMSO-d6) δ 7.75 (d, 2H, J = 8.3, Hb), 7.39 (d, 2H, J = 8.3, Hc), 7.30 
(s, 2H, Ha), 6.92 (t, 1H, J = 5.2, Hf), 3.22-3.15 (m, 2H, He), 2.82-2.76 (m, 2H, Hd), 1.38 (s, 9H, Hg). 
13C NMR (101 MHz, DMSO-d6) δ 155.5, 143.7, 142.0, 129.1, 125.6, 77.6, 41.1, 35.1, 28.2. IR: 
(υmax/cm-1) 3384, 3333, 3235, 1660, 1524, 1338, 1307, 1280, 1154, 1094, 906, 683. HR-ESI MS 
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tert-Butyl (4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)carbamate (61) 
 
Under a nitrogen atmosphere, 60 (0.15 g, 0.50 mmol) and CuCl (5.0 mg, 0.050 mmol) were 
dissolved in DMF (2.0 mL), cyclohexyl isocyanate (0.1 mL, 0.75 mmol) was added dropwise 
and the mixture was stirred for 24 hours at room temperature. The resultant precipitate was 
filtered off and the filtrate was poured slowly into ice cold water (50 mL). Concentrated HCl 
(0.1 ml) was added to acidify the resultant mixture and the precipitate was isolated by suction 
filtration and washed with water (50 mL) to give 61 as a white solid (0.18 g, 84%, M.p. 184-
186 °C). 1H NMR (400 MHz, CDCl3) δ 7.95-7.73 (bs, 2H, Hg), 7.42-7.32 (bs, 2H, Hh), 6.56-6.30 
(bs, 1H, He), 4.66-4.52 (bs, 1H, Hk), 3.66-3.54 (bs, 1H, Hd), 3.43-3.32 (bs, 2H, Hj), 2.96-2.83 (bs, 
2H, J = 5.8, Hi), 1.96-1.59 (m, 6H, Ha,c), 1.43 (s, 9H, Hl), 1.32-1.10 (m, 4H, Hb) 13C NMR (101 
MHz, CDCl3) δ 183.4, 155.9, 145.3, 129.6, 127.5, 127.4, 79.5, 49.3, 41.4, 36.1, 33.7, 32.9, 28.4, 
25.4, 24.8, 24.6. IR: (υmax/cm-1) 3331, 3271, 2935, 2856, 1690, 1660, 1532, 1435, 1352, 1296, 
























Boc protected 61 (132 mg, 0.310 mmol) was dissolved in DCM (4.0 mL) and trifluoracetic acid 
(0.4 mL) was added dropwise. The reaction was stirred overnight at room temperature. The 
solvent was evaporated under reduced pressure and the product was used without 
purification in the next step. 1H NMR (400 MHz, D2O) δ 7.95 (d, 2H, J = 8.4, Hg), 7.57 (d, 2H, J 
= 8.4, Hh), 3.38-3.30 (m, 3H, Hj,d), 3.17-3.09 (m, 2H, Hi), 1.74-1.51 (m, 6H, Ha,c), 1.37-1.10 (m, 











After de-protection, the product 62 was dissolved in ethanol (2.0 mL), then Na2CO3 (65.7 mg, 
0.620 mmol) was added to the above solution. 4-Bromo-1,8-naphthalic anhydride (85.9 mg, 
0.310 mmol) was added and the mixture was refluxed for 6 hours. After the reaction complete, 
the solvent was evaporated in vacuo and the residue was washed with water (30 mL). The 
precipitate was collected by filtration and dried in vacuo to obtain 63 (149 mg, 82%, M.p. 264-
268 °C) as a white solid. 1H NMR (400 MHz, DMSO-d6) δ 8.61-8.53 (m, 2H, Hk,m), 8.35 (d, 1H, J 
= 7.9, Ho), 8.23 (d, 1H, J = 7.9, Hn), 8.05-7.97 (m, 1H, Hl), 7.65 (d, 2H, J = 7.9, Hg), 7.25 (d, 2H, J 
= 7.9, Hh), 5.70-5.58 (bs, 1H, He), 4.29-4.18 (m, 2H, Hj), 3.27-3.14 (bs, 1H, Hd), 2.99-2.88 (m, 
2H, Hi), 1.72-1.47 (m, 6H, Ha,c), 1.20-0.99 (m, 4H, Hb). 13C NMR (101 MHz, DMSO-d6) δ 162.6, 
132.6, 131.5, 131.3, 130.9, 129.6, 129.2, 128.7, 128.5, 128.1, 127.8, 127.1, 127.0, 122.5, 121.7, 
48.6, 40.9, 33.2, 32.8, 25.2, 24.6. IR: (υmax/cm-1) 3378, 2929, 2854, 1700, 1653, 1590, 1344, 
1254, 1231, 1122, 1086, 1007, 880, 779, 655. HR-ESI MS (m/z) [M+H]+ calcd for C27H26BrN3O5S 











The compound 63 (148 mg, 0.253 mmol) was dissolved in DMF (2.0 mL) and NaN3 (25 mg, 
0.385 mol) was added to the solution. The mixture was stirred for 24 hours under room 
temperature. The reaction mixture was poured to water (20 mL) and the precipitate was 
collected by filtration and dried in vacuo to obtain 64 (94.0 mg, 68%, M.p. 200-204 °C) as a 
yellow solid. 1H NMR (400 MHz, DMSO-d6) δ 8.51 (d, 1H, J = 7.3, Hk), 8.46 (d, 1H, J = 7.9, Ho), 
8.42 (d, 1H, J = 8.5, Hm), 7.90- 7.83 (m, 1H, Hl), 7.80 (d, 2H, J = 7.9, Hg), 7.74 (d, 1H, J = 7.9, Hn), 
7.48 (d, 2H, J = 7.9, Hh), 6.34-6.26 (bs, 1H, He), 4.31-4.21 (m, 2H, Hj), 3.06-2.95 (m, 2H, Hi), 
1.68-1.46 (m, 6H, Ha,c), 1.21-1.06 (m, 4H, Hb). 13C NMR (101 MHz, DMSO-d6) δ 162.8(d), 156.6, 
150.8, 144.3, 142.8, 138.7, 131.6, 129.2, 128.4, 128.2, 127.5, 127.2, 123.4, 121.9, 117.9, 115.9, 
48.1, 40.5, 33.4, 32.3, 25.4, 25.0, 24.5, 24.2. IR: (υmax/cm-1) 3299, 2930, 2854, 2123, 1738, 
1651, 1591, 1533, 1437, 1353, 1229, 1129, 1087, 843, 780, 690. HR-ESI MS (m/z) [M+H]+ calcd 











Under an atmosphere of nitrogen, 64 (76.0 mg, 0.150 mmol) and 54 (35.6 mg, 0.150 mmol) 
were dissolved in NMP (2.0 mL) and tetrakis(acetonitrile)copper(I) hexafluorophosphate 
(11.2 mg, 0.030 mmol) was added. The mixture was stirred at room temperature for 24 hours. 
After the reaction finished, saturated EDTA in 17% NH3:H2O (20 mL) was poured to the 
mixture and the precipitate was collected by filtration, and washed with water (30 mL). This 
crude product was purified by flash chromatography (eluent: DCM/MeOH 20:1) to give 65 as 
a brown solid (96 mg, 82%, M.p. 148-151 °C). 1H NMR (400 MHz, CDCl3) δ 8.72-8.66 (m, 2H, 
Hk,o), 8.56 (d, 2H, J = 4.3, Hv), 8.31 (d, 1H, J = 8.3, Hm), 8.19 (s, 1H, Hp), 7.90-7.82 (m, 4H, Hl,n,g), 
7.69 (td, 2H, J = 7.6, 1.7, Ht), 7.62 (d, 2H, J = 7.8,  Hh), 7.53 (d, 2H, J = 8.5, Hs), 7.21-7.15 (m, 2H, 
Hu), 6.48 (s, 1H, He), 4.49-4.41 (m, 2H, Hj), 4.09 (s, 2H, Hq), 3.97 (s, 4H, Hr), 3.58 (bs, 1H, Hd), 
3.20-3.10 (m, 2H, Hi), 1.87-1.55 (m, 6H, Ha,c), 1.32-1.18 (m, 4H, Hb). 13C NMR (101 MHz, CDCl3) 
δ 163.6, 163.1, 159.0, 149.2, 145.0, 138.6, 136.8, 132.4, 131.0, 130.2, 130.0, 129.2, 128.7, 
127.4, 126.5, 125.9, 123.6, 123.5, 122.7, 122.4, 59.9, 49.2, 48.6, 41.4, 34.2, 33.0, 25.5, 24.7.  
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IR: (υmax/cm-1) 3288, 2926, 2853, 1699, 1654, 1590, 1534, 1433, 1342, 1230, 1157, 1036, 998, 















Under an atmosphere of nitrogen, 64 (109 mg, 0.200 mmol) and 40 (108 mg, 0.200 mmol) 
were dissolved in NMP (2.0 mL) and tetrakis(acetonitrile)copper(I) hexafluorophosphate 
(14.9 mg, 0.040 mmol) was added. The mixture was stirred at room temperature for 24 hours. 
After the reaction finished, saturated EDTA in 17% NH3:H2O (20 mL) was poured to the 
mixture and the precipitate was collected by filtration, and washed with water (30 mL). This 
crude product was purified by flash chromatography (eluent: DCM/MeOH 20:1) to give 66 as 
a brown solid (193 mg, 89%, M.p. 126-129 °C). 1H NMR (400 MHz, CDCl3) δ 8.68-8.61 (m, 2H, 
Hk,o), 8.28 (d, 1H, J = 5.6, Hm), 8.04 (bs, 1H, Hp), 7.94-7.80 (m, 4H, Hl,n,g), 7.49 (d, 2H, J = 8.2, 
Hh), 6.36 (d, 1H, J = 7.8, He), 4.40 (bs, 2H, Hj), 3.95 (s, 2H, Hq), 3.55 (bs, 1H, Hd), 3.34 (bs, 12H, 
Hs-x), 3.14-3.07 (m, 2H, Hi), 2.72 (bs, 2H, Hr), 2.57 (bs, 2H, Hy), 1.96-1.51 (m, 8H, Hc,z,a’), 1.50-
1.17 (m, 33H, Ha,b,b’). 13C NMR (101 MHz, CDCl3) δ 163.3(d), 155.7(d), 143.4, 141.0, 138.4, 
132.3, 130.9, 130.0, 129.6, 129.5, 129.0, 128.6, 127.6, 126.6, 126.4, 123.6, 123.4, 122.6, 79.7, 
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53.5, 53.2, 49.1, 48.9, 47.3, 45.6, 41.4, 34.0, 33.9, 33.8, 32.9, 28.5, 25.6, 25.4, 24.9, 24.6. IR: 
(υmax/cm-1) 2972, 2930, 1740, 1663, 1589, 1411, 1365, 1230, 1157, 1034, 782, 728. HR-ESI MS 
















The tri-Boc protected compound 66 (109 mg, 0.100 mmol) was dissolved in a solution of 20% 
TFA in DCM (2.0 mL) and stirred for 10 h at room temperature. Then the solvent was removed 
in vacuo and the residue was dissolved in chloroform (10 mL) and washed with 1M aqueous 
NaOH solution (2.0 mL). The aqueous layer was extracted with chloroform (3 × 10 mL) and 
the organic layers were combined, dried over MgSO4, filtered and concentrated in vacuo to 
give 67 as a brown solid (42 mg, 54 %, M.p. 202-205 °C). 1H NMR (400 MHz, CD3OD) δ 8.62-
8.54 (m, 3H, Hk,o,p), 8.26 (d, 1H, J = 8.4, Hm), 7.99 (d, 1H, J = 7.8, Hn), 7.89-7.82 (m, 3H, Hg,l), 
7.47 (d, 2H, J = 8.3, Hh), 4.35-4.28 (m, 2H, Hj), 4.03 (bs, 2H, Hq), 3.46-3.37 (m, 4H, Hs,v), 3.34-
3.32 (m,1H Hd), 3.30-3.18 (m, 4H, Ht,u), 3.13-2.90 (m, 10H, Hi,r,w-y), 2.19 (bs, 2H, Hz), 1.93 (bs, 
2H, Ha’), 1.79-1.52 (m, 5H, Ha,c), 1.35-1.13 (m, 5H, Ha,b). 13C NMR (101 MHz, CD3OD) δ 164.5(d), 
163.1(d), 153.1, 146.4, 139.8, 139.3, 133.1, 131.8, 130.6, 130.0, 129.8, 128.8, 127.4, 125.3, 
124.9, 123.9, 119.6, 116.7, 55.5, 54.8, 54.2, 50.7, 50.4, 50.1, 49.8, 48.2, 46.6, 45.9, 42.2, 34.8, 
33.8, 26.4(overlapping signals), 25.8, 24.1. IR: (υmax/cm-1) 2929, 2853, 1661, 1587, 1516, 1433, 
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1347, 1231, 1200, 1121, 864, 782, 719. HR-ESI MS (m/z) [M+H]+ calcd for C40H53N10O5S 











Diethyl 2,2'-azanediyldiacetate (68) 
 
Thionyl chloride (7.26 mL, 100 mmol) was added slowly to stirred absolute ethanol (30 mL) in 
ice-water bath and the mixture stirred for about 30 mins at room temperature. After the 
addition of iminodiacetic acid (3.33 g, 25.0 mmol), the reaction mixture was heated at reflux 
overnight and then the solution was evaporated in vacuo. Saturated NaHCO3 solution (20 mL) 
was added and extracted with CH2Cl2 (3 × 30 mL), the organic layers combined, dried over 
MgSO4, filtered and dried in vacuo to give 68 (3.89 g, 82 %) as a colourless oil. 1H NMR (400 
MHz, CDCl3) δ 4.08 (q, 4H, J = 7.2, Hb), 3.35 (s, 4H, Hc), 1.98 (s, 1H, Hd), 1.17 (t, 6H, J = 7.2, Ha). 
13C NMR (101 MHz, CDCl3) δ 171.6, 60.6, 50.0, 14.0. All other spectroscopic data were 











Diethyl 2,2'-(prop-2-yn-1-ylazanediyl)diacetate (69) 
 
Diethyl iminodiacetate 68 (2.68 g, 14.2 mmol) was dissolved in MeCN (30 mL), then K2CO3 
(3.92 g, 28.4 mmol) and propargyl bromide (2.52 mL, 17.0 mmol) were added slowly and the 
mixture heated at reflux for 16 h. After cooling to room temperature, the suspension was 
filtered and the filtrate evaporated in vacuo. The resultant oil was purified by column 
chromatography (petrol/EtOAc = 20:1 to petrol/EtOAc = 5:1) to obtain 69 as a red oil (1.61 g, 
50 %). 1H NMR (400 MHz, CDCl3) δ 4.04 (q, 4H, J = 7.1, Hb), 3.53 (d, 2H, J = 2.4, Hd), 3.40 (s, 4H, 
Hc), 2.18 (t, 1H, J = 2.4, He), 1.13 (t, 6H, J = 7.1, Ha). 13C NMR (101 MHz, CDCl3) δ 170.0, 78.1, 
73.6, 60.4, 54.0, 43.0, 13.9. All other spectroscopic data were consistent with those previously 
reported.149 There was a by-product 108 obtained in this reaction, which is the reason for its 














Under an atmosphere of nitrogen, 64 (109 mg, 0.200 mmol) and 69 (45.4 mg, 0.200 mmol) 
were dissolved in NMP (1.0 mL) and EtOH (1.0 mL), then tetrakis(acetonitrile)copper(I) 
hexafluorophosphate (14.9 mg, 0.040 mmol) was added. The flask was covered with 
aluminium foil and the mixture was stirred at room temperature for 24 hours. After the 
reaction had finished saturated EDTA in 17% NH3:H2O (20 mL) was poured into the mixture 
and the precipitate formed was collected by filtration, and washed with water (30 mL). This 
crude product was purified by flash chromatography (eluent: DCM/MeOH 20:1) to give 70 as 
a brown solid (133 mg, 86%, M.p. 164-168 °C). 1H NMR (400 MHz, CDCl3) δ 8.66 (m, 2H), 8.30 
(d, 1H, J = 8.6), 8.16 (s, 1H), 7.86-7.80 (m, 4H), 7.52 (d, 2H, J = 8.3), 6.48 (m, 1H), 4.47-4.40 (m, 
2H), 4.24 (s, 2H), 4.18 (q, 4H, J = 7.1), 3.69 (s, 4H), 3.66-3.55 (m, 1H), 3.18-3.10 (m, 2H), 1.85-
1.56 (m, 6H), 1.35-1.17 (m, 10H).13C NMR (101 MHz, CDCl3) δ 171.2, 163.7, 163.1, 150.7, 146.5, 
145.2, 139.3, 138.6, 138.0, 135.6, 132.5, 131.0, 130.0, 129.2, 128.8, 127.4, 126.6, 125.8, 123.7, 
123.6, 122.8, 60.9, 55.1, 49.3, 49.2, 41.4, 34.2, 33.0, 25.5, 24.6, 14.4. IR: (υmax/cm-1) 3287, 
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2930, 2853, 1697, 1656, 1589, 1535, 1433, 1344, 1229, 1157, 1037, 783, 605. HR-NSI MS (m/z) 






























2-Azidoacetic acid (71) 
 
To a solution of 2-chloroethanamine hydrochloride (567 mg, 6.00 mmol) in H2O (25 mL) was 
added NaN3 (1.95 g, 30.0 mmol) at room temperature. After stirring at 65 °C for 48 h, the 
reaction mixture was acidified with concentrated HCl to pH = 2. Then the aqueous layer was 
extracted with diethyl ether (3 × 20 mL), the organic layers were combined and washed with 
brine (10 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to give 71 
(373 mg, 61 %) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ 11.55 (s, 1H, Hb), 3.97 (s, 2H, 
Ha).  13C NMR (101 MHz, CDCl3) δ 174.8, 50.1.  All other spectroscopic data were consistent 













To a solution of L-cysteine (363 mg, 3.00 mmol) in TFA (6.0 mL), trityl chloride (836 mg, 3.00 
mmol) was added and the reaction mixture was stirred at room temperature for 30 minutes. 
Then the excess TFA was removed in vacuo and diethyl ether (10 mL) was added. Then 
aqueous NaOAc (1 M) was added to bring the pH near to neutrality and at this point a white 
precipitate was formed. The precipitate was collected by filtration and washed with cold 
water (20 mL), ethanol (6.0 mL) and dried in vacuo to give 72 (840 mg, 77%, M.p. 143-146 °C) 
as a white solid. 1H NMR (400 MHz, DMSO-d6) δ 7.39 – 7.17 (m, 15H, Ha-c), 2.93 (dd, 1H, J = 
9.2, 4.3, He), 2.58 (dd, 1H, J = 12.5, 4.3, Hd), 2.40 (dd, 1H, J = 12.5, 9.2, Hd). 13C NMR (101 MHz, 
DMSO-d6) δ 144.2, 129.1, 128.0, 126.7, 66.0, 53.4, 33.6. All other spectroscopic data were 
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Methyl S-trityl-L-cysteinate (73) 
 
To a stirred solution of 72 (233 mg, 0.650 mmol) in methanol (10 mL), thionyl chloride 
(0.36 mL, 5.00 mmol) was added in drops at 0 °C. The solution was allowed to warm to room 
temperature and then refluxed for 5 hours. The solvent was removed in vacuo and the crude 
product was extracted with ethyl acetate (15 mL), which was washed with saturated NaHCO3 
(3 × 20 mL). The organic layer was dried over anhydrous MgSO4, filtered and concentrated in 
vacuo to obtain 73 (196 mg, 80%) as a pale-yellow gum. 1H NMR (400 MHz, CDCl3) δ 7.35-7.07 
(m, 15H, Ha-c), 3.52 (s, 3H, Hg), 3.11 (dd, 1H, J = 7.4, 4.7, He), 2.51 (dd, 1H, J = 12.5, 4.7, Hd), 
2.40 (dd, 1H, J = 12.5, 7.4, Hd), 2.18-2.02 (bs, 2H, Hf). 13C NMR (101 MHz, CDCl3) δ 173.8, 144.5, 
129.6, 128.0, 126.8, 66.9, 53.6, 52.2, 36.6. All other spectroscopic data were consistent with 










Methyl N-(2-azidoacetyl)-S-trityl-L-cysteinate (74) 
 
To a stirred solution of 2-azidoacetic acid 71 (260 mg, 2.57 mmol) and N-methylmorpholine 
(314 µL, 2.80 mmol) in THF (10 mL) was added isobutyl chloroformate (364 µL, 2.80 mmol) at 
-15 °C. The mixture was stirred at the same temperature for 30 min, then 73 (970 mg, 2.57 
mmol) was added to the mixture. Stirring was continued for 1 hour at -15 °C and then the 
cooling bath was removed. The reaction was allowed to warm up to room temperature and 
stirring was continued overnight. The solvent was removed in vacuo and the residue dissolved 
in EtOAc (30 mL) which was washed with saturated NaHCO3 (30 mL) and water (30 mL), dried 
over MgSO4 and concentrated in vacuo to give 74 (854 mg, 72%, M.p. 115-117 °C) as a white 
solid. 1H NMR (400 MHz, CDCl3) δ 7.45-7.23 (m, 15H, Ha-c), 6.77 (d, 1H, J = 7.9, Hf), 4.64 – 4.57 
(m, 1H, He), 3.97 (s, 2H, Hh), 3.75 (s, 3H, Hg), 2.78 – 2.62 (m, 2H, Hd). 13C NMR (101 MHz, CDCl3) 
δ 170.4, 166.4, 144.3, 129.6, 128.1, 127.1, 67.2, 52.9, 52.5, 51.2, 33.7. IR: (υmax/cm-1) 3056, 
2105, 1742, 1667, 1521, 1442, 1207, 742, 698. HR-ESI MS (m/z) [M-H]- calcd for C25H23N4O3S 












Under an atmosphere of nitrogen, 74 (138 mg, 0.300 mmol) and 38 (94.2 mg, 0.300 mmol) 
were dissolved in DMF (2.0 mL) and tetrakis(acetonitrile)copper(I) hexafluorophosphate 
(22.4 mg, 0.060 mmol) was added. The mixture was stirred at room temperature for 24 hours. 
After the reaction was complete, saturated EDTA in 17% NH3:H2O (20 mL) was poured into 
the reaction mixture and the precipitate that formed was collected by filtration, and washed 
with water (30 mL), dried in vacuo. This crude product was purified by flash chromatography 
(eluent: DCM/MeOH = 50:1) to give 75 as a brown solid (160 mg, 68%, M.p. 133-136 °C).  1H 
NMR (400 MHz, CDCl3) δ 8.68 (dd, 1H, J = 7.3, 1.1, Hk), 8.59 (dd, 1H, J = 8.5, 1.1, Hm), 8.43 (d, 
1H, J = 7.9, Ho), 8.04 (d, 1H, J = 7.9, Hn), 7.88 – 7.84 (m, 1H, Hl), 7.83 (s, 1H, Hi), 7.39 – 7.21 (m, 
15H, Ha-c), 6.25 (d, 1H, J = 7.6, Hg), 5.51 (s, 2H, Hj), 4.97 (m, 2H, Hh), 4.47 – 4.41  (m, 1H, He), 
3.64 (s, 3H, Hf), 2.69 – 2.59 (m, 2H, Hd). 13C NMR (101 MHz, CDCl3) δ 170.1, 164.7, 163.4 (×2), 
144.2, 144.1, 133.6, 132.5, 131.6, 131.2, 130.8, 130.6, 129.6, 129.2, 128.2, 127.1, 125.1, 123.0, 
122.2, 67.2, 52.9, 52.6, 51.7, 35.3, 33.4. IR: (υmax/cm-1) 3055, 1744, 1702, 1662, 1588, 1432, 
1342, 1234, 1177, 1046, 782, 699. HR-ESI MS (m/z) [M+H]+ calcd for C40H33BrN5O5S 774.1385, 











The compound 75 (157 mg, 0.202 mmol) was dissolved in DMF (2.0 mL) and NaN3 (40.0 mg, 
0.606 mol) was added to the solution. The mixture was stirred for 48 hours at room 
temperature. The reaction mixture was poured into water (20 mL) and the precipitate that 
formed was collected by filtration, washed with water (20 mL × 3) and dried in vacuo to obtain 
76 (142 mg, 95%, M.p. 142-145 °C) as a yellow solid. 1H NMR (400 MHz, CDCl3) δ 8.51 (d, 1H, 
J = 6.6, Hk), 8.45 (d, 1H, J = 8.0, Ho), 8.31 (d, 1H, J = 8.4, Hm), 7.75 (s, 1H, Hi), 7.64 – 7.58 (m, 
1H, Hl), 7.32 (d, 1H, J = 8.0, Hn), 7.28 – 7.09 (m, 15H, Ha-c), 6.44 (d, 1H, J = 7.6, Hg), 5.38 (s, 2H, 
Hj), 4.88 (d, 2H, J = 2.0, Hh), 4.38 – 4.30 (m, 1H, He), 3.53 (s, 3H, Hf), 2.61– 2.48 (m, 2H, Hd). 13C 
NMR (101 MHz, CDCl3) δ 170.2, 164.8, 163.7, 163.3, 144.2, 144.1, 143.8, 132.6, 132.1, 129.6, 
129.3, 129.1, 128.2, 127.1, 127.0, 125.2, 124.4, 122.5, 118.7, 114.8, 67.2, 52.8, 52.6, 51.7, 
35.2, 33.4. IR: (υmax/cm-1) 3322, 3063, 2959, 2123, 1745, 1695, 1659, 1583, 1440, 1344, 1286, 















Under an atmosphere of nitrogen, 76 (110 mg, 0.150 mmol) and 54 (35.6 mg, 0.150 mmol) 
were dissolved in NMP (2.0 mL) and tetrakis(acetonitrile)copper(I) hexafluorophosphate 
(11.2 mg, 0.030 mmol) was added. The mixture was stirred at room temperature for 24 hours. 
After the reaction finished, saturated EDTA in 17% NH3:H2O (20 mL) was poured to the 
mixture and the precipitate was collected by filtration, and washed with water (30 mL). This 
crude product was purified by flash chromatography (eluent: DCM/MeOH 20:1) to give 77 as 
a brown solid (99.1 mg, 68%, M.p. 127-130 °C). 1H NMR (400 MHz, CDCl3) δ 8.58 – 8.52  (m, 
2H, Hk,o), 8.46 (d, 2H, J = 4.2, Hv), 8.16 (d, 1H, J = 8.4, Hm), 8.11 (s, 1H, Hp), 7.80 (s, 1H, Hi), 7.71– 
7.64 (m, 2H, Ht), 7.62 – 7.57 (m, 2H, Hs), 7.55 – 7.57 (m, 2H, Hl,n), 7.28 – 7.06 (m, 17H, Ha-c,u), 
6.70 (d, 1H, J = 7.5, Hg), 5.40 (s, 2H, Hj), 4.93 (s, 2H, Hh), 4.37 – 4.31 (m, 1H, He), 3.99 (s, 2H, 
Hq), 3.88 (s, 4H, Hr), 3.51 (s, 3H, Hf), 2.60 – 2.49 (m, 2H, Hd). 13C NMR (101 MHz, CDCl3) δ 170.2, 
164.9, 163.4, 162.9, 159.0, 149.2, 145.1, 144.2, 143.7, 138.5, 136.7, 132.5, 131.1, 130.0, 129.5, 
129.2, 128.6, 128.1, 127.0, 126.4, 125.8, 125.2, 123.5 (×2), 122.7, 122.3, 67.2, 59.9, 52.8, 52.5, 
51.7, 48.6, 35.4, 33.4.  IR: (υmax/cm-1) 3016, 2949, 1739, 1663, 1588, 1434, 1365, 1230, 1217, 
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To a stirred solution of 77 (48.7 mg, 0.050 mmol) in CH2Cl2 (1.0 mL) at 0 °C was added 
trimethylsilane (35 µL, 0.025 mmol) and trifluoroacetic acid (35 µL, 0.050 mmol) and the 
resultant solution was stirred at room temperature overnight. After the reaction had finished, 
solid NaHCO3 (42 mg, 0.50 mmol) was added and the mixture stirred for 10 minutes. The 
solution was then filtered and the collected solids washed with CH2Cl2 (3 mL × 3). The solid 
was then suspended in MeCN (10 mL) and stirred for 10 minutes, filtered and the filtrate was 
concentrated in vacuo to obtain 78 as a yellow solid (18.6 mg, 51%, M.p. 127-130 °C). 1H NMR 
(400 MHz, CDCl3: CD3CN = 1:1) δ 8.66 – 8.60 (m, 2H, Hi,m), 8.55 (d, 2H, J = 4.2, Ht), 8.32 (s, 1H, 
Hn), 8.19 (d, 1H, J = 8.0, Hk), 7.86 (s, 1H, Hg), 7.85 – 7.76 (m, 4H, Hj,l,r), 7.63 (d, 2H, J = 7.8, Hq), 
7.34 – 7.25 (m, 3H, He,s), 5.43 (s, 2H, Hh), 5.11 (d, 2H, J = 1.4, Hf), 4.70 – 4.64 (m, 1H, Hc), 4.09 
(s, 2H, Ho), 4.06 (s, 4H, Hp), 3.67 (s, 3H, Hd), 2.92 – 2.86 (bs, 2H, Hb). 13C NMR (101 MHz, CDCl3: 
CD3CN = 1:1) δ 171.3, 168.0, 166.8, 164.7, 164.2, 159.1, 149.6, 145.5, 144.9, 139.8, 139.3, 
133.6, 132.3, 131.3, 130.4, 130.0, 128.0, 126.6, 125.4, 125.2, 124.3, 124.1, 60.4, 55.8, 54.0, 
53.6, 50.1, 36.8, 27.6. IR: (υmax/cm-1) 3458, 3016, 1741, 1662, 1588, 1432, 1369, 1229, 1216, 











To a solution of 2-chloroethanamine hydrochloride (400 mg, 3.44 mmol) in H2O (4.0 mL) wad 
added NaN3 (672 mg, 10.36 mmol) at room temperature. After stirring at 80 °C for 24 h, the 
reaction was quenched with aqueous KOH solution (15%, 1.0 mL). Then the aqueous layer 
was extracted with diethyl ether (3 × 20 mL), the organic layers were combined and washed 
with brine (10 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to give 
79 as a colourless oil (265 mg, 90 %). 1H NMR (400 MHz, CDCl3) δ 3.36 (t, 2H, J = 5.7, Ha), 2.90-
2.85 (m, 2H, Hb), 1.49-1.41 (bs, 2H, Hc). All other spectroscopic data were consistent with 












To a solution of 79 (265 mg, 3.08 mmol) in CH2Cl2 (4.0 mL), the 4-toluenesulfonyl chloride 
(587 mg, 3.08 mmol) was added at room temperature. The reaction mixture was stirred at 
the same temperature for 2 h and concentrated in vacuo. The residue was purified with flash 
column chromatography (petroleum ether: ethyl acetate = 5:1) to give 80 as a white solid 
(688 mg, 93 %, M.p. 67-69 °C). 1H NMR (400 MHz, CDCl3) δ 7.76 (d, 2H, J = 8.3, Hc), 7.32 (d, 2H, 
J = 8.3, Hb), 5.06 (t, 1H, J = 5.9, Hd), 3.39 (t, 2H, J = 5.9 Hz, Hf), 3.14-3.06 (m, 2H, He), 2.43 (s, 
3H, Ha). 13C NMR (101 MHz, CDCl3) δ 143.9, 136.9, 130.0, 127.2, 51.0, 42.4, 21.6. IR: (υmax/cm-
1) 3265, 2102, 1598, 1417, 1304, 1157, 1085, 939, 811, 685. HR-ESI MS (m/z) [M-H]- calcd for 










(4-Azidobutyl)triphenylphosphonium bromide (81) 
 
A solution of sodium azide (0.14 g, 2.20 mmol) and (4-bromobutyl)triphenylphosphonium 
bromide (0.96 g, 2.00 mmol) in EtOH/H2O (1:1, 20 mL) was heated at reflux under N2 overnight. 
The mixture was cooled and the solvent was evaporated under reduced pressure to afford a 
yellow oil. To the oil was added H2O (2.0 mL) and the precipitate formed was collected by 
filtration and washed with water, dried under vacuum to afford 81 as a white solid (0.85 g, 
87%). 1H NMR (400 MHz, CDCl3) δ 7.97-7.67 (m, 15H, Ha-c), 4.08-3.97 (m, 2H, Hd), 3.52-3.42 
(m, 2H, Hg), 2.13-2.02 (m, 2H, He), 1.83-1.71 (m, 2H, Hf). 13C NMR (101 MHz, CDCl3) δ 135.1 (d, 
J = 3.0), 133.7 (d, J = 10.0), 130.6 (d, J = 12.6), 118.2 (d, J = 86.2), 50.7, 29.2 (d, J = 16.7), 22.3 
(d, J = 50.8), 19.9 (d, J = 4.0). All other spectroscopic data were consistent with those 









(4-Azidobutyl)triphenylphosphonium tetrafluoroborate (82) 
 
Compound 81 (2.27 g, 5.15 mmol) was dissolved in CH2Cl2 (40 mL). This solution was 
thoroughly washed with a saturated aqueous solution of ammonium tetrafluoroborate (3 × 
50 mL). The organic phase was dried over MgSO4 and the solvent was removed in vacuo to 
yield tetrafluoroborate 82 as a white solid (2.18 g, 95%).1H NMR (400 MHz, CDCl3) δ 7.81-7.64 
(m, 15H, Ha-c), 3.38-3.22 (m, 4H, Hd,g), 1.89-1.79 (m, 2H, He), 1.74-1.63 (m, 2H, Hf). 13C NMR 
(101 MHz, CDCl3) δ 135.3 (d, J = 3.0), 133.4 (d, J = 9.9), 130.6 (d, J = 12.6), 117.9 (d, J = 86.4), 
50.4, 29.1 (d, J = 16.9), 21.4 (d, J = 52.0), 19.8 (d, J = 3.8). 31P NMR (162 MHz, CDCl3) δ 23.64. 
19F NMR (377 MHz, CDCl3) δ -152.16 (d, J = 19.8). All other spectroscopic data were consistent 
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2-Chloro-N-(2-(dimethylamino)ethyl)acetamide hydrochloride (83) 
 
Chloroacetyl chloride (2.26 g, 20 mmol) in ethyl acetate (50 mL) was cooled in an ice/water 
bath to 0 °C and a solution of N,N-dimethylethylenediamine (1.77 g, 20 mmol) in ethyl acetate 
(50 mL) was added drop wise. The reaction was stirred at 0 °C for 1 h under nitrogen. The 
precipitate formed was collected by filtration, washed with diethyl ether and then dried in 
vacuo to yield the product in its hydrochloride form 83 (2.90 g, 72 %) as a white powder. 1H 
NMR (400 MHz, DMSO-d6) δ 8.72-8.64 (bs, 1H, Hd), 4.13 (s, 2H, He), 3.50-3.44 (m, 2H, Hc), 3.15 
(t, 2H, J = 6.2, Hb), 2.76 (s, 6H, Ha). 13C NMR (101 MHz, CDCl3) δ 167.1, 55.8, 43.2, 42.7, 34.7. 











Compound 83 (1.01 g, 5.0 mmol) was dissolved in H2O (25 mL), NaN3 (1.96 g, 30 mmol) was 
added to the flask, and the reaction mixture stirred for 48 h at 65 °C. After cooling, the solution 
was adjusted to pH 10 using saturated aqueous NaHCO3 and extracted with EtOAc (3 × 20 mL). 
The remaining aqueous layer was adjusted to pH 14 with aqueous NaOH (1.0 M), and 
extracted with EtOAc (3 × 20 mL). All organic extracts were combined, dried over MgSO4 and 
the solvent was removed in vacuo to give azide 84 as a pale-yellow oil (0.71 g, 83%). 1H NMR 
(400 MHz, CDCl3) δ 6.91-6.65 (bs, 1H, Hd), 3.91 (s, 2H, He), 3.34-3.26 (m, 2H, Hc), 2.41-2.34 (m, 
2H, Hb), 2.19 (s, 6H, Ha). 13C NMR (101 MHz, CDCl3) δ 166.7, 57.6, 52.7, 45.2, 36.8. All other 
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General procedure of top click reaction to obtain 85-87.  
Under an atmosphere of nitrogen, alkyne 59 (51.4 mg, 0.10 mmol) and azide 80, 82 or 84 
(0.10 mmol) were dissolved in the mixture of NMP (1.0 mL) and EtOH (1.0 mL),  
tetrakis(acetonitrile)copper(I) hexafluorophosphate (7.5 mg, 0.020 mmol) was added. The 
mixture was stirred at room temperature for 24 hours.  After the reaction had finished, 
saturated EDTA in 17% NH3·H2O (10.0 mL) was poured into the mixture and the precipitate 
that formed was collected by filtration and washed with water (30 mL). The crude product 
was purified by flash chromatography on silica gel (eluent: CH2Cl2/MeOH 20:1) to give product 




















85 (67.1 mg, 89%, M.p. 103-107 °C). 1H NMR (400 MHz, CDCl3) δ 8.72-8.67 (m, 2H, Hi,m), 8.55 
(d, 2H, J = 4.1, Ht), 8.28 (d, 1H, J = 7.8, Hk), 8.17 (s, 1H, Hn), 7.85-7.78 (m, 2H, Hj,l), 7.72-7.65 
(m, 5H, Hc,g,r), 7.63-7.59 (m, 2H, Hq), 7.29 (d, 2H, J = 8.0, Hb), 7.21-7.15 (m, 2H, Hs), 5.50 (s, 2H, 
Hh), 5.18-5.09 (m, 1H, Hd), 4.45-4.38 (m, 2H, Hf), 4.08 (s, 2H, Ho), 3.96 (s, 4H, Hp), 3.51-3.45 (m, 
2H, He), 2.41 (s, 3H, Ha). 13C NMR (101 MHz, CDCl3) δ 163.4, 162.90, 159.1, 149.2, 145.0, 143.8, 
143.2, 138.5, 136.9, 136.8, 132.5, 131.1, 129.9, 129.0, 128.6, 127.1, 126.3, 125.8, 124.9, 123.5, 
123.3, 122.6, 122.4, 59.9, 50.3, 48.6, 42.7, 35.4, 21.6. IR: (υmax/cm-1) 3073, 1704, 1662, 1589, 
1432, 1329, 1233, 1157, 1041, 996, 786, 660. HR-NSI MS (m/z) [M+H]+ calcd for C39H36N11O4S 















86 (130 mg, 68%, M.p. 131-135 °C). 1H NMR (400 MHz, CDCl3) δ 8.58-8.50 (m, 2H, Hj,n), 8.47 
(d, 2H, J = 4.3, Hu), 8.22 (s, 1H, Ho), 8.17 (d, 1H, J = 8.5, Hl), 7.78-7.74 (m, 2H, Hk,m), 7.72-7.57 
(m, 20H, Ha-c,g,r,s), 7.15-7.07 (m, 2H, Ht), 5.34 (s, 2H, Hi), 4.34 (t, 2H, J = 6.3, Hg), 4.01 (s, 2H, Hp), 
3.90 (s, 4H, Hq), 3.30 (t, 2H, J = 14.3, Hd), 2.17-2.04 (m, 2H, Hf), 1.62-1.49 (m, 2H, He). 13C NMR 
(101 MHz, CDCl3) δ 163.3, 162.7, 159.0, 149.0, 145.1, 143.3, 138.4, 136.7, 135.1 (d, J = 2.8), 
133.4 (d, J = 10.0), 132.3, 131.0, 130.5 (d, J = 12.6), 129.9, 129.0, 128.4, 126.3, 125.8, 123.6, 
123.5, 123.4, 123.3, 122.6, 122.2, 117.8 (d, J = 85.8), 59.8, 53.5, 48.6, 35.5, 29.9 (d, J = 17.3), 
21.1 (d, J = 53.5), 19.2. 31P NMR (162 MHz, CDCl3) δ 23.91. 19F NMR (377 MHz, CDCl3) δ −151.75. 
IR: (υmax/cm-1) 3067, 1738, 1585, 1436, 1366, 1232, 1112, 1037, 785, 689. HR-NSI MS (m/z) 




















87 (92.4 mg, 90%, M.p. 113-117 °C). 1H NMR (400 MHz, CDCl3) δ 8.71-7.64 (m, 2H, Hh,l), 8.53 
(d, 2H, J = 4.7, Hs), 8.26 (d, 1H, J = 8.6, Hj), 8.17 (s, 1H, Hm), 7.86 (s, 1H, Hf), 7.83-7.76 (m, 2H, 
Hi,k), 7.70-7.63 (m, 2H, Hq), 7.59 (d, 2H, J = 7.8, Hp), 7.18-7.12 (m, 2H, Hr), 6.70-6.58 (bs, 1H, 
Hd), 5.52 (s, 2H, Hg), 5.00 (s, 2H, He), 4.06 (s, 2H, Hn), 3.94 (s, 4H, Ho), 3.32-3.23 (m, 2H, Hc), 
2.34 (t, 2H, J = 6.1, Hb), 2.13 (s, 6H, Ha). 13C NMR (101 MHz, CDCl3) δ 165.1, 163.3, 162.8, 159.0, 
149.2, 145.0, 143.6, 138.5, 136.6, 132.4, 131.0, 130.0, 129.1, 128.5, 126.3, 125.7, 125.1, 123.4, 
122.6, 122.2, 59.8, 57.4, 52.9, 48.5, 45.0, 37.2, 35.4. IR: (υmax/cm-1). HR-NSI MS (m/z) [M+H]+ 













4-Bromo-1,8-naphthalic anhydride (0.55 g, 2.0 mmol) and ethylamine (70% solution in water, 
0.14 mL, 2.4 mmol) was refluxed in dioxane (20 mL) for 7 hours. Then the reaction mixture 
was cooled to room temperature and a second aliquot of ethylamine (70% solution in water, 
0.10 mL, 1.6 mmol) was added and the mixture was refluxed for another 7 hours. The solution 
was cooled to room temperature and poured into H2O (100 mL) and the precipitate formed 
was collected by filtration, washed with H2O (100 mL) and dried in vacuo to give 88 (0.58 g, 
95%) as a yellow solid.  1H NMR (400 MHz, CDCl3) δ 8.66 (dd, 1H, J = 7.4, 0.8, Hc), 8.57 (d, 1H, 
J = 8.4, He), 8.42 (d, 1H, J = 7.9, Hg), 8.04 (d, 1H, J = 7.9, Hr), 7.84 (dd, 1H, J = 8.4, 7.4, Hd), 4.24 
(q, 2H, J = 7.1, Hb), 1.34 (t, 3H, J = 7.1, Ha). 13C NMR (101 MHz, CDCl3) δ 163.4, 133.2, 132.0, 
131.2, 131.1, 130.6, 130.2, 129.0, 128.1, 123.2, 122.4, 35.6, 13.3. All other spectroscopic data 













The bromide compound 88 (0.49 g, 1.6 mmol) was dissolved in N-methypyrrolidionone 
(5.0 mL) and sodium azide (0.13 g, 1.9 mmol) was added and the mixture was stirred at 40 °C 
for 24 h. The reaction mixture was diluted with H2O (30 mL) and extracted with EtOAc (3 × 
20 mL). The organic phase was washed with brine (30 mL) and dried over MgSO4, 
concentrated in vacuo to give 89 (0.39 g, 91%) as a dark brown solid. 1H NMR (400 MHz, CDCl3) 
δ 8.64 (dd, 1H, J = 7.4, 1.0, Hc), 8.58 (d, 1H, J = 8.0, Hg), 8.43 (dd, 1H, J = 8.4, 1.0, He), 7.74 (dd, 
1H, J = 8.4, 7.4, Hd), 7.46 (d, 1H, J = 8.0, Hf), 4.24 (q, 2H, J = 7.1, Hb), 1.33 (t, 3H, J = 7.1, Ha). 13C 
NMR (101 MHz, CDCl3) δ 163.8, 163.4, 143.4, 132.1, 131.6, 129.1, 128.7, 126.8, 124.4, 122.7, 














Under nitrogen atmosphere, the azide 89 (0.16 g, 0.62 mmol) and alkyne 54 (0.15 g, 
0.62 mmol), DIPEA (62 µL, 0.35 mmol) was dissolved in the mixture of NMP (2.0 mL) and EtOH 
(2.0 mL). The tetrakis(acetonitrile)copper(I) hexafluorophosphate (46 mg, 0.12 mmol) was 
added to the above solution and the mixture was stirred at room temperature for 24 hours. 
After the reaction complete judged by TLC, saturated EDTA in 17% NH3·H2O (20 mL) was 
poured to the mixture and the precipitate formed was collected by filtration, then washed 
with water (30 mL). This crude product was purified by flash chromatography (eluent: 
DCM/MeOH 20:1) to give 90 (0.29 g, 93%, M.p. 93-97 °C) as a brown solid. 1H NMR (400 MHz, 
CDCl3) δ 8.67-8.60 (m, 2H, Hc,g), 8.48 (dd, 2H, J = 4.9, 0.8, Hn), 8.19 (dd, 1H, J = 8.6, 1.0, He), 
8.11 (s, 1H, Hh), 7.78-7.71 (m, 2H, Hd,f), 7.65-7.58 (m, 2H, Hl), 7.54 (d, 2H, J = 7.8, Hk), 7.13-
7.07 (m, 2H, Hm), 4.20 (q, 2H, J = 7.1, Hb), 4.01 (s, 2H, Hi), 3.89 (s, 4H, Hj), 1.29 (t, 3H, J = 7.1, 
Ha). 13C NMR (101 MHz, CDCl3) δ 163.4, 162.9, 158.9, 149.1, 144.9, 138.2, 136.6, 132.0, 130.6, 
129.5, 128.9, 128.5, 126.3, 125.7, 123.7, 123.4, 122.9, 122.2, 59.8, 48.4, 35.7, 13.3. IR: 
(υmax/cm-1) 3196, 1703, 1611, 1551, 1473, 1427, 1365, 1230, 1119, 1037, 950, 726. HR-NSI 
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Appendix 1: Ceramide synthesis 
As ceramide is used as a Golgi apparatus targeting unit in commercial dyes for this organelle, 
its synthesis was attempted following reported procedures.154,155 As shown in Scheme A.1, 
the synthesis to azide functioned ceramide 107 was planned, which it was envisioned could 
then be incorporated into alkyne 59 through a ‘click’ reaction to generate a Golgi targeted 
Zn2+ probe. However, this synthesis failed at the last corss-metathesis step, despite multiple 
attempts to get the product 107 and as a result of the long multi-steps synthesis and low 
yields in some steps, an alternative Golgi targeting strategy was sought. 
 
Scheme A.1 The synthetic route towards ceramide azide derivative, 107. 
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Appendix 2: The unexpected by-product formed in the synthesis of 69 
During the synthesis of 69 (see section 7.3) an unexpected by-product was identified as allene 
108. This presumably forms as a result of quaternisation of the nitrogen centre, increasing 
the acidity of the -carbonyl proton, which after its removal, then allows a sigmatropic 
rearrangement to occur. 
N,N-bis(2-ethoxy-2-oxoethyl)-N-(prop-2-yn-1-yl)propa-1,2-dien-1-aminium bromide (108) 
  
108 (1.32 g, 35%) as a red oil. 1H NMR (400 MHz, CDCl3) δ 5.22 (dd, 1H, J = 14.2, 6.7, Hd), 4.78 
(dd, 2H, J = 6.7, 2.3, Hc), 4.15 - 4.06 (m, 5H, He,g), 3.60 (d, 2H, J = 2.4, Hb), 3.55-3.52 (m, 2H, Hf), 
2.20 (t, 1H, J = 2.4, Ha), 1.23-1.16 (m, 6H, Hh). 13C NMR (101 MHz, CDCl3) δ 209.4, 170.6, 170.5, 
87.2, 78.7, 77.0, 73.5, 64.3, 60.8, 60.5, 50.9, 41.3, 14.1 (×2). HR-NSI MS (m/z) [M+H]+ calcd for 
C14H20NO4 266.1387, found 266.1383. 
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